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Cross-sectional evidence associates breakfast omission with negative health 
outcomes. The present work aimed to examine if these cross-sectional associations 
have a causal component, by conducting randomised control trials in healthy humans. 
It was established using lean individuals that there are divergent hormonal responses 
to morning feeding and fasting, although increased energy intake at lunch following 
fasting incompletely compensated for breakfast intake. Hormonal and subjective 
appetite responses in the afternoon did not consistently provide evidence for increased 
hunger following fasting. In the same participants assigned to a 6-week free-living 
intervention of either 700 kcal pre 11:00 or fasting until 12:00 daily, it was found that 
energy intake was greater in those assigned breakfast consumption, but that physical 
activity was also greater than those fasting. Cardiovascular risk factors and measures 
of metabolic control were largely unaffected by either intervention. There was no 
adaptation of acute metabolic/hormonal responses to feeding following either 
intervention. In obese individuals, similar patterns of results were obtained for the 
hormonal and metabolic responses to acute feeding and fasting, but with no 
compensation for breakfast intake at lunch. Results from the free-living intervention 
demonstrated no difference in energy intake between groups or physical activity over 
the entire day, but greater energy expenditure during the morning in those consuming 
breakfast. Markers of cardiovascular health and metabolic control were generally not 
differently affected by either intervention. Neither intervention caused adaptation of 
the acute hormonal and metabolic responses to feeding. In summary, acute morning 
fasting does not cause complete compensation for breakfast intake at lunch, or result 
in greater hunger throughout the afternoon. Daily morning fasting does not affect acute 
responses to feeding or cause increased energy intake or weight gain relative to self-
selected breakfast consumption, but seems to limit physical activity in lean, and to a 
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Chapter 1: Review of Literature 
 
1.1 General Introduction 
 
Obesity is a growing public health problem; it has been predicted that there 
will be 11 million more obese adults in the UK by 2030, with associated yearly 
medical costs of ~£2 billion pounds (Wang et al., 2011). While there is much debate 
as to whether the predominant contributor to this development is reduced physical 
activity (Church et al., 2011; Ladabaum et al., 2014) or greater energy intake 
(Swinburn et al., 2009; Westerterp and Speakman, 2008), concurrent with increased 
obesity it has been reported that breakfast consumption has been declining over time 
in US adults (Kant and Graubard, 2006). Some authors suggest that this may be a 
contributory factor in the increased prevalence of obesity and associated chronic 
diseases (Timlin and Pereira, 2007). 
There have long been suggestions that increased food frequency may be 
associated with beneficial metabolic outcomes. As early as 1963, Gwinup and 
colleagues presented experimental work in humans advocating a “nibbling” pattern of 
eating for improved glucose tolerance and reduced serum lipids (Gwinup et al., 1963a; 
Gwinup et al., 1963b). Subsequently, Fabry and colleagues highlighted cross sectional 
associations between infrequent meal patterns and impaired glucose tolerance, 
hypercholesterolaemia and overweight (Fabry et al., 1964). While an infrequent meal 
pattern does not necessarily equate to skipping breakfast, the concept of breakfast 
consumption being important for health has long been entrenched in the public 
consciousness (Brown et al., 2013; Casazza et al., 2013). A central tenet of this belief 
has been based around a proliferation of associational evidence linking breakfast 
skipping and risk of obesity. Despite the extremely robust nature of this relationship 
(Figure 1.1), the evidence for causal mechanisms linking breakfast consumption with 
improved health is limited.   
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Figure 1.1: Cumulative analysis of the relationship between breakfast omission and 
obesity. The dashed line represents the p value over time, and diamonds represent the 
odds ratio for obesity bounded by a 95% confidence interval. Taken from Brown et al 
(2013). This figure illustrates that over time when studies are examined cumulatively, 
the odds ratio for breakfast skipping and obesity has changed very little. However, the 
statistical significance of this relationship has now reached p = 10-42, indicating a very 
strong associational relationship.   
 
Despite the relative lack of evidence from randomised controlled trials, 
breakfast consumption is strongly promoted by public health organisations. For 
example, amongst the 8 basic tips for healthy eating provided on the NHS choices 
website, one point is “Don’t skip breakfast”. The potential implications for public 
health of a better understanding of the effects of breakfast consumption/omission 
cannot be underestimated. Unlike a number of other behaviours that are relevant for 
health, the decision to either consume food in the morning or extend the overnight fast 
is one that is taken by every individual on a daily basis. As such, the potential impact 
of more refined public health messages better supported by causal evidence 
concerning the effects of morning fasting/breakfast consumption are vast. If public 
health messages are to be as definitive as “Don’t skip breakfast” it is crucial they are 
supported by a level of evidence to warrant such absolutism. 
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1.2 Components of Energy Balance 
 
 The first law of thermodynamics states that energy cannot be destroyed but 
can only be transformed from one form to another. In the context of human energy 
balance, this law is generally expressed as:  
ES = EI – EE 
Where:  
ES = Energy Storage, EI = Energy Intake and EE = Energy Expenditure 
 The constituent parts contributing to energy balance will be considered below, 
but the net results of fluctuations of energy balance are reflected in energy storage. 
Energy is stored in the body as carbohydrate, fat and protein stores. Fat and 
carbohydrate are the primary dynamic energy storage depots within the body, but the 
relative contributions of both macronutrients to energy storage are vastly different. 
Carbohydrate storage is mostly limited to glycogen stored in muscles and the liver and 
is in the range of several hundred grams (Wasserman, 2009). In contrast, the storage 
capacity of energy in the form of stored fat is much greater and essentially infinite, 
with the potential for ≥1 million kcal of stored energy as triglycerides in adipocytes in 
a severely obese individual (Hirsch and Knittle, 1970). Therefore, as carbohydrate 
storage is limited, increased energy storage over an extended period of time takes the 
form of increased adiposity (Schrauwen, 2007).       
Energy intake is solely determined by the metabolically available energy from 
food intake. Not all of the energy present in food is metabolically available, with the 
net absorption of the major macronutrients (carbohydrate, protein and fat) incomplete 
due to faecal losses accounting for between 2-10% of gross intake (Hall et al., 2012). 
The magnitude of these losses are influenced by factors such as macronutrient 
composition (Southgate and Durnin, 1970), fibre and resistant starch intake (Behall 
and Howe, 1995) and gut microbiota (Jumpertz et al., 2011). Metabolically available 
energy varies between macronutrients, with the most commonly used energy densities 
4 kcal/g for carbohydrate and protein, 9 kcal/g for fat and 7 kcal/g for alcohol (Hall et 
al., 2012). The regulation of energy intake will subsequently be addressed. 
 Unlike energy intake, which is determined solely by dietary intake of 
macronutrients, energy expenditure is comprised of three components; namely resting 
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metabolic rate (otherwise referred to as resting energy expenditure), diet induced 
thermogenesis (otherwise referred to as the thermic effect of feeding) and activity 
energy expenditure. 
 Resting metabolic rate (RMR) is in a large proportion of individuals the 
greatest single contributor to energy expenditure (Carpenter et al., 1995). Resting 
metabolic rate is not consciously modifiable but is related to body mass (Ravussin et 
al., 1982; James et al., 1978) and in particular fat-free mass (Johnstone et al., 2005; 
Fukagawa et al., 1990; Cunningham, 1991; Weinsier et al., 1992), although other 
factors such as the high metabolic rate of the brain and other organs (Javed et al., 2010) 
contribute to some of the variability observed in resting metabolic rate. The factors 
mentioned above are generally relatively stable over short periods of time, but energy 
imbalance has also been suggested to cause alterations in resting metabolic rate 
beyond those accountable by change in body mass, referred to as adaptive 
thermogenesis (Dulloo et al., 2012). Decreases in mass adjusted RMR have been 
demonstrated in both starvation and hypocaloric dieting (Dulloo and Jacquet, 1998; 
Doucet et al., 2001; Martin et al., 2007). Conversely, shorter-term overfeeding (2-8 
weeks) has been found to cause increased RMR beyond that predicted by weight gain 
(Ravussin et al., 1985c; Harris et al., 2006), although some authors suggest this may 
be partly attributable to persistently increased diet induced thermogenesis from the 
evening before regardless of overnight fasting (Joosen et al., 2005).  
 Diet induced thermogenesis (DIT) is the smallest component of energy 
expenditure in normal circumstances and reflects the obligatory energy expended for 
the processing and digestion of food. This is due to energy requirements of ATP 
hydrolysis during intestinal absorption, initial steps in metabolism and nutrient storage 
(Tappy, 1996). Diet induced thermogenesis is normally calculated as the energy 
expenditure above basal fasting level divided by the energy content of the food 
ingested, and is therefore expressed as a percentage (Westerterp, 2004). Different 
macronutrients induce varying levels of thermogenesis (Tappy, 1996; Westerterp et 
al., 1999), with proteins responsible for the greatest increase in expenditure (~20-
30%), followed by alcohol (~10-30%), carbohydrates (~5-10%) and finally fat, which 
induces the least thermogenesis (~0-3%). In individuals consuming mixed diets, the 
generally suggested proportion of energy intake that is expended as DIT is 10% 
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(Westerterp, 2004). Therefore, if an individual is in energy balance, DIT would only 
contribute 10% towards energy expenditure, although there is substantial variation 
between and within individuals. It has been observed that DIT is reduced with obesity 
(Segal et al., 1992; Laville et al., 1993; D'Alessio et al., 1988).  
 Activity energy expenditure (AEE) is split into two main components, non-
exercise activity thermogenesis (Levine et al., 1999) and exercise energy expenditure. 
Non-exercise activity thermogenesis (NEAT) was originally defined as “the activities 
of daily living, fidgeting, spontaneous muscle contraction and maintaining posture 
when not recumbent” (Levine et al., 1999). These two components combined can be 
referred to as physical activity (Caspersen et al., 1985). Physical activity energy 
expenditure is the most malleable of the components of energy expenditure 
(Westerterp, 2003), and the factor that is most under volitional control for the majority 
of individuals. Physical activity energy expenditure can account for between 5 % of 
total energy expenditure in the most sedentary individuals, to 70 % of total energy 
expenditure in endurance athletes undertaking heavy, sustained exercise (Westerterp 
et al., 1986). In an individual with an average level of physical activity this percentage 
is approximately 33% (Westerterp, 2008). Components of physical activity energy 
expenditure will be discussed in further detail subsequently.     
 Energy balance is dynamically regulated, and energy balance can only be 
considered when an element of time is included. Energy balance changes substantially 
within days (primarily due to the intake of meals) and between days due to varying 
dietary intake and physical activity (McKiernan et al., 2008). Despite this short-term 
variability in energy balance, it is energy imbalance over longer periods of time that 
leads to the development of excess adiposity. However, it is also possible that obese 
individuals can maintain long term energy balance but that this occurs at a greater 
level of body fat (Hall et al., 2012). If energy balance is considered over a period of a 
year, in individuals that change by less than one kilogram in mass, it has been 
suggested that energy intake has to be matched to expenditure within ~ 22 kcal/day 
(Hall et al., 2011). Therefore, energy balance to maintain long term weight 
maintenance has to be very precise. 
 The components of energy balance have been considered in isolation above 
but various components of energy balance can (and do) interact with each other. These 
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interactions between specific components of energy balance will be considered in 
greater detail when reviewing literature specific to the effect of interventions upon 
energy balance.     
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1.3 Measuring Components of Energy Balance 
 
As discussed above there are several different components of energy balance. 
There are numerous different methodologies for assessing the volitional aspects of 
energy balance (namely physical activity energy expenditure and energy intake) which 
will be discussed briefly below.  
 
1.3.1 Laboratory Energy Intake Assessment 
 
 Within the laboratory setting there are two main methodologies for assessing 
ad libitum energy intake; namely the fixed course approach and the buffet design 
(Blundell et al., 2010). While the buffet meal allows some assessment of food choices, 
it has been argued that unless food choice is the particular research question of interest, 
that this approach should be avoided. The rationale behind this assertion is that the 
provision of a wide variety of food items in a buffet scenario is at odds with the usual 
eating behaviour of the majority of the population (Blundell et al., 2010). It is also 
likely that the presence of a variety of food cues will delay satiation and promote 
increased food intake (Hetherington et al., 2006).  
 The fixed course approach involves provision of one foodstuff, which is 
normally comprised of a variety of ingredients combined (e.g pasta with tomato sauce) 
and provided ad libitum. This approach is beneficial when the research question is 
directed towards assessment of energy intake as opposed to nutrient intake (Blundell 
et al., 2010). It is important to consider the nature of the food provided in the single 
course approach, as several factors will combine to determine the amount consumed. 
It is important that the food provided is considered “appropriate” for consumption; 
this assessment of suitability is mainly based upon cultural ideals influenced by a wide 
range of factors (e.g geography, climate, food availability) (Furst et al., 1996). In 
addition to the learned acceptability of food for consumption, total energy intake is 
also influenced by prior learning effects relating to the expected satiating quality of 
foods (Brunstrom, 2007). This assessment of the expected satiety from a meal usually 
occurs in concert with visual cues relating to consumption volumes (e.g knowing a 
bowl of soup is a “normal” amount), such that covert manipulation of visual cues 
(secretly refilling the soup bowl as it is being eaten) results in greater consumption 
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volumes with no difference in perceived consumption (Wansink et al., 2005). 
Therefore, if the aim of the ad libitum meal is to attempt to reduce the influence of 
these prior portion expectations upon intake, then it is advisable to attempt to minimise 
visual feedback and an ability to complete a “portion”, as in the majority of cases 
humans complete what is on their plate (de Graaf et al., 2005). 
 While it has been stated previously that the provision of a wide variety of foods 
in a buffet setting may delay satiation, the converse is also the case. This phenomenon 
is referred to as sensory specific satiety (Rolls et al., 1981a), and relates to the 
reduction in acceptability of a food as it is consumed and explains monotony and 
reduced palatability of homogenous meals (Rolls, 1986). This decrease in palatability 
of the specific food consumed does not result in similar reductions to other types of 
foods not consumed (Rolls et al., 1981b; Rolls et al., 1984). Indeed, the most common 
manifestation of this phenomenon in food consumption is the maintained pleasantness 
of sweet foods after eating savoury foods to satiety (Guinard and Brun, 1998; de Graaf 
et al., 1993; Griffioen-Roose et al., 2009). Therefore, as palatability affects satiation 
(De Graaf et al., 1999), it should be taken into account that the lack of variety 
(particularly the lack of contrast between sweet and savoury foods) may result in 
termination of feeding due to boredom rather than “true” satiety. 
Therefore, as outlined above, the choice of methodology for assessing satiation 
should take into account the specific aims of the ad libitum meal and be carefully 
considered to maximise the appropriateness of the meal provided. In the work 
presented, a single course meal will be utilised as the primary outcome in the 
laboratory work is assessment of energy intake rather than food choices per se, as these 
aspects of food selection will be assessed during the free-living elements of the 
research.    
  
1.3.2 Free-Living Energy Intake Assessment 
 
There are several methods of attempting to establish energy intake, which 
require varying levels of experimenter and participant involvement. These include 
prospective methods where participants record synchronous with intake (i.e food 
diaries, both weighed and estimated) and retrospective methods that involve recall of 
foods consumed (usually with questioning via an experimenter). Diet records have 
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been shown to be more accurate in assessing macronutrient composition of diets of 
known composition than food frequency questionnaires (Schaefer et al., 2000). 
Weighed records have been shown to result in less underreporting when compared 
with food history interviews (Martin et al., 2002). Weighing of foodstuffs also negates 
the potential error in estimation of weight as Gittelsohn and colleagues (1994) have 
reported lower accuracy of weight estimates in foods of high volume and low weight. 
All methods of dietary assessment are prone to several forms of bias (Lissner et al., 
1998), such as the participant changing behaviours due to greater awareness of food 
consumption (Macdiarmid and Blundell, 1997; Barrett-Connor, 1991), the participant 
deliberately omitting foods consumed due to a desire to provide socially desirable 
responses (Hebert et al., 1995) and the participant forgetting foods consumed (Trabulsi 
and Schoeller, 2001). 
  The result of all of these issues is that when compared with known energy 
intake (either via control of food provision) or when compared to energy expenditure 
measured via doubly labelled water reported energy intake is usually below that 
expected. The magnitude of this underestimation is highly variable (Hill and Davies, 
2001), with factors such as gender (with females generally underreporting to a greater 
extent) (de Vries et al., 1994; Johnson et al., 1994) and obesity status (with obese 
individuals usually underreporting to a greater extent than lean) (Prentice et al., 1986; 
Goris et al., 2000; Lichtman et al., 1992) affecting the degree of underreporting. 
Despite this variability, several studies indicate an approximate underestimation of 
~20% from weighted food records (De Castro, 1994b; Livingstone et al., 1990). As a 
result, several authors have suggested that self-reported energy intake should not be 
utilised for forming scientific conclusions (Dhurandhar et al., 2014b). However, it is 
important to recognise that when comparing experimental groups the inherent error in 
measurement of self-reported energy intake should be similar (De Castro, 1994b). 
Therefore, whilst the reported energy intake of individuals should not be used to 
estimate absolute measures of energy balance (i.e energy intake versus expenditure), 
estimates of energy intake can be compared (i.e comparing the self-reported intakes 
of the two experimental groups). 
 Food diaries are normally of a duration between 3 (typically 2 weekdays and 
1 weekend day) and 7 days. The main reason for this is to attempt to capture some of 
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the difference between weekday and weekend days, as it has been observed that intake 
is greater on weekend days (de Castro, 1991). It has previously been suggested that 
the degree of misreporting increases as the recording duration increases (Young and 
Trulson, 1960), however, more recent work has suggested that the reduction in 
reported energy intake is <15 kcal per day of reporting (Whybrow et al., 2008). As 
there is between day variability in energy intake (Tarasuk and Beaton, 1991), this 
variability can be reduced by taking a mean from a longer period of recording 
(Borrelli, 1990) with a week of recording generally reflecting one cycle of human 
behaviour (de Castro, 1991), it is therefore recommended that longer duration 
recording periods are used (Whybrow et al., 2008). It has been suggested that one way 
to attempt to minimise biased reporting with food diaries and to minimise any fatigue 
effects is to utilise a contingent reinforcer (De Castro, 1994b). This involves informing 
the participants that feedback will be provided on their diet data provided, to promote 
faithful and thorough reporting.             
 It is clear that there are some inherent limitations of the self-reporting of food 
intake. However, with these issues considered (and in the absence of viable 
alternatives) a 7 day weighed food diary to compare reported energy intake between 
groups is an appropriate methodology. 
  
1.3.3 Free-Living Energy Expenditure  
 
 Measurement of energy balance would not be complete without assessment of 
physical activity energy expenditure. In free-living situations there are several 
different approaches for quantifying energy expenditure, including self-report 
measures and various different monitoring devices that measure various parameters to 
attempt to estimate energy expenditure. These include devices that measure heart rate, 
motion and other instruments that combine multiple measurements to estimate energy 
expenditure. The measurement methodology that is considered the “gold standard” for 
estimating total energy expenditure is the use of doubly labelled water (DLW). While 
this methodology has been suggested to have a bias between 1 and 7% depending on 
the population and model used (Bluck, 2008) there are some drawbacks of this 
methodology. Firstly, from a practical perspective the cost of this methodology is high 
relative to other approaches and requires access to specialist equipment, but of greater 
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importance to the work in this thesis, the DLW method does not provide any 
information about the temporal or intensity distribution of activity. Not only is the 
intensity of activity relevant as certain aspects of physical activity are associated with 
disease risk (e.g sitting time (Katzmarzyk et al., 2009; Dunstan et al., 2005)) but as the 
nature of our intervention involves restriction of energy intake during a specific time 
period, it is particularly instructive to establish if physical activity is affected at certain 
times. Therefore, this eliminates methods where there is no temporal information 
provided with physical activity data, leaving direct measurement devices as viable 
options (i.e accelerometers, HR monitors and combined devices).  
 
Of these devices there are specific limitations with both accelerometry (where 
there may be occasions when energy expenditure is high but acceleration is low) and 
heart rate (which at times may be elevated by factors other than those resulting in 
substantial energy expenditure such as stress and is individually highly variable). As 
a result of this it has been suggested that the combination of these two sources of data 
improves energy expenditure estimates than using either source individually (Rennie 
et al., 2000) and that a branched equation model combining these data sources 
improves these estimates further (Brage et al., 2004; Strath et al., 2005). The Actiheart 
device utilises this methodology and has been shown to be valid in estimating energy 
expenditure of low to moderate intensity activities with no substantial fixed or 
proportional bias (6%) relative to indirect calorimetry while used in the group 
calibration setting utilising basic anthropometric measurements, gender and the age of 
individuals (Thompson et al., 2006). Whilst some studies have identified that 
individual calibration (e.g exercise tests with indirect calorimetry) of these devices 
results in greater explanation of the variance between individuals (Brage et al., 2007) 
and reduces the mean bias and limits of agreement of estimates of EE (Villars et al., 
2012) this was not undertaken in this work due to the additional associated participant 
burden (discussed further in Chapter 2).  
 
 The previous section has identified the various methodologies available to 
measure energy balance, with the associated limitations and strengths of the selected 
approaches. The next section will cover the regulation of appetite which contributes 
to energy intake.  
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1.4 Appetite Regulation  
Appetite regulation is multifactorial, with energy intake influenced by both 
internal and external stimuli (see Figure 1.2). As well as physiological signals that can 
both signal hunger and satiety in the short and long term (generally referred to as 
homeostatic signals) (Badman and Flier, 2005) there are also other cognitive and 
hedonic processes that influence the control of food intake (non-homeostatic signals) 
(Berthoud, 2011). Focus will be on the homeostatic regulation of appetite, through 
tonic and episodic appetite signals.    
 
 
Figure 1.2: Interactions between metabolic-homeostatic and cognitive-hedonic 
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As well as the regulation of the consumption of food, several different factors 
contribute to the regulation of satiation (the process that brings an end to eating) and 
satiety (processes that inhibit further eating in the postprandial period) (Blundell et al., 
2010). As can be seen in Figure 1.3, these include both cognitive as well as 
physiological responses to feeding. The focus of the laboratory work in this thesis will 
be in examining elements of the post-ingestive and post-absorptive responses to 
feeding (in particular appetite regulating hormones), which are described in further 
detail in this literature review.   
 
 
Figure 1.3: The “satiety cascade” first constructed by Blundell and colleagues and 
subsequently modified by Mela (2006).   
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1.5 Factors That Can Influence Appetite 
 
As well as the various factors that combine to regulate eating behaviour on an 
individual basis as illustrated in Figures 1.2 and 1.3, research has identified differences 
in appetite regulation between certain groups of individuals that are outlined below. 
   
1.5.1 Obesity 
 
Obese individuals display delayed satiation to feeding, as energy intake prior 
to reaching maximum satiation is greater than lean counterparts (Delgado-Aros et al., 
2004). This may be a product of a number of factors, including the greater gastric 
capacity of obese individuals (Geliebter, 1988) which is positively correlated with test 
meal intake (Geliebter et al., 1992), potentially due to reduced mechanical stretch of 
the stomach resulting in slower gastric emptying, inhibited CCK release and therefore 
delayed satiation (Geliebter et al., 1992). Additionally, several hormones implicated 
in regulation of appetite have been found in differing concentrations in obese 
individuals. Batterham et al (2003) have reported that PYY (a hormone implicated in 
satiety discussed in further detail subsequently) is lower postprandially in obese 
individuals, which le Roux and colleagues (2006) have suggested is a contributor to 
reduced satiety induced by meals in obese individuals. Ghrelin (an appetite stimulating 
hormone) concentrations are lower in obese individuals (Tschop et al., 2001b; Shiiya 
et al., 2002) but the feeding induced suppression of ghrelin has been reported to be 
lessened (le Roux et al., 2005) or abolished completely (English et al., 2002). 
Glucagon-like peptide-1 (a hormone implicated in glucose tolerance and satiation) 
release is also suggested to be reduced in obese individuals by most (Ranganath et al., 
1996; Verdich et al., 2001b; Adam and Westerterp-Plantenga, 2005) but not all authors 
(Feinle et al., 2002).  
As well as these differences in hormone responses to feeding in obese 
individuals, it has also been suggested that obese individuals display elevated neural 
responses to palatable and energy dense foods (Burger and Berner, 2014). Several 
authors have also suggested that obese individuals are more susceptible to 
environmental cues to eat than hormonal regulation (Schachter, 1968; Mela, 2001). 
Therefore, the combination of all the factors described suggests that both the initiation 
of, and responses to feeding are potentially different in obese individuals.  




 It has been observed that elderly individuals do not compensate as effectively 
for overfeeding or underfeeding resulting in weight change as young counterparts 
(Roberts et al., 1994). Additionally, older adults do not reduce energy intake at an ad 
libitum feeding occasion following a snack despite greater fullness (Rolls et al., 1995). 
These studies have been used to propose potentially impaired energy compensation in 
older adults. Beyond this suggested general imprecision in compensating for 
deviations from energy balance, older adults (above 65 y) display reductions in body 
weight, even in those that were previously of healthy weight (Steen, 1988), with one 
of the potential explanations for this phenomenon termed the “anorexia of aging” 
(Morley, 1997; Morley and Silver, 1988).  
Anorexia of aging refers to the decrease in energy intake and appetite 
associated with aging (Hays and Roberts, 2006), with several contributors including 
social (e.g isolation), psychological (e.g depression) and physiological factors thought 
to be involved (Atalayer and Astbury, 2013; Morley, 1997; Hays and Roberts, 2006). 
Of particular relevance to the work in this thesis, physiological regulation of appetite 
has been shown to be different in older individuals. Older adults report greater 
satiation after consumption of preloads (Sturm et al., 2004), consume less at test meals 
than younger individuals (MacIntosh et al., 2001; Rolls et al., 1995), with lesser 
hunger and desire to eat after a fixed meal in older individuals, despite no difference 
in fullness (Clarkston et al., 1997). There have been numerous hormonal differences 
that have been suggested may contribute to these findings (Moss et al., 2012), with 
greater CCK concentrations in older than young individuals (MacIntosh et al., 1999; 
MacIntosh et al., 2001), which may contribute to the observed slower gastric emptying 
time in older individuals (Horowitz et al., 1984; MacIntosh et al., 1999; Clarkston et 
al., 1997). It has also been postulated that the balance between hormones that stimulate 
(i.e ghrelin) and suppress hunger (i.e leptin) (Di Francesco et al., 2006) is biased 
towards those that suppress energy intake in elderly individuals. This hypothesis is 
supported by reports of greater leptin (Di Francesco et al., 2006) and lower ghrelin 
concentrations (Rigamonti et al., 2002; Di Francesco et al., 2008) in elderly 
individuals.  
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 As there are numerous differences in the physiological responses to feeding as 
well as other salient factors that may affect free-living appetite differently in older 
individuals, in the present work individuals above 60 years of age will not be included 
in the experimental studies conducted. This is also appropriate as in the majority of 
the adult age range, focus is upon prevention of positive energy balance leading to 
obesity. However, in elderly individuals due to the potential problems arising from 
negative energy balance related to the anorexia of aging, positive energy balance is a 




 Gender differences in food intake and selection appear from adolescence, with 
men consuming more than women (Rolls et al., 1991). Females at equivalent normal 
BMI have greater levels of adiposity than males (Lovejoy et al., 2009; Gallagher et 
al., 1996) and in the US are reported to be approximately twofold more susceptible to 
severe and morbid obesity than males (Flegal et al., 2010). Accordingly, there has been 
some interest in differences in appetite regulation between men and women.  
 Physiological differences between males and females include slower gastric 
emptying in females (Hutson et al., 1989; Knight et al., 1997), greater concentrations 
of leptin relative to fat mass (Asarian and Geary, 2013) and lack of acute (Benedict et 
al., 2008) and chronic responsiveness to the anorexigenic effects of insulin 
administration (Hallschmid et al., 2004). Differences between genders of episodic 
regulators of appetite are less clear, with Carroll and colleagues (2007) not identifying 
any differences in several hormones implicated in appetite within the first hour after a 
liquid meal apart from greater GLP-1 concentrations in men. Other investigators have 
suggested that females display greater fasting (Barkan et al., 2003; Makovey et al., 
2007) and fed (Greenman et al., 2004; Hagobian et al., 2009) concentrations of ghrelin, 
although some authors have failed to detect these differences (Tschop et al., 2001a; 
Shiiya et al., 2002).  Neural responses to food cues (Uher et al., 2006; Cornier et al., 
2010; Geliebter et al., 2013; Frank et al., 2010) and ingestion (Del Parigi et al., 2002) 
have predominantly demonstrated greater neural activation in females, particularly in 
areas related to cognitive-affective processing regions (Geliebter et al., 2013).  
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 Despite these differences in physiology between the genders, the relative 
effects of gender upon appetite regulation are not well elucidated. Davy and colleagues 
(2007) report that in matched males and females, acute energy compensation at an ad 
libitum lunch meal for a preload in a laboratory setting was lower by 12.5% in females, 
despite no differences in appetite ratings. In contrast, work in free-living adults by 
Cornier et al (2010) suggest that when controlled eucaloric feeding occurs that women 
experience greater satiety than men. Additionally, the authors suggest that once the 
same participants were permitted to eat ad libitum that males overconsumed food, 
whereas females ate to energy needs. Therefore, there is no consistent evidence for 
specific appetitive responses in females. The laboratory and free-living regulation of 
appetite may be influenced by different factors, which is of particular relevance due 
to the potential role of social pressures and dietary restraint in females (Rolls et al., 
1991). The effects of these moderators of intake behaviours will be discussed in the 
next section.         
 
1.5.4 Dietary Restraint 
 
 Dietary restraint was first proposed by Herman and Mack (1975) and has been 
defined as restricting food intake in order to control body weight. It has been suggested 
that dietary restraint is greater in females and that restrained eaters consume less 
during free-living (de Castro, 1995), with this greater restraint potentially a result of 
greater body shame and self-objectification in women (Fredrickson et al., 1998). The 
body of correlational evidence linking dietary restraint and BMI has been suggested 
to be overwhelmingly positive in normal weight individuals and negative in obese 
individuals (Johnson et al., 2012). It was initially proposed there may be a role of high 
dietary restraint and development of eating disorders (Polivy and Herman, 1985) and 
data has related level of restraint with frequency/severity of binge eating (Marcus et 
al., 1985; Spencer and Fremouw, 1979). It has been suggested that atypical behaviours 
may be displayed in restrained eaters with some suggestions of counterregulatory 
eating (i.e greater energy intake after a preload) in laboratory situations (Herman and 
Mack, 1975), but others have suggested restraint alone may not predict overeating 
(Bellisle et al., 2009; Yeomans and Coughlan, 2009). Counterregulatory eating may 
only be exhibited if a highly palatable “diet breaking” (e.g ice cream) food is used for 
the test meal (Martins et al., 2008). Additionally, it is contended that dietary restraint 
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is not homogenous (Westenhoefer, 1991; Westenhoefer et al., 1999), with rigid and 
flexible forms of restraint, with the rigid type more likely to elicit counterregulation 
(Westenhoefer et al., 1994). It therefore remains difficult to conclusively establish the 
effect of high levels of dietary restraint upon laboratory or free-living food intake 
behaviours, due to a lack of consistency of data and also difficulties in assessing 
dietary restraint itself (Martins et al., 2008).        
 
 The previous section has introduced a variety of different factors that may 
affect appetite, with some consideration of their effects. The next section will 
introduce some of the specific hormonal mechanism affecting appetite that will be 
measured in this thesis. 
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1.6 Hormonal Control of Appetite Regulation 
 The homeostatic regulation of appetite is generally split into two main signal 
types, long-term (tonic) signals of energy storage and the short-term (episodic) 
regulators of appetite (Stensel, 2010; Hagobian and Braun, 2010). There are two key 
tonic signals of energy status, leptin and insulin. However, episodic regulators of 
appetite are more numerous, with several different hormones implicated in the 
concerted responses to both initiate feeding and respond to consumption to bring about 
satiation. As illustrated in Figure 1.2, the regulation of eating occasions is influenced 
by a range of factors beyond simple homeostatic regulation and it has been suggested 
that hormonal regulation is more relevant for determining the amount consumed at 
each feeding occasion (Strubbe and Woods, 2004; Woods, 2009). In this regard, it is 
suggested that the tonic appetite hormones provide a “background tone” that modifies 
the efficacy of the episodic hormones that bring about satiation dependent on the 
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1.7  Tonic Hormones 
 
1.7.1 Leptin 
 Leptin is primarily secreted by adipocytes in the white adipose tissue and was 
originally identified and characterised by Zheng et al (1994). Concentrations of leptin 
are proportionate to fat mass (Schwartz et al., 1996a; Maffei et al., 1995). Leptin 
responds to short term energy status, although with fasting/energy restriction the 
reductions in leptin are far greater than the loss in fat mass (Weigle et al., 1997), a 
response that strongly protects against loss of fat mass. 
  Leptin acts on two main neuronal populations (Elias et al., 1999) in the arcuate 
nucleus within the hypothalamus (Schwartz et al., 1996b), suppressing expression of 
the orexigenic peptides Neuropeptide Y (NPY), and agouti related peptide (AgRP). 
Additionally, leptin stimulates action of proopiomelanocortin (POMC) neurons 
(Cowley et al., 2001), where this protein precursor is cleaved to α-melanocyte-
stimulating hormone (α-MSH), an anorexigenic peptide. Therefore, during times of 
nutrient deficiency and low leptin levels, the reduced inhibitory influence of leptin on 
NPY/AgRP neurons and limited activation of POMC containing neurons cause an 
overall increase in orexigenic signalling (Moran et al., 2006).  
Leptin displays a strong diurnal rhythm, peaking in the late evening and with 
a nadir in the morning (Schoeller et al., 1997) and is responsive to feeding, with 
increases in leptin concentrations due to successive meals (Saad et al., 1998b), an 
effect suggested to be related to the effect of insulin on modulating leptin (Saad et al., 
1998a). Administration of leptin to a deficient patient resulted in decreased appetite 
and body mass, highlighting a key role in appetite regulation (Farooqi et al., 1999). 
The reported mode of action of leptin in reducing food intake is via a reduction in meal 
size (Eckel et al., 1998; Kahler et al., 1998; Flynn et al., 1998), through its potentiating 
of the feeding inhibitory effects of both cholesystokinin (CCK) (Emond et al., 1999) 
and gastric nutrient loads (Emond et al., 2001). 
 
1.7.2 Insulin 
Insulin is produced by the pancreas and also acts a tonic signal of energy status. 
Insulin concentrations are positively correlated with adiposity, and act on similar 
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neuronal populations within the brain as leptin (Wynne et al., 2005), although there 
has been recent work to demonstrate that subpopulations of POMC neurons are 
responsive to either insulin or leptin (Williams et al., 2010). It has also been reported 
that leptin receptors are also present within pancreatic islet cells and therefore leptin 
overproduction may modify basal and glucose stimulated insulin production 
(Emilsson et al., 1997). Administration of insulin has been found to decrease food 
intake and body weight in mice (Brown et al., 2006), rats (Chavez et al., 1995) and 
men (Hallschmid et al., 2004), although the effects on reducing food intake are less 
potent than leptin (Belgardt and Bruning, 2010), reductions of food intake and weight 
can be additive with leptin (Air et al., 2002).  
Insulin resistance has been suggested to attenuate the responsiveness of 
glucose metabolism in brain regions implicated in appetite regulation to the effects of 
insulin (Anthony et al., 2006). These authors suggest that this may predispose 
individuals to obesity due to reduced reward responses to palatable foods. More 
applied work has demonstrated that insulin response is negatively correlated with 
subsequent intake in lean individuals (Holt et al., 1996). In contrast, studies comparing 
lean and obese individuals this relationship was only observed in lean but not obese 
individuals (Speechly and Buffenstein, 2000; Verdich et al., 2001b). This pattern of 
results has been further reinforced by Flint and colleagues (2007) who report a similar 
lack of relationship between insulin and intake in obese individuals when combining 
the results of 6 controlled feeding studies. It therefore appears that obese individuals 
have a reduced sensitivity to the satiating effects of insulin, potentially due to central 




Chapter 1  Review of Literature 
38 
1.8 Episodic Hormones 
 
 Episodic hormones are generally split into two different categories based upon 
their effects upon appetite. An orexigenic hormone stimulates appetite, whereas an 
anorexigenic hormone suppresses appetite (Smitka et al., 2013). There is currently 
only one known orexigenic hormone (ghrelin) but numerous anorexigenic hormones, 
of which those examined in the experimental work presented are subsequently 




 Ghrelin is a hormone predominantly secreted by the stomach (Kojima et al., 
1999), with the gastric oxyntic glands the most abundant source of circulating ghrelin 
(Karra and Batterham, 2010). It is unique amongst episodic hormones, as the only 
known orexigenic (appetite stimulating) hormone. The primary site of action of 
ghrelin is the arcuate nucleus, where ghrelin has opposite effects to that of leptin. 
Ghrelin stimulates the activity of neurons expressing the orexigenic peptides NPY and 
AgRP (Nakazato et al., 2001; Kamegai et al., 2001), and inhibits POMC neurons 
(Cowley et al., 2003). The two main forms of ghrelin are derived from pre-proghrelin, 
with the biologically active form of the hormone acylated by the enzyme ghrelin O-
acyl transferase (GOAT) (Delhanty et al., 2012). The acylated form of the hormone 
has been suggested to have appetite regulatory properties, as it can bind to the growth 
hormone secretagogue receptor type 1a (GHSR1a) with des-acyl ghrelin simply a 
degradation byproduct without biological activities (Kojima and Kangawa, 2005). As 
a result, many studies measure total ghrelin (i.e acylated + des-acyl ghrelin) although 
recent work is beginning to suggest that des-acyl ghrelin may have distinct biological 
functions to acylated ghrelin (Delhanty et al., 2012).    
 Peripheral ghrelin administration stimulates food intake in both rats (Wren et 
al., 2001b; Wren et al., 2000; Tschop et al., 2000) and in humans (Wren et al., 2001a; 
Druce et al., 2005; Druce et al., 2006). Ghrelin concentrations are reduced in obesity 
(Tschop et al., 2001b; Cummings et al., 2002) but increase in response to weight loss 
(Cummings and Overduin, 2007; Hansen et al., 2002), although acute energy 
restriction (-800 kcal·d-1 for 4 days) does not increase fasting or postprandial 
concentrations (Doucet et al., 2004). Gastric bypass surgery has been observed to 
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reduce ghrelin concentrations (Beckman et al., 2010), with this reduction suggested to 
contribute to reduced hunger and sustained weight loss with these procedures. 
However, this is not a universal finding, with some authors suggesting that 
inconsistencies in surgical (Pournaras and le Roux, 2010) and experimental methods 
(Beckman et al., 2010) may explain the discrepant findings.    
Ghrelin levels are reduced postprandially (Tschop et al., 2001a) and rise with 
fasting (Cummings et al., 2001), with authors reporting pre-prandial rises in plasma 
ghrelin in the absence of time cues with close overlap of temporal ghrelin and appetite 
profiles, suggesting a role of ghrelin in meal initiation (Cummings et al., 2004). 
However, there is some evidence that the pre-meal surges in ghrelin may be an 
anticipatory response due to the entraining of meals (Drazen et al., 2006).  
 Ghrelin suppression following meals is proportional to the caloric load 
ingested (Callahan et al., 2004), with proteins and carbohydrates having a more potent 
effect in suppressing ghrelin than lipids (Foster-Schubert et al., 2008). The suppression 
of ghrelin by carbohydrates has been shown to be biphasic, with an increase above 
baseline levels after approximately 3 hours (Foster-Schubert et al., 2008). There is 
evidence to suggest that the meal induced suppression of ghrelin is either reduced (le 
Roux et al., 2005) or completely absent in obese individuals (English et al., 2002).  
  
1.8.2 Peptide Tryosine-Tyrosine 
 Peptide tyrosine-tyrosine (PYY) is a hormone that is secreted by L-cells in the 
intestine and is co-secreted with glucagon-like peptide-1 (Habib et al., 2013). There 
are two circulating forms of the hormone, PYY1-36 and PYY3-36 which are produced 
by N-terminal cleavage of PYY1-36 by dipeptidyl peptidase-4 (DPP-4) (Mentlein et al., 
1993). PYY3-36 the most abundant form (Batterham et al., 2006) and is thought to be 
most relevant in regulating intake, with studies identifying no effect of administration 
of PYY1-36 (Sloth et al., 2007a; Sloth et al., 2007b). The effects of PYY are thought to 
be mediated through effects on the ARC in the hypothalamus, with PYY3-36 selective 
for Y2-receptors that inhibit NPY/AgRP neurons and therefore remove repression of 
adjacent melanocortin producing cells (Batterham et al., 2002). After infusion of 
PYY3-36  it has been found that functional magnetic resonance imaging (fMRI) blood 
oxygen level dependent (BOLD) activity in orbitofrontal cortex (an area of the brain 
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implied in hedonic rather than homeostatic regulation) predicted subsequent food 
intake (Batterham et al., 2007). The implication drawn by these researchers was that 
PYY enhances the discrimination of the reward value of food (Batterham et al., 2007).              
 Circulating levels of PYY are low and fall in the fasted state (Batterham et al., 
2007), and are increased rapidly in response to nutrient ingestion (Adrian et al., 1985) 
remaining elevated for several hours. The elevation of PYY is proportional caloric 
load (le Roux et al., 2006), although the macronutrient composition of feedings can 
have differing effects upon PYY with some authors suggesting a key role for protein 
(Batterham et al., 2006) and others suggesting greater PYY stimulation after high fat 
relative to high carbohydrate meals (Essah et al., 2007; Cummings and Overduin, 
2007). PYY has been shown to act additively with glucagon-like peptide-17-36 in 
reducing food intake (De Silva et al., 2011; Neary et al., 2005). 
 Administration of PYY has been shown to bring about a dose dependent 
reduction in food intake in rodents, and reduce appetite and 24 hour energy intake in 
lean humans (Batterham et al., 2002), with further work indicating that obese humans 
are also responsive to the anorectic effects of administered PYY3-36 (Batterham et al., 
2003). It has been suggested that PYY contributes to satiation, with attenuated 
postprandial PYY release in obese subjects associated with impaired satiety (le Roux 
et al., 2006) and positive correlations apparent between postprandial PYY and changes 
in satiety (Guo et al., 2006). “High responders” for PYY report the greatest reduction 
in hunger following a meal (Stoeckel et al., 2008).  
   
1.8.3 Glucagon-like peptide-1 
 Glucagon-like peptide-1 (GLP-1) is one of several incretin hormones. Incretins 
are gut hormones that amplify the secretion of insulin in response to nutrients (Holst, 
2013). GLP-1 is secreted from the L cells of the intestine in response to nutrients, and 
is post-translationally cleaved into the biologically active forms GLP-1(7-36) amide and 
GLP-1(7-37), with the majority of the circulating form in humans GLP-1(7-36) (Orskov et 
al., 1994), although this is rapidly inactivated by DPP-4 (Deacon et al., 1995), such 
that only 10-15% leaves the liver (Holst, 2007). While incompletely understood, it is 
suggested that GLP-1 exerts its effects through both peripheral afferents originating in 
the gut that activate central nervous system nuclei involved in satiation (Williams, 
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2009) and central GLP-1 expression in neurons in the solitary tract (NTS) of the 
medulla oblongata (Dailey and Moran, 2013). 
 Administration of GLP-1 in humans reduces food intake in the majority of 
studies (Gutzwiller et al., 1999a; Gutzwiller et al., 1999b; Verdich et al., 2001a; Flint 
et al., 1998), with the anorectic effect of GLP-1 also evident in obese individuals 
(Verdich et al., 2001a). GLP-1 concentrations are reduced in obesity (Verdich et al., 
2001b; Carr et al., 2010), and are increased with weight loss (Verdich et al., 2001b). 
Plasma GLP-1 increases in response to feeding, but the increase elicited is relatively 
minor, due to the activity of DPP-4 introduced above. Within the context of the dose-
response relationship observed, it is suggested that this increase is unlikely to be 
accountable for reduced food intake (Holst, 2013), although additive effects with PYY 
(Neary et al., 2005; De Silva et al., 2011) and prevention of the postprandial decline 
in ghrelin levels (although at supraphysiological infusion concentrations) have been 
observed (Hagemann et al., 2007). It is therefore possible that the effects of GLP-1 are 
partly due to its interaction with other appetite hormones. 
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1.9 Subjective Indicators of Appetite 
  
 As well as measurement of hormones that are implicated in the regulation of 
appetite, subjective measures are also used in research settings to assess various 
elements of appetite in individuals. In some instances these scales are used to assess 
the desire to eat a specific type of foodstuff (i.e for something salty), or as utilised in 
the experimental work presented, to assess perceived general states of hunger and 
perceived consumption (Blundell et al., 2010). 
 While it is important to consider the reliability and validity of self-report 
measures of appetite, it is also crucial to acknowledge that the validity of these 
measures is not contingent upon a correlation with actual intake (Hill et al., 1995). 
There are occasions when humans eat without hunger and vice versa and as such 
appetite measures cannot be used as a surrogate of measured intake (Mattes, 1990). 
With this important caveat in mind, the majority of laboratory studies have reported 
significant relationships between appetite ratings and subsequent energy intake at test 
meals (Drapeau et al., 2007; Flint et al., 2000; Hulshof et al., 1993; Parker et al., 2004).  
The reliability of these measures has been examined in several studies. A study 
using 9 participants ingesting purely carbohydrate meals, has suggested large 
variability of subjective appetite response (peak and nadir) to repeated tests (Raben et 
al., 1995). However, the same group subsequently examined the reliability of appetite 
measures with greater subject numbers and a more typical test meal. Flint and 
colleagues (2000) have established that when repeating both fasted and mean appetite 
sensations over 4.5 hours to a breakfast test meal, there was no mean difference 
between either of the testing occasions. Correlations between fasting appetite 
measures were least reliable, particularly when participants had not undergone prior 
diet standardisation. Using the data obtained in their study, power calculations suggest 
for a power of 0.8 and to detect a 10mm difference in a measure, that required 
participant numbers may be between 8-35 dependent on the nature of the experimental 
design (with paired designs requiring substantially fewer participant numbers). In a 
more recent design, it has also been established that time averaged appetite ratings 
assessed for 2 hours after a milk and cereal test meal are similarly reproducible to 
those reported over 4.5 hours (Gonzalez et al., 2012). It has therefore been established 
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that subjective appetite ratings are a reliable measure that can be used to detect 
differences between conditions given sufficient participant numbers.  
        
 The previous sections have introduced the various hormones that are thought 
to affect appetite and are to be measured in this thesis, as well as the methods of 
measuring subjective appetite. Combined with the earlier sections examining the 
components of energy balance and the measurement of those components, the basic 
theoretical framework of the relevant factors to be measured in this thesis have been 
considered. Therefore, the next sections begin to assess the specific literature relating 
to breakfast consumption and components of energy balance and other health markers.  
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1.10  Background to Evidence Examining Breakfast Studies 
  
1.10.1 Scope of Literature Used 
 Due to the ease of implementation of breakfast interventions in school children 
and the putative benefits of breakfast consumption upon cognitive function (Simeon 
and Grantham-McGregor, 1989; Wesnes et al., 2003), numerous studies have been 
conducted investigating the effect of breakfast consupmtion in children and 
adolescents (Hoyland et al., 2009; Rampersaud et al., 2005; Edefonti et al., 2014). 
However, for the purposes of this thesis, focus will be on studies in adults. The two 
key reasons for this are that the populations used in this work are adults, and secondly, 
that appetite regulation and energy balance in children is necessarily influenced by 
different factors. As discussed in the overview of energy balance, in the majority of 
situations to maintain stable weight, energy intake and expenditure have to be tightly 
equivalent. In children, while the fundamental tenets of the energy balance equation 
hold, for the purposes of growth, children and adolescents necessarily require an 
excess of energy intake to contribute to energy storage (Hall et al., 2012). Additionally, 
food choices/frequency are less self-selected in children than adults, with parental 
habits strongly influencing behaviours in offspring (Keski-Rahkonen et al., 2003).    
 
1.10.2 Prevalence and Trends in Breakfast Consumption 
 “Breakfast” is not a universally defined term, with different definitions in use 
throughout the literature (Timlin and Pereira, 2007). These vary based upon energy 
intake of the eating occasions, the types of food eaten, the time of day at which they 
are consumed and the time at which they are consumed relative to waking. With such 
a range of factors that could contribute to the definition of breakfast consumption (both 
when retrospectively analysing data already obtained and when asking individuals to 
self-report breakfast intake) it is difficult to compare associational studies that use 
different definitions of what constitutes the breakfast meal. Throughout this literature 
review, attention will be drawn where appropriate to key differences between 
definitions of breakfast used by different investigators. 
 Gibson and Gunn (2011) analysed data from 7-day food records in 1724 adults 
aged 19-64 y in the British National Diet and Nutrition Survey from 2000/2001. They 
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defined breakfast as food consumed between 06:00 and 10:00, and report that 22 % of 
days in men and 20 % of days in women did not include a breakfast. However, this is 
the proportion of all person-days and therefore no information can be obtained about 
the frequency of breakfast consumption in individuals (i.e whether the proportion of 
days missing breakfast observed is a product of ~20 % of adults missing breakfast 
every day, or every adult missing breakfast approximately 20 % of the week, or as 
would be expected to be the case, some mixture of both possibilities). In a more recent 
study, Reeves and colleagues (2013) utilised an internet survey in a demographically 
representative sample of the UK population to establish breakfast consumption 
patterns. In the sample of 1066 adults, 64 % of respondents reported consuming 
breakfast every day, with a further 8 % reporting consuming breakfast 5-6 days of the 
week. Infrequent consumption (1-4 days) was reported in 22 % of individuals while 
the remaining 6 % never eat breakfast. What constituted a breakfast was not defined 
in this study, as one of the objectives was to ascertain what the respondents considered 
to be “breakfast”. In this regard, 82 % of individuals listed one of the reasons as “first 
meal of the day”, with less popularity for eating before a certain time (14 %) and a 
certain type of food (19 %). While there is some evidence for cross-sectional 
assessment of breakfast consumption habits in the United Kingdom, there is no 
published research on trends in consumption over time. 
 Evidence on temporal trends in breakfast consumption is available from the 
United States, using data from the National Health and Nutrition Examination Survey 
(NHANES). From NHANES in 1971-1975 to 2001-2002, the proportion of 
participants who classified foods as breakfast as part of a 24 h dietary recall decreased 
significantly (p <0.0001) from 89 ± 0.6 % to 82 ± 0.6 % (Kant and Graubard, 2006). 
This decrease in breakfast consumption in US adults has also been reported from 1965-
1991 in 24 h diet recalls from the National Food Consumption Survey (NFCS) and the 
Continuing Survey of Food Intakes by Individuals (CSFII), with intake of foods and 
drinks reported between 05:00 and 09:00 decreasing from 86 to 75% (Haines et al., 
1996). A more recent report utilising the NHANES databases confirm the general 
trend observed previously for decreased reporting of breakfast consumption over time 
from 1971 to 2010 in both sexes (Kant and Graubard, 2014). However, for the 
continuous NHANES data for 1999-2002 up to 2007-2010, there has been no further 
decrease in breakfast consumption, with some evidence for stability around 80% in 
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both genders (Kant and Graubard, 2014). As all of this data is from single day recalls, 
like the work of Gibson and Gunn (2011) it is impossible to establish the frequency of 
breakfast consumption amongst these individuals. However, evidence would seem to 
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1.11 Literature Examining Breakfast Consumption 
 There is much available literature examining the relationship between 
breakfast consumption and weight/other markers of health. This evidence will be split 
according to the research designs employed, with three main strands of evidence 
examined: cross-sectional associations, prospective/longitudinal designs and finally, 
randomised controlled trials. As stated previously, the evidence presented will be 
mainly from studies in adults but where insufficient evidence exists in this population, 
relevant studies conducted in adolescents will be introduced for context. 
 
1.11.1 Cross-Sectional Studies 
 Cross-sectional studies can provide information as to whether an association 
exists between two factors, but cannot be used to confirm the existence or direction of 
causality between those two factors. The most rigorously established of the 
associations between breakfast consumption exists with overweight/obesity. Whilst 
there has been much work completed in children examining this relationship, there are 
still copious numbers of studies that have examined this relationship in adults. A 
summary of  recent studies examining this effect have been included in Table 1.1. 
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Table 1.1: Cross sectional associations between breakfast consumption/omission and obesity 
 
Author Study  
Population 
Definition of  
Breakfast/Skipping 
Adjustment for  
Confounders 
Outcomes 
(Azadbakht et al., 2013) Iran 
411 women 
18-28 y 
Food or drink before 10:00 h in 
>5 d per week, <5 d counted as 
skipper.  
 
None 20% prevalence of overweight/obesity amongst 
skippers, 0.5% amongst consumers. 
(Barr et al., 2013) Canada 
19913 both genders 
>19 y 
Any foods/beverages defined as 
breakfast by participants for  
24 h recall 




BMI greater amongst skippers relative to 
relative to ready to eat cereal consumers (but 
not other breakfast consumers). 
(Berteus Forslund et al., 2002) Sweden 
83 obese women 
94 lean women 
37-60 y 
Participant defined meal 
consumption between 06:00 h 
and 09:59 h 
None No difference in breakfast frequency between 
lean and obese women. 
Greater proportion of meals consumed at 
breakfast in lean women.  
 
(Cho et al., 2003) USA 
16452 both genders 
> 18 y 
Participant defined as 
“breakfast” for 24 h recall 
Numerous including PA, 
diet, smoking, alcohol 
Greater BMI in breakfast skippers but only 
relative to cooked cereal, ready to eat cereal and 
quick breads. Not different to other breakfast 
types. 
 
(Deshmukh-Taskar et al., 2013) USA 
5316 both genders 
20-39 y 
Self-reported breakfast 
consumption in 24 h recall 
Numerous including PA, 
diet, smoking, 
demographic factors 
Weight/BMI greater in breakfast skippers, but 
only than those consuming ready to eat cereal, 
not those consuming other breakfast types.  
 
(Huang et al., 2010) Taiwan 
15340 both genders 
18-64 y 
Respondents who answered 
question “Typically, how many 
days a week do you eat 
breakfast?” as 1 or 0 classified 
as skippers. 
Age, sex, exercise habits, 
smoking, demographic 
factors. 
Prevalence of obesity (BMI>27) greater in 
breakfast skipping. 
OR (1.34, 1.15-1.56) when controlling for 
confounders. 
Prevalence rate of obesity decreased as 
breakfast consumption frequency increased.  
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Table 1.1 continued: Cross sectional associations between breakfast consumption/omission and obesity 
 
Author Study  
Population 
Definition of  
Breakfast/Skipping 
Adjustment for  
Confounders 
Outcomes 
(Horikawa et al., 2011) Asia Pacific Region 
18+, 4 different 
studies 
Variable, but skipping generally 
defined as <1 breakfast 
occasions per week 
Limited adjustment for 
confounders, majority 
controlled for gender. 
Pooled OR from adult studies in region for 
those that skipped breakfast and the risk of 
overweight/obesity was 1.93 (1.22-3.06). 
 
(Ma et al., 2003) USA 
499 both genders 
20-70 y 
75 % of repeated (10-15) diet 
recalls to include self- reported 
breakfast intake 
Age, gender, educational 
level, total EI, physical 
activity 
OR for obesity with breakfast skipping 4.50 
(1.57, 12.90), but very limited numbers 
classified as skippers (18:481).  
 
(Marin-Guerrero et al., 2008) Spain 
34974 both genders 
25-64 y 
Response to interview question 
of whether breakfast was eaten 
or not eaten  
Age, physical activity, 
smoking, alcohol intake, 
demographic factors. 
OR for risk of obesity was 1.58 (1.29-1.93) in 
men and 1.53 (1.15-2.03) in women skippers 
when controlling for confounders.  
 
(Mekary et al., 2012) USA 
29206 men 
40-75 y 
Reporting eating anything in the 
morning in response to 
questionnaire. 
 
None Greater BMI in those that skipped breakfast 
relative to those who consumed breakfast. 
(Mekary et al., 2013) USA  
46289 women 
30-55 y 
Regular-Report 7 days per week 
breakfast consumption 
Irregular-Between 0-6 days. 
 
None Greater BMI in irregular breakfast consumers 
relative to regular breakfast consumers. 
(Merten et al., 2009) USA 
7788 both genders 
18-26 y 
Response to interview, > 4 days 
a week breakfast consumption 
defined as regular breakfast, < 4 
as no breakfast 
Demographic variables 
(e.g poverty, parental 
presence), race and sex 
OR for obesity lower in those that ate breakfast  
0.41 (0.34, 0.48) for those that ate breakfast in 
adolescence and adulthood vs skippers, 0.77 
(0.64-0.94) for those who ate breakfast in 
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Table 1.1 continued: Cross sectional associations between breakfast consumption/omission and obesity 
 
Author Study  
Population 
Definition of  
Breakfast/Skipping 
Adjustment for  
Confounders 
Outcomes 
(Mills et al., 2011) USA 
1,099 women 
40-60 y 
Presence of food labelled as 
breakfast in 24 h food record 
Physical activity, age, 
income, marital status, 
education, energy intake 
OR for risk of overweight/obesity not different 
in those eating breakfast 0.74 (0.35-1.54). 
Suggested low proportion of skippers (4%) 
limits sensitivity to effect. 
 
(Mostad et al., 2014) Norway 
50, 339 both genders 
> 19 y  
Frequency of breakfast 
consumption-response to 
questionnaire 
Age, sex Individuals in highest quartile of waist:hip ratio 
had 5% less breakfast consumption than those in 
lowest waist:hip ratio quartile 
 
(Odegaard et al., 2013) USA 




(0-3, 4-6 and 7 d per week) 
 
None Stepwise increase in BMI with reduced reported 
frequency of breakfast consumption.   
(Smith et al., 2010) Australia 
2184 both genders 
26-36 y 
No foods indicated between 
06:00 h and 09:00 h for 24 h 
meal frequency recall 
None Individuals who skipped breakfast in both 
adulthood and as a child had a significantly 
greater BMI than those who had always 
consumed breakfast. 
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The studies presented in Table 1.1 conclusively demonstrate that cross-
sectional associations between skipping breakfast and risk of obesity/overweight are 
apparent. These associations are present regardless of the various definitions of 
breakfast/skipping and the range of comparisons made (i.e different contrasts based 
upon simple yes/no responses, specific extremes of frequency of consumption and 
other intermediates). The associations are also apparent in several countries as well as 
different age and gender groups. Indeed, the relationship between breakfast skipping 
and obesity has been described as “gratuitously established” (Brown et al., 2013). In 
conducting a cumulative meta-analysis of this relationship over time, Brown and 
colleagues (2013) report that in studies including adults and children sourced from 4 
different systematic reviews, the strength of this relationship was p = 10-42 by 2011. 
However, despite the strength of this particular association, this adds no further value 
in establishing whether the relationship is causal in nature. This is particularly relevant 
as numerous studies have also reported that breakfast skipping is also associated with 
other negative health behaviours and demographic characteristics that are 
independently associated with obesity and poorer health (Table 1.2). 
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 From an energy balance perspective, some cross-sectional studies have 
reported whether estimated physical activity levels are greater or lesser in individuals 
who skip breakfast. Several of these studies report greater levels of physical activity 
in those individuals classified as breakfast consumers (Barr et al., 2013; Cahill et al., 
2013b; Mekary et al., 2013; Mekary et al., 2012; Smith et al., 2013; van der Heijden 
et al., 2007; Wyatt et al., 2002). However, all of these studies have used a physical 
activity questionnaire to do so, which limits their effectiveness due to their limited 
reliability and validity (Shephard, 2003).  
On the other side of the energy balance equation, several studies have also 
reported relationships between breakfast skipping and energy intake. Of those studies 
that have related breakfast skipping or consumption to energy intake, an inconsistent 
relationship is apparent. The majority of studies that have simply examined whether 
individuals consumed more total calories when reporting skipping breakfast have 
reported significantly lower energy intake in those that skip breakfast (Cho et al., 2003; 
Deshmukh-Taskar et al., 2010a; Nicklas et al., 1998), although this has not been the 
case in all studies (Mekary et al., 2012). Two studies that have split breakfast 
consumers on the basis of breakfast consumption frequency into regular and irregular 
consumers, have reported that when defining irregular consumers as any less than 
daily (Mekary et al., 2013) or <4 days a week (Wyatt et al., 2002) there was no 
difference in energy intake between the two groups. Similarly, Odegaard and 
colleagues (2013) when examining varying frequencies of weekly breakfast 
consumption have not reported any difference in energy intake between individuals 
reporting consuming breakfast 0-3, 4-6 or 7 days a week. Two further studies 
(Schusdziarra et al., 2011; Purslow et al., 2008) have examined in breakfast consumers 
whether total daily energy intake increases concurrently with breakfast energy intake. 
Both of these studies conclude that as breakfast energy intake increases, total energy 
intake also does so. This cross-sectional evidence suggests that energy intake may 
potentially be reduced in those that skip/consume less energy dense breakfasts, with 
no evidence in adults to suggest breakfast consumers have lower energy intake. 
Therefore, for breakfast consumption to not result in positive energy balance relative 
to skipping, energy expenditure would have to be greater, an association which has 
been observed in some studies. 
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1.11.2 Prospective Studies 
 Whilst cross-sectional studies are a useful basis upon which to establish 
associations between variables, prospective designs are beneficial to establish the 
occurrence of clinical events/development of disease states over time in the same 
individuals. Within the context of human health and obesity this allows an additional 
level of association to be developed between certain baseline characteristics of 
participants (in this instance breakfast consumption/skipping) and development of 
conditions. However, it should be noted that studies utilising this design still do not 
provide causal evidence relating the variable of interest with the outcomes assessed. 
Because of their longer term nature, these studies tend to be less prevalent in the 
literature but there have been some examinations linking breakfast consumption with 
a variety of disease and weight change outcomes. 
 
Body Mass Change with Breakfast Consumption 
 Breakfast consumption has been clearly associated with excess weight in the 
cross-sectional associations already presented. Whether breakfast consumption is 
associated with weight change in adults is less comprehensively examined. However, 
there is some consistency in the findings garnered. In 20064 male health professionals 
who were between 40-75 y at baseline, a 10 year follow-up period demonstrated 
reduced risk of 5% BMI gain in those that reported usually eating breakfast at baseline 
(van der Heijden et al., 2007). The odds ratio for 5% BMI gain in the individuals 
classified as breakfast consumers was 0.87 (95 % CI, 0.82-0.93) when accounting for 
other relevant health mediators (e.g smoking status, physical activity quintile, alcohol 
intake). Interestingly, this reduction in risk was stronger in individuals with a BMI < 
25 at baseline (0.78, 95% CI, 0.70-0.87), relative to those individuals that were >25 at 
baseline (0.92, 95% CI, 0.85-1.00). However, in breakfast “non-consumers” a greater 
proportion of participants reported dietary intake before breakfast (3.9 vs 0.4 %) and 
between breakfast and lunch (21.9 vs 7.4 %) than breakfast consumers. Therefore this 
suggests that ~20-25% of the “non-consumer” cohort did not undertake an unbroken 
fast prior to lunch, limiting their discrepancy from the consuming group somewhat. 
Despite this general consideration, this work provides some evidence that the 
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potentially protective association of breakfast consumption against weight loss may 
be mediated by an individual’s weight status.  
Goto and colleagues (2010) have reported in a substantially younger 
population of 4634 Japanese University students (21.5 ± 1.9 y) with a baseline BMI 
of >22, that 1 year BMI gain of 5% was more prevalent in those reporting skipping 
breakfast twice a week or more (OR 1.34, 95 % CI, 1.12-1.61). This demonstrates that 
more rapid weight gain (i.e the same BMI gain endpoint but in 1 rather than 10 years) 
than assessed in the work of van der Heijden and colleagues (2007) is also apparent in 
those that report skipping breakfast more frequently. In addition to these findings, 
Nooyens et al. (2005) reported that the change in breakfast consumption frequency 
over a 5 year follow up period was associated with increased weight in 288 Dutch 50-
65 year olds. However, this relationship which originally related an increase in each 
unit of breakfast consumption frequency to greater weight gain of 0.07 kg per year (p 
= 0.03), was moderated to 0.04 kg per year and was no longer significant (p = 0.2) 
when accounting for other covariates. Therefore, although this study does not provide 
evidence that increasing breakfast frequency is associated with weight gain when 
appropriate adjustments are made, it also does not provide support for increasing 
breakfast frequency as associated with reducing weight gain. However, it is important 
to consider that this study investigated the effect of changing breakfast habits upon 
weight outcomes, and yet in the 4 subgroups studied the greatest potential range of 
change in breakfast frequency (95% CI) was -0.47 occasions per week in a group 
whose mean change in frequency was -0.16 and 0.89 in a group whose mean change 
was 0.44 occasions per week, indicating that the magnitude of change in this variable 
over the course of the follow up period was in fact very small, somewhat limiting the 
application of this analysis. 
 In a more nuanced analysis of the relationship between breakfast consumption 
and weight gain, Purslow and colleagues (2008) examined the relationship between 
energy intake at breakfast and ~4 year weight gain amongst 6,764 men and women 
aged 40-75. The experimenters split individuals into quintiles based upon proportion 
of total energy intake (as assessed by 7 day food diary) consumed at breakfast. They 
report that as the proportion of daily energy intake from breakfast decreased, weight 
gain increased (p < 0.001). Those in the lowest quintile for EI at breakfast gained (± 
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SEM) 1.23 ± 0.12 kg compared with 0.79 ± 0.11 kg in those in the highest quintile. 
As observed in the majority of cross-sectional studies discussed earlier, these authors 
also report that as energy intake from breakfast increased, so did total energy intake 
(p < 0.001). Therefore, individuals reporting greater energy intake were less likely to 
gain weight, suggesting a potential role for energy expenditure in moderating the 
relationship between breakfast consumption and weight change. 
 Taking a similar approach in attempting to move beyond straightforward 
categorical (i.e yes/no) definitions of breakfast consumption, Odegaard and colleagues 
(2013) have reported that over an 18 year follow-up period, that those individuals 
reporting breakfast consumption both daily and 4-6 days per week had lower weight 
gain than those who ate breakfast on 3 or less days a week. Specifically, daily 
consumers gained 1.9 kg less over the period than the infrequent breakfast consumers.   
  
Breakfast Consumption and Disease Risk    
There is a recently emerging body of evidence from prospective studies that is 
beginning to link breakfast consumption and disease risk in individuals. Cahill and 
colleagues (2013) have examined the incident coronary heart disease risk in the Health 
Professionals Follow Up Study. Men aged 45-82 (n=26902) who were free of 
cardiovascular disease and cancer at baseline, were asked about eating habits in 1992 
and followed up for 16 years. The research group examined the frequency of non-fatal 
myocardial infarctions and deaths from coronary heart disease and found that those 
reporting not eating in the morning had a 33% greater age adjusted risk of CHD 
incident (95% CI, 1.13-1.57). When adjusting comprehensively for diet, demographic 
and physical activity factors this risk was only slightly reduced (1.27, 95 % CI, 1.06-
1.53). However, when also adjusting for BMI and other health conditions (presence of 
diabetes, hypercholesterolemia, hypertension) this risk was reduced again and to a 
greater extent to 1.18 (95 % CI, 0.98-1.43, p = 0.08).  
 Utilising the same dataset, Mekary and colleagues (2012) have established a 
similar relationship between breakfast skipping and cases of diabetes. Individuals who 
reported skipping breakfast had a 27% greater risk of diabetes (95% CI, 1.13, 1.43) 
when accounting for numerous other potential risk factors, this risk was reduced 
slightly when BMI was also included (1.21, 1.07-1.35). Interestingly, these 
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relationships were not different whether comparing people who did not eat anything 
prior to lunch or those who simply reported not eating breakfast (but did report eating 
at another occasion prior to lunch). The same investigators have also examined this 
relationship in women in a partner study (Mekary et al., 2013). In this investigation, 
daily breakfast consumption was compared with irregular consumption (6 days per 
week or less) and followed up after 6 years. These results were remarkably similar, 
with the risk factor adjusted OR 1.28 (1.14-1.44) in those not consuming daily, which 
was attenuated to 1.20 (1.07-1.35) when BMI was also included. Unfortunately, 
despite the original questionnaire including frequency of breakfast consumption 
questions (i.e how many days per week breakfast was consumed), the authors chose 
to dichotomise this variable, so further information is not available relating to the 
frequency of breakfast consumption and relative risk in this cohort.   
 In an analysis that has utilised a more detailed description of breakfast 
consumption frequency, Odegaard and colleagues (2013) have demonstrated a 
stepwise reduction in metabolic risk with increased breakfast consumption frequency. 
The authors report that when comparing infrequent (0-3 days per week), frequent (4-
6 days per week) and daily consumers, that in all cases, daily consumption was 
associated with the greatest reduction in risk of incidence of abdominal obesity, 
obesity, metabolic syndrome, hypertension and type 2 diabetes. This evidence 
suggests that greatest protection from development of metabolic risk is conferred with 
the highest frequency of breakfast consumption, with a dose-response relationship 
evident.            
 These prospective studies examined provide consistent evidence that omission 
of breakfast is longitudinally associated with increased risk of weight gain over time 
and that potentially increased frequency of breakfast consumption is beneficial in 
preventing weight gain. Several studies have also established that breakfast omission 
is associated with a greater risk of the development of metabolic risk and disease 
states, even when other relevant variables are accounted for. Despite this, these studies 
do not provide evidence to support potential mechanisms to explain the associations 
observed.        
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1.12 Randomised Controlled Trials 
 
 Despite the large volume of associative studies examining breakfast 
consumption, there are relatively few studies that have attempted to establish the 
causal role of breakfast consumption/omission upon components of energy balance. 
Whilst there have been several studies that have examined responses to various 
different compositions of breakfast, very few have examined the variable of particular 
interest in this thesis; the morning fast. The studies that have examined the relative 
presence versus absence of breakfast per se can be split into two main categories: acute 
studies (e.g laboratory based investigations conducted within a day) and chronic 
interventions (e.g adherence to a prescribed breakfast or no breakfast routine, typically 
over multiple days or weeks). 
 
1.12.1 Acute Studies 
 
 Acute breakfast studies are generally used to provide detailed information 
relating to appetite regulation and energy intake. Whilst these studies can provide 
some information relating to minor parts of energy expenditure (i.e DIT), the 
restrictive nature of the environment means acute studies do not provide a 
comprehensive picture of energy expenditure, due to restrictions upon physical 
activity. 
One of the potential mechanisms that omission of breakfast may act through 
to affect energy balance is alteration of energy intake. If there is a causal component 
to the association of breakfast skipping and obesity, this may be due to increased 
energy intake after fasting. Therefore, despite the absence of energy intake through 
breakfast, it could be that breakfast skippers overcompensate through other feedings 
later in the day, resulting in greater overall (absolute) energy intake with breakfast 
skipping. However, the majority of cross-sectional evidence presented previously does 
not support this notion (Cho et al., 2003; Deshmukh-Taskar et al., 2010a; Nicklas et 
al., 1998; Schusdziarra et al., 2011; Purslow et al., 2008).  
In two related studies, Levitsky and Pacanowski (2013) investigated whether 
breakfast skipping results in compensatory increases in energy intake at other feeding 
occasions. In their first experiment, the authors provided either a high carbohydrate or 
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fibre breakfast of ~335 kcal and compared these breakfast conditions against a 
breakfast omission condition in 24 predominantly female university students. They 
report no difference (all conditions within 50 kcal) in energy intake at an ad libitum 
lunch, thus a significantly greater absolute intake in the breakfast conditions than the 
morning fasting condition. The authors speculated that this may be due to the relatively 
small breakfast and/or that energetic compensation may occur throughout the day, 
leading them to conduct a further investigation. In a similar population, the authors 
then provided a variety of food items in a buffet style breakfast or asked participants 
to skip breakfast. Subsequently, a buffet style lunch was eaten within the research unit, 
with snacks and dinners that could be eaten outside the laboratory. In this investigation 
they found that in the morning fasting trial, lunch intake was approximately 170 kcal 
greater (p = 0.04) than in the breakfast condition. However, no other eating occasions 
were significantly affected by morning breakfast or skipping, such that when the 
energy intake from breakfast (624 kcal) was included, those that had fasted in the 
morning had consumed ~450 kcal less (p < 0.01) over the course of the day. Consistent 
with the lack of energetic compensation throughout the rest of the day, hunger was 
assessed as significantly greater in the morning fasting trial during the mid-morning 
and prior to lunch but not different from the breakfast trial from the afternoon onwards.   
Two further investigations in young, lean men have contrasted an extended 
morning fast with a breakfast consumption condition, also including metabolic and 
hormonal measures as well as investigating energy intake compensation to extended 
morning fasting (Astbury et al., 2011; Gonzalez et al., 2013). These two investigations 
provide contrasting results, with one investigation reporting greater energy intake at 
an ad libitum lunch sufficient to compensate for omitted breakfast energy intake 
following extended fasting (Astbury et al., 2011) and the other no difference in intake 
at lunch (Gonzalez et al., 2013). These discrepant results may be partly due to 
differences in the morning feedings in the two studies, with the former investigation 
providing less energy at breakfast (~270 kcal vs 444 kcal). Additionally, a crucial point 
is that in both the breakfast and no breakfast condition, participants consumed a mid-
morning preload (i.e a snack), such that in the no breakfast condition participants had 
not undertaken an unbroken fast prior to consuming lunch. In the work of Gonzalez 
and colleagues (2013) the preload was greater (358 kcal vs 250 kcal) than in the study 
of Astbury and colleagues (2011). These two differences in the size of the feedings 
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provided may partly explain the discrepant findings, as the similar total energy intake 
between those consuming and skipping breakfast in the work of Astbury et al (2011) 
may be because those not eating breakfast had “missed” less energy intake at breakfast 
compared with Gonzalez et al (2013) and had also been provided less energy in the 
form of preload prior to eating lunch. 
Both investigations show that appetite was increased in those not consuming 
breakfast throughout the morning leading to lunch. Breakfast omission resulted in a 
tendency for (Gonzalez et al., 2013) and greater (Astbury et al., 2011) glucose and 
insulin responses to the mid-morning preload, with both investigations reporting 
greater free fatty acid concentrations during the morning in those omitting breakfast. 
GLP-1 was not different following the preload in the work of Gonzalez et al. (2013), 
but was lower 15 minutes after the preload (as was PYY at 15 and 30 minutes) in those 
who had skipped breakfast in the work of Astbury et al. (2011). Astbury and 
colleagues (2011) also monitored appetite hormones and metabolic variables after 
lunch, reporting no difference between any of the measured outcomes in the breakfast 
and no breakfast trials.  
While both of these studies provide relevant and useful information analogous 
to the mechanisms of appetite regulation when those skipping breakfast choose to 
consume a mid-morning snack, the responses to unbroken fasting prior to lunch have 
not been examined in a laboratory setting. 
 
1.12.2 Intervention Studies 
                              
 Whilst the acute interventions above can provide valuable mechanistic 
information relating to short term responses to a single exposure of either breakfast or 
morning fasting, intervention studies allow examination of responses to chronic 
exposure to either morning fasting or breakfast outside the laboratory environment. 
The studies that have examined a breakfast omission intervention in a randomised 
controlled trial are summarised in Table 1.3. As can be seen, there are few randomised 
controlled trials that have investigated an extended morning fast.  
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Table 1.3: Intervention studies that have examined a breakfast omission condition 
 
Author Participants Design Intervention Restrictions Key Outcomes 








Mixture of skippers 
and consumers 
16 weeks, 







Breakfast-Nutrition pamphlet + 
instruction to eat breakfast prior to 
10am 
No Breakfast-Nutrition pamphlet + 
instruction to not consume anything 
other than water/zero calorie 
beverages until 11:00. 
None No difference in weight loss 
between treatments. 
No difference between individuals 
classified as skippers (breakfast <4 
per week) and consumers 
(breakfast ≥4 per week) at baseline 
on weight loss. 
 
 
(Farshchi et al., 2005b) N=10 women 
19-38 y 













Breakfast-45 g Bran flakes with 
200 ml milk between 07:00 and 
08:00, chocolate covered cookie 
between 10:30 and 11:00 
No Breakfast-Chocolate covered 
cookie between 10:30 and 11:00 
and cereal with milk between 12:00 
and 12:30 
Asked to consumed 2 more 
meals and 2 snacks of 
usual content at 
predetermined times 
throughout day.  
Dinner to be consumed 
between 18:00 and 18:30  
No effect on weight. 
Reported energy intake lower in 
breakfast condition. 
Increased total and LDL 
cholesterol following no breakfast. 
AUC of insulin to test meal lower 
after breakfast than no breakfast.  
(Halsey et al., 2012) N=49 
Both genders 
22.6 ± 3.9 y 
BMI not specified  




1 week on each 
intervention, no 
washout period 
Breakfast-Ad libitum intake of high 
carbohydrate foods between 08:00 
and 09:00, tea/coffee permitted in 
morning, no other foods allowed 
until 12:00 
No Breakfast-No food intake in the 
morning, tea and coffee permitted 
throughout morning. 
Participants had to report 
to feeding lab each 
morning between 08:00 
and 09:00. 
Participants returned to lab 
between 17:00 and 18:00 
to return monitors. 
No diet restrictions. 
No difference in energy intake 
between conditions. 
No difference in mean pedometer 
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Table 1.3 continued: Intervention studies that have examined a breakfast omission condition 
 
Author Participants Design Intervention Restrictions Key Outcomes 
(Reeves et al., 2014) N=37 Both genders 
Lean (30 ± 8 y) and 
overweight/ obese 









Breakfast-Asked to eat breakfast 
by 10am.  
No Breakfast-Refrain from eating 
until midday. 
None Greater energy intake with 
breakfast consumption. 
No effect of habits or BMI upon 
energy intake. 
(Schlundt et al., 1992) N=52 women 
18-55y 








Breakfast-400 kcal breakfast as 
part of menu 
No Breakfast-No breakfast 
prescribed 
1200 kcal menus provided 
to participants, specifying 
meal energy intakes. 
Weight loss in both groups. 
Habit x intervention interaction (p 
= 0.06) for weight loss, those who 
changed from their normal 
breakfast habit during intervention 
lost more weight. 
 












No Breakfast-Nothing permitted 
until all energy intake consumed 
within one meal between 17:00 and 
21:00   
Participants not permitted 
to consume foods other 
than those provided by or 
consumed in the research 
facility. Feeding frequency 
was fixed at either 3 
meals/d or 1 meal a day. 
Energy intake was 
designed to maintain 
energy balance. 
Body and fat mass loss in 1 meal/d 
group. 
Increases in all measures of 
cholesterol in 1 meal/d regimen. 
No difference in physical activity. 
 
Chapter 1  Review of Literature 
62 
Effect on Body Mass 
  
The effect of extended morning fasting upon body mass is not well established 
in randomised controlled trials. Several of the studies conducted have been of a 
relatively short term nature (≤ 2 weeks), such that weight change was not a measure 
obtained (Halsey et al., 2012; Reeves et al., 2014) or was not expected to change 
(Farshchi et al., 2005b). In two other studies, weight loss was either part of the 
intervention as a calorie restricted diet was prescribed (Schlundt et al., 1992) or weight 
loss was attempted to be avoided as participants were provided with foods to attempt 
to maintain energy balance (Stote et al., 2007). Despite these energy balance 
prescriptions, some differences in body composition changes were apparent between 
morning fasting and breakfast consumption. In the work of Schlundt and colleagues 
(1992) there were no differences in weight loss between the breakfast and fasting 
interventions. However, there was a tendency (p = 0.06) for greater weight loss in 
those individuals that changed from their habitual behaviour during the intervention 
(i.e a habitual breakfast skipper asked to consume breakfast during the intervention 
and vice versa). Stote and colleagues (2007) report greater total mass and fat loss in 
those consuming only 1 meal per day relative to a 3 meal a day regimen. This 
difference may be partly attributable to the slight reduction in provided energy intake 
during the 1 meal regimen of 65 kcal daily. Additionally, it is important to 
acknowledge that although this intervention did prescribe an extended morning fast, it 
also included omission of lunch as well so is not an equivalent comparison to a 
morning fasting intervention. 
 Therefore, only one randomised controlled trial remains that examined body 
mass change with breakfast omission. The study of Dhurandhar et al (2014) 
implemented a pragmatic intervention involving a recommendation to either consume 
breakfast daily by 10:00 or to not consume anything prior to 11:00 for 16 weeks in 
overweight/obese men and women. They report no difference in weight change 
between those asked to consume or skip breakfast. Additionally, despite using a 
similar definition of habitual breakfast consumption (self-reported frequency ≥ 4 days 
per week) as Schlundt and colleagues (1992), they report no effect of pre-
randomisation consumption habits upon weight change. Considering the much greater 
sample size (283 vs 52) in the more recent work, the authors have suggested that the 
proposed effect of prior breakfast habit upon weight change in an intervention may 
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have been a type 1 error or specific to the intensive nature of the weight loss 
programme delivered in the Schlundt study.             
 
Effect on Metabolic Outcomes 
Only two studies have examined the metabolic outcomes arising from an 
extended morning fasting intervention (Farshchi et al., 2005b; Stote et al., 2007). The 
work of Stote and colleagues (2007) established that individuals only consuming one 
large meal in the evening for 8 weeks had increased concentrations of total, HDL and 
LDL cholesterol concentrations at follow-up. In a less severe and more realistic 
extended morning fasting intervention, Farshchi and associates (2005) report 
increased total and LDL cholesterol in participants who were asked to delay their first 
feeding occasion until 10:30 each morning. In this study, the authors also report no 
difference between fasting measures of insulin sensitivity, or blood glucose and insulin 
profiles to a mixed macronutrient drink. However, a treatment x visit interaction was 
apparent (p = 0.001) for insulin iAUC, with a reduction in insulin response following 
breakfast consumption and an increase after breakfast skipping for 2 weeks. This 
finding was suggested as potentially a reason for the increased cholesterol 
concentrations observed following the no breakfast condition, due to greater insulin 
stimulation of hydroxyl methyl glutaryl-Co-A reductase (one of the rate limiting 
enzymes in cholesterol synthesis). 
 
Effects on Components of Energy Balance 
Of the randomised controlled trials identified, none of the investigations have 
quantified all elements of energy balance. All of the investigations with the exception 
of Dhurandhar and colleagues (2014) have attempted to measure energy intake. 
However, in two of these studies, energy intake was prescribed and therefore is not a 
reflection of volitional eating habits, but the successful implementation of the 
intervention (Schlundt et al., 1992; Stote et al., 2007). Of the three studies that remain 
and did not explicitly define an energy intake target, results obtained are equivocal, 
with increased (Farshchi et al., 2005b), similar (Halsey et al., 2012) and reduced 
(Reeves et al., 2014) total daily energy intake in those that did not consume breakfast. 
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 These varying reported energy intakes may have arisen from differences in the 
nature of the morning fasting and breakfast interventions. In the work of Farshchi and 
colleagues (2005), feeding frequency was strictly prescribed throughout the day, with 
4 time windows for meal and snack intakes following consumption of the same food 
items in the morning in the two conditions (but delayed by 2-3 hours in the no 
breakfast condition). In a slightly less prescriptive model, Halsey and colleagues 
(2012) detected no difference between the morning fasting (no food consumption until 
12:00) and breakfast interventions. However, in this investigation, participants had to 
report to the laboratory in the morning to consume a prescribed high carbohydrate 
breakfast ad libitum. In the only study that has not prescribed either breakfast 
composition, or any other aspect of feeding behaviours, energy intake was found to be 
reduced when individuals were asked to not consume foods prior to 12:00 (Reeves et 
al., 2014). It therefore appears that the reported energy intake of participants may be 
partly dependent upon the level of dietary prescription imposed, and that individuals 
freely choosing all aspects of feeding may consume less energy daily when fasting 
during the morning. 
 Only two studies have measured changes in RMR in response to a morning 
feeding intervention (Farshchi et al., 2005b; Schlundt et al., 1992). Of these, the work 
of Schlundt and colleagues (1992) demonstrated that the weight loss induced by 
caloric restriction in both the breakfast consumption and morning fasting trials 
resulted in similar reductions in RMR, with no differences between the two feeding 
regimens. In accord with these findings, in the two week intervention of Farshchi and 
associates (2005), there was no difference in RMR (or weight/body composition) 
following either the breakfast consumption or skipping regimens. This limited 
evidence suggests that consistently extending a morning fast does not differently affect 
RMR, beyond the associated responses that would be predicted, based upon the 
relative stability or fluctuations of body composition induced by interventions. 
 The two least well understood components of energy expenditure are DIT and 
physical activity energy expenditure. Diet induced thermogenesis after an intervention 
has only been examined by Farshchi et al (2005), with the authors reporting no effect 
on the thermic effect of a mixed macronutrient test drink after either of the morning 
feeding interventions undertaken. Whilst this is a component of energy expenditure 
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that warrants further investigation, DIT contributes a small proportion towards energy 
expenditure. Undoubtedly, the most quantitatively significant and malleable 
component of energy expenditure is physical activity thermogenesis, although this has 
received surprisingly little attention. 
 Only two of the studies identified have examined the impact of their 
interventions upon free-living physical activity. Stote and colleagues (2007) report no 
difference in physical activity measured by accelerometry between individuals 
consuming either 1 or 3 meals per day. It should be noted that participants “were 
encouraged to maintain their normal exercise throughout the study”, so it is entirely 
plausible that any effects of the feeding interventions may be precluded by the 
instruction to continue normal habits. The other intervention that has attempted to 
measure physical activity is the work of Halsey and colleagues (2012). This study 
utilised a combination of pedometers and HR monitors to attempt to quantify 
differences in physical activity. However, these devices were used in University 
students on campus, that had to report to the laboratory to consume breakfast or 
tea/coffee in the morning (where they were provided with the monitors) and then 
returned the monitors between 17:00 and 18:00 each day. Therefore, these records 
provide very incomplete assessments of activity as they were only worn for 
approximately 8 hours a day, and during a time where the majority of their activities 
would be expected to be dictated by their University schedules. It is therefore not 
surprising that apart from an increase in HR during the morning (presumably due to 
DIT) there were no other observed differences in the measures for the breakfast 
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1.13 Aim of Thesis 
This review of literature has examined the evidence relating to omission of 
breakfast upon energy balance and health. Despite entrenched beliefs that breakfast 
consumption has several positive effects for health, the scientific evidence for this 
contention is not convincing. A wealth of cross sectional and prospective literature 
supports that omission of breakfast is associated with an increased risk of adiposity 
but is also associated with a number of other risk factors for obesity and poorer health 
(e.g lower physical activity, greater alcohol consumption etc.). This cross sectional 
evidence cannot be used to establish the existence or direction of a causal relationship 
between breakfast consumption and health. Evidence from randomised controlled 
trials is lacking, with no short term studies examining the hormonal and metabolic 
responses to unbroken fasting prior to ad libitum lunch intake. Free-living 
interventions have generally been of relatively short durations (i.e 1-2 weeks), and not 
measured all components of energy balance or have placed several restrictions upon 
participants. Therefore, the aim of this thesis is to examine the effect of morning 
fasting in both laboratory and free-living studies. A variety of measurement techniques 
will be employed to investigate the effects of morning fasting upon components of 
energy balance and human health in both lean and obese individuals. 
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Chapter 2: General Methods 
 
2.1  Participant Eligibility Criteria 
 
Inclusion Criteria 
 Aged 21-60 
 Body Mass Index 20-25 kg∙m-2 or >30 kg∙m-2 
 Able and willing to safely comply with all study procedures 
 Able to provide written informed consent for participation 
 Females must maintain a record of regular menstrual cycle phase or 
contraceptive use 
 No anticipated changes in diet and/or physical activity habits during the study 
period (e.g. pre-planned holidays, diets/exercise plan, etc.) 
 
Exclusion Criteria 
 Any reported condition or behaviour deemed either to pose undue personal risk 
to the participant or introduce bias into the experiment 
 Any reported use of substances which may pose undue personal risk to 
participants or introduce bias into the experiment 
 Any individual whose habitual lifestyle does not conform to a standard sleep-
wake cycle (e.g. shift workers)  
 Simultaneous or recent (i.e. last 3 months) participation in another clinical trial 
or blood donation, to allow full recovery of blood volume (Pottgiesser et al., 
2008)  
 Any reported recent (i.e. last 6 months) shift (>2%) in body mass, this criteria 
was based upon a more stringent interpretation of the classification of 3% 
variability set out by Stevens et al. (2006) as weight maintenance.   
 Any reported tendency towards keloid scarring  
 Any reported bleeding disorder 
 Females known to be pregnant or planning to become so over the course of the 
study 
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 Females with oral or implanted contraceptives fitted within 6 months of 
participation, due to reported effects upon carbohydrate metabolism (Biswas 
et al., 2001). 
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2.2 Overall Experimental Design 
 The general design of the study involved three experimental phases attempting 
to address three main research questions. 
 Phase 1) Using a randomised, counterbalanced crossover design to establish 
the acute effects of morning fasting and breakfast consumption on energy 
intake, appetite and metabolic responses in a laboratory based protocol. 
 Phase 2) Using a randomised, parallel groups design to establish the effects 
during free-living of chronic adherence to a daily morning fasting or breakfast 
consumption intervention for 6 weeks on all aspects of energy balance and 
markers of metabolic control and cardiovascular disease risk. 
 Phase 3) Establish if the chronic intervention in Phase 2 causes adaptation of 
the acute responses measured in a repetition of the breakfast consumption trial 
from Phase 1 after completion of Phase 2. 
These three phases ran consecutively in the same participants (both lean and obese), 
with the progression through the project displayed in Figure 2.1. 
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Figure 2.1: Overall experimental design showing the progression of participants 
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2.3 Allocation to Experimental Groups 
 
The aim of the project was to test a total cohort of 60-70 men and women in 
the main part of the experiment, half of whom were broadly classified as normal 
weight (BMI ~20-25 kg∙m-2), and the other half obese (BMI ≥30 kg∙m-2). The broad 
classification according to BMI was intended to generate two separate and diverse 
overall populations for subsequent more accurate and gender specific stratification 
based upon DEXA-derived fat-mass index (♂ FMI ≤7.5 kg∙m-2<; ♀ FMI ≤11 kg∙m-
2<), thus controlling for differences in lean tissue (Kelly et al., 2009) allowing separate 
analyses according to obesity status. Furthermore, baseline breakfast habits were 
assessed prior to intervention, and included in our randomisation scheme to broadly 
distribute habitual consumers and those that omit breakfast within the experimental 
groups, with frequent breakfast consumption defined as the ingestion of ≥50 kcal 
within two hours of waking on most days of the week.  Both the above factors were 
included in a stratified randomisation scheme, with generation of 4 separate block 
randomisation schedules. These randomisation schedules were produced by the 
principal investigator using a computer-based random number generator. 
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2.4 Sample Size Estimation 
 
The number of research participants to be recruited was estimated based upon 
a worthwhile effect dictated by the smallest shift in energy balance necessary to induce 
chronic weight loss. In a population not dissimilar to the participants to be used 
(Verboeket-van de Venne et al., 1993), daily energy expenditure measured using 
doubly labelled water from which a mean of ~2870 kcal∙d-1 was established with a 
standard deviation in the region of ~480 kcal∙d-1. The daily breakfast to be consumed 
in the free-living part of this thesis will provide in excess of ~700 kcal∙d-1 with pilot 
work using this breakfast indicating that this is likely to stimulate metabolism in the 
lead up to lunch by ~35 kcal∙d-1 and reduce energy intake at lunch by ~35 kcal∙d-1, 
relative to continued fasting. Therefore, for breakfast consumption to exert a 
worthwhile effect on net energy balance (sufficient to compensate for the energy it 
provides directly), physical activity energy expenditure would need to increase and/or 
subsequent energy intake to decrease by a further 640 kcal∙d-1. Using the above 
figures, a worthwhile increase in energy expenditure would require ~14 participants 
in each treatment group to confer a 90% probability of detecting such an effect 
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2.5 Standardisation Prior to Laboratory Visits 
 Participants were assigned (but did not commence; Figure 2.1) their free-living 
intervention prior to attending the laboratory for their first laboratory trial. Participants 
were asked to fast overnight (≥10 h) prior to arrival at 08:00 ± 1 h, with subsequent 
trials commencing within an hour of the first visit and the timeframe stated above. In 
the 48 h prior to their first lab visit for each phase of the trial, participants kept a 
weighed food diary, which they subsequently replicated prior to corresponding visits 
to the laboratory. Participants were permitted to keep two food diaries, one for feeding 
trials in phases 1 and 3, and another for the pre- and post-intervention laboratory visits 
in phase 2. During the two mornings prior to all laboratory visits, participants were 
asked to follow their assigned free-living intervention dietary pattern (i.e ≥700 kcal by 
11:00 or fasting until 12:00). In the 24 h before a lab visit, individuals were asked to 
refrain from caffeine and alcohol intake and avoid strenuous physical activity. Upon 
waking on the day of laboratory testing participants consumed 568 ml of plain water 
to promote adequate hydration. Between laboratory visits participants either continued 
their normal lifestyles or undertook their free-living intervention as appropriate 
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2.6  Laboratory Methods 
 
2.6.1  Blood Sampling 
All bloods were obtained via cannula inserted into the antecubital fossa of 
participants, with the cannula kept patent through regular flushing with 0.9% Sodium 
Chloride infusion (B.Braun, UK). Samples were drawn from a 3-way tap, with the first 
5 mL of blood drawn discarded to avoid contamination with saline.  
 
 Plasma Samples 
Blood was dispensed into tubes coated in the anti-coagulant 
ethylenediaminetetraacetic acid (EDTA) (Sarstedt Ltd, UK). They were then 
immediately centrifuged at 3466 x g rpm for 10 minutes at 4 ˚C (Biofuge Primo R, 
Heraeus, Germany), with the plasma fraction removed and cooled using dry ice until 
subsequent storage at -80 ˚C. 
 
Serum Samples     
Blood was dispensed into a plain blood tube with no anti-coagulant treatment 
(Sarstedt Ltd, UK) and left at room temperature to clot for 45 minutes. They were then 
centrifuged at 3466 x g for 10 minutes at 4 ˚C (Biofuge Primo R, Heraeus, Germany). 
The serum fraction was then removed and cooled using dry ice until storage at -80 ˚C. 
 
Samples for Analysis of Acylated Ghrelin 
One mL of whole blood was dispensed into a tube coated in EDTA (Sarstedt 
Ltd, UK) which had 50 µL of a p-hydroxymercuribenzoic acid solution (prepared as a 
100 mM concentrate solution in potassium phosphate buffer containing 1.2% 10 N 
NaOH) added to prevent the degradation of acylated ghrelin by proteases (Chandarana 
et al., 2009). Samples were then centrifuged at 3466 x g for 10 minutes at 4 ˚C. Five 
hundred µL of the supernatant was then transferred to an untreated blood tube to which 
10 µL 1 N hydrochloric acid had been added. Samples were centrifuged again as 
described above, with the supernatants removed, cooled using dry ice and then stored 
at -80 ˚C. 
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Arterialisation of Venous Bloods 
In obese participants during collection of blood samples for measurement of 
glucose and insulin for assessment of insulin sensitivity in Chapter 7, a “heated hand” 
technique for arterialisation of venous blood was used (Gallen and Macdonald, 1990). 
This technique was employed to enable measurement of blood glucose more reflective 
of arterial levels prior to metabolism by the tissues of the forearm. 
Prior to any measurements being obtained the hand was warmed for 15 
minutes, which has been demonstrated by Kurpad et al (1994) to cause sufficient 
arterialisation, as demonstrated by increased PO2 from 67 % to 96 % following 10 
minutes of heating. The chosen method utilises static air at 55 ˚C to heat the hand, 
which has previously been shown to minimally affect core temperature (Gallen and 
Macdonald, 1990), and cause less hemodynamic disturbance than use of direct heating 
using a warming blanket (Blaak et al., 1992). As suggested by Frayn and MacDonald 
(1992), to reduce the potential muscle mass for metabolism, cannulation was 
performed retrograde in the dorsal veins of the heated hand.   
Quantitatively, in the context of hyperglycaemia induced during a clamp 
procedure, McGuire and colleagues (1976)  have indicated that in a forearm vein the 
A-V difference in glucose was approximately 43 % 2 minutes into glucose infusion, 
and reduced to around 15 % by the end of the 70 minute clamp procedure. In a heated 
hand condition this difference was around 11 % at 2 minutes and was reduced to the 
basal difference by 50 minutes. While this response may be exaggerated relative to the 
oral glucose tolerance test being conducted in the present work; it would seem to 
indicate that metabolism of the tissues in the forearm is a potentially significant 
moderator of measured blood glucose, particularly within a hyperinsulinaemic 
environment as would be expected (at least transiently) during a glucose challenge. 
This methodology only became available for use in our laboratory following 
completion of the majority of the testing of lean participants as presented in Chapter 
4. While this must be taken into consideration when attempting to directly compare 
between participants in the lean and obese groups, for the main comparisons of pre-
post intervention insulin sensitivity within groups, there is no evidence to suggest that 
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the pattern of results obtained using venous blood would be different in response to 
the intervention.  
 
2.6.2 Analysis of Blood Samples 
 Analysis of blood samples for concentrations of triglycerides, non-esterified 
fatty acids (NEFA), glucose, C-Reactive Protein (CRP), urea, total cholesterol and 
high density lipoprotein (HDL) cholesterol were conducted on a Daytona (Randox 
Laboratories, Crumlin, NI) automated analyser according to manufacturer instructions 
using commercially available immunoassays (Randox Laboratories, Crumlin, NI). 
Low density lipoprotein (LDL) cholesterol was estimated using the Friedewald 
equation (Friedewald et al., 1972). This equation calculates LDL cholesterol as the 
following: 
 
LDL Cholesterol = Total Cholesterol – HDL Cholesterol – (Triglycerides / 2.2) 
 Total and acylated ghrelin (Bertin Pharma, Montigny le Bretonneux, France), 
PYY and total GLP-1 (Merck Millipore, Billerica, USA), adiponectin and leptin (R&D 
Systems Inc., Abingdon, UK) and insulin (Mercodia AB, Uppsala, Sweden) analyses 
were conducted using commercially available enzyme-linked immunosorbent assays 
(ELISA) according to manufacturer instructions. For all blood analyses, all samples 
for each participant (i.e each laboratory visit for the same person) were completed on 
the same ELISA plate or analyser run. Where samples were undetectable by the 
analysis method employed, they were included as the lowest detectable concentration 
for the purposes of statistical analysis.  Further details of the biochemical analyses 
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Table 2.1: Intra-assay and inter-assay coefficient of variation of assays employed* 
Parameter Intra-Assay (CV) Inter-Assay (CV) 
Total Cholesterol < 4 % < 2 % 
HDL Cholesterol < 4 % < 3 % 
Triglycerides < 4 % < 4 % 
NEFA < 5 % < 5 % 
CRP < 3 %  < 5 % 
Glucose < 5 % < 6 % 
Urea < 5 % < 3 % 
Total Ghrelin 4.0 % 7.8 % 
Acylated Ghrelin 4.2 % 11.3 % 
PYY 4.3 % 11.1 % 
GLP-1 4.8 % 27.0 % 
Adiponectin 4.0 % 6.3 % 
Leptin 3.4 %  6.4 % 
Insulin  4.7 % 12.5 % 
*Where intra- and inter-assay CV is displayed as “less than” the CV is established 
across multiple quality controls, therefore the greatest of these is listed.  
 
2.6.3  Urine Collection 
 Participants’ urine was collected in a vessel containing 5 mL of 10 % thymol 
isopropanol which acted as a preservative. For a given measurement period the 
collected urine was mixed thoroughly, with a 1 mL aliquot obtained and kept at -80 
˚C prior to analysis. Analyses of urinary urea were conducted using a commercially 
available immunoassay on a Daytona automated analyser according to manufacturer 
instructions (Randox Laboratories, Crumlin, NI).     
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2.6.4 Expired Gas Analysis 
All samples of expired air were collected for a 5 minute duration. A minute 
prior to commencement of sampling, participants were provided with a nose clip and 
the respiratory valve in order to clear any atmospheric air from the apparatus. The 
respiratory valve was connected to a 200 L Douglas Bag (Hans Rudolph, MO, USA) 
via falconia tubing (Baxter, Woodhouse and Taylor, UK). The obtained samples were 
then run through tubing containing anhydrous calcium sulphate (Drierite, OH, USA) 
to remove water content from the samples. Relative proportions of O2 and CO2 were 
then measured in a known volume of the sample using paramagnetic and infra-red 
analysers, respectively (Servomex 1440, UK). This analyser was calibrated on the 
morning of each testing day using two gases of known composition of ~0 % and 16 % 
O2 and ~0 % and 5 % CO2, respectively (British Oxygen Company, UK). The volume 
of expired air (V̇E) was established using a dry gas meter (Harvard Apparatus, UK), 
with the temperature of the expired gases measured using a CheckTemp1C (Hanna 
Instruments, RI, USA) during evacuation from the Douglas bags.  
Where possible, atmospheric conditions within the laboratory were obtained 
for each individual gas collection due to the potential effects of differences in 
atmosphere within confined environments (Betts and Thompson, 2012). This involved 
measurement of laboratory temperature using a Testo 625 thermohygrometer (Testo, 
UK) and measurement of the composition of inspired gases (within ~1 metre of the 
participant during expiration into the Douglas Bag) as described above. Where this 
was not feasible, established laboratory norms for O2 and CO2 were used instead.  
 
2.6.5 Calculation of Energy Expenditure  
Expired air samples were converted to the standard temperature (0 ˚C) and 
pressure (760 mmHg) for a dry gas. The Haldane Transformation was used to 
determine inspired gas volumes (V̇I), such that rates of both oxygen utilisation (V̇O2) 
and carbon dioxide production (V̇CO2) could be calculated (Frayn, 1983). These rates 
were then used to calculate energy expenditure using the methods of Weir (1949) 
utilising the methods of establishing urinary nitrogen excretion of (Jequier et al., 
1987).  
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Energy expenditure was thus established using the following equation: 
 
EE = 3.941 x V̇O2 + 1.106 x V̇CO2 + 2.17 x Nitrogen Excretion 
 
2.6.6 Measurement of Resting Metabolic Rate 
 Measurements of resting metabolic rate (RMR) were obtained in accordance 
with the guidelines for best practice set out by Compher and colleagues (2006). 
Participants were asked to lie supine in the laboratory (which was maintained between 
20-25 ˚C) for a period of 15 minutes prior to any measurement, during this time 
procedures were explained fully to the participant. Upon completion of the quiet rest 
period, participants were then familiarised with the mouthpiece and breathing 
apparatus, which also acted to flush atmospheric air from the tubing of the system. 
Four expired air samples of five minutes duration were then obtained. These samples 
were then analysed as previously described, with three measured daily energy 
expenditures within 100 kcal agreement deemed acceptable variation. The mean of the 
values within 100 kcal were then taken to represent RMR. If the first 4 measurements 
obtained did not provide samples of acceptable agreement, then additional measures 
(up to a maximum of six samples) were taken until the criteria described above were 
fulfilled. 
 
2.6.7  Diet Induced Thermogenesis 
 
For establishing diet induced thermogenesis (DIT) during laboratory visits, 5 
minute expired gas samples were obtained hourly, after meals (for 3 hours post-
breakfast and 3 hours post-lunch), in a semi-supine position following 5 minutes of 
complete rest. Diet induced thermogenesis was calculated as the mean energy 
expenditure over each 3 hour period of measurement minus the resting energy 
expenditure from the corresponding lab visit (i.e at baseline on the same day). 
 
Chapter 2  General Methods 
80 
2.6.8 Dual Energy X-Ray Absorptiometry  
 Dual Energy X-Ray Absorptiometry (DEXA) scans were performed (QDR, 
Discovery W, Hologic, UK) prior to and after the free-living intervention. Prior to 
each scan, the device was calibrated using a quality control material provided by the 
manufacturer. Scans were normally performed at ~7.30 ± 1 h with participants 
overnight fasted, having consumed 568 mL of plain water upon waking and having 
voided immediately prior to scans. Participants were scanned in light clothing (i.e 
shorts for men and athletic clothing for women). Participants were positioned centrally 
on the scanning bed; with feet spread apart and hands placed in a mid-prone position 
such that there was a gap between the arms and trunk. This allowed regions of interest 
to be defined by an operator using the software provided by the manufacturer (QDR 
for Windows, Hologic, UK). The device operator was the same for both scanning 
occasions, with the same individual analysing participants’ scans pre- and post-
intervention. In certain cases due to availability of the scanning equipment, 
participants were scanned following the OGTT on Phase 2 trials. In these instances 
participants were scanned at the same time on both occasions due to the observed 
effects upon body composition of daily activities and food ingestion (Nana et al., 
2011). Scans were analysed for assessment of total fat mass, lean body mass, and 
percentage body fat. Fat mass index was calculated as fat mass in kilograms estimated 
by DEXA divided by height in metres squared, with classification of obesity status 
according to the criteria established by Kelly and colleagues (2009). 
 
2.6.9 Anthropometry  
Height was measured and recorded to the nearest 0.1 cm using a fixed 
stadiometer (Holtain Ltd, UK). Body mass was measured post-void in light clothing 
(i.e shorts for men and athletic clothing for women) to the nearest 0.1 kg using 
electronic scales (Tanita Corporation, Japan). Waist circumference was taken as the 
midway point between the lowest rib and the top of the iliac crest, with hip 
circumference taken as the widest part of the buttocks. For both of these measures, 
measurements were obtained in triplicate, with an acceptable range of 1 cm for the 
three measurements. If this was not achieved in the first three measurements additional 
measurements were obtained until this criteria was met, with the mean of the three 
observations within 1 cm used. Sagittal abdominal diameter was measured using a 
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manual abdominal calliper (Holtain Ltd, UK), with participants supine and upon 
gentle expiration, at the level of the umbilicus. Three measures were obtained, with 
the mean of these measures used. All anthropometric measures were obtained by the 
same experimenter pre- and post-intervention for the same participant.     
 
2.6.10 Adipose Tissue Biopsies 
Subcutaneous abdominal adipose tissue biopsies were carried out under local 
anaesthetic. The area to be biopsied was first cleaned superficially using Videne 
(Ecolab, UK) and then anaesthetised using 1 % Lidocaine (Antigen Pharmaceuticals, 
UK) injected in a fan pattern to the subcutaneous adipose tissue parallel to the 
umbilicus using a 27G needle. Following 5 minutes to allow the anaesthetic to take 
effect, a 14G needle was then attached to a 60 mL syringe containing ~5 mL of 0.9 % 
Sodium Chloride infusion (B.Braun, UK). The plunger was removed to create a 
vacuum which was maintained throughout the biopsy. The needle was then inserted 
into the anaesthetised area and rocked gently for ~2 minutes to yield ≥ 500 mg of 
adipose tissue. Once sufficient tissue was removed, pressure was immediately applied 
to the biopsy site to minimise bruising.  
2.6.11 Oral Glucose Tolerance Test 
Participants consumed a glucose solution, comprised of 140 g of an orange 
flavoured high energy carbohydrate supplement (Polycal, Nutricia, UK) providing 75 
g of glucose, diluted with water to a volume of 200 mL. In addition, participants 
consumed a further 100 mL of water from the same glass after they had consumed the 
glucose solution to ensure all of the glucose solution had been consumed and secondly, 
to allow the participant to clear any remaining glucose solution from the mouth. 
Following complete ingestion of the glucose solution, 5 mL blood samples were 
obtained every 15 min hereafter, with the final sample drawn at 120 min. 
 
2.6.12 Insulin Sensitivity Indices 
 Analysis of the OGTT results included calculation of the incremental area 
under the curve (iAUC) for insulin and glucose concentrations according to the 
method recommended by Wolever (2004).  Both the homeostatic model assessment 
of insulin resistance (HOMA-IR) (Matthews et al., 1985) and composite index of 
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insulin sensitivity (C-ISI) (Matsuda and DeFronzo, 1999) indexes were calculated 
using the plasma glucose and serum insulin concentrations from the oral glucose 
tolerance tests. These were calculated using the following formula: 
HOMA-IR = ((Fasting Glucose (mmol·l-1) x Fasting Insulin (μIU·ml-1)) /22.5 
C-ISI = 10000/SQRT ((Fasting Glucose (mg·dl-1) x Fasting Insulin (μIU·ml-1))  
x (Mean Glucose over OGTT (mg·dl-1) x (Mean Insulin over OGTT (μIU·ml-1)) 
 
2.6.13 Appetite Sensations 
Paper based, 100 mm visual analogue scales were used to assess subjective 
appetite. Participants marked on 100 mm vertical lines their response to questions 
assessing desire to eat, hunger, fullness and prospective consumption with anchor 
terms on each end of the scale (e.g not at all hungry vs as hungry as I have ever felt). 
Higher scores were indicative of greater sensations. A composite hunger score 
(Anderson et al., 2002) was calculated as the following:  
 
(Desire to Eat + Hunger + (100-Fullness) + Prospective Consumption) /4. 
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2.7 Free-Living Measurements 
 
2.7.1  Diet Analysis  
 For the analysis of energy intake, participants maintained weighed dietary 
records. Weighed records have been shown to be a more valid measure of energy 
intake than food dietary recall methods (Martin et al., 2002). Weighing of foodstuffs 
also negates the potential error in estimation of weight as Gittelsohn and colleagues 
(1994) have reported lower accuracy of weight estimates in foods of high volume and 
low weight. Participants maintained these records for a 7-day period, allowing an 
accurate representation of energy intake, as previous work has shown variation 
between weekday and weekend energy intake (Whybrow et al., 2008). This also 
allowed an analysis of measured energy balance, as this period was simultaneous with 
a 7-day period of physical activity energy expenditure measurement.  
Details for individual food items were, wherever possible, obtained directly 
from manufacturers information on composition. These foods were then added to a 
database of “custom” food items that was accessible within the dietary analysis 
software for reference by the investigators. In instances where this was not possible 
(as information on brand was not provided or composition data was not available), or 
food was fresh (e.g fruits and vegetables) then foods were analysed using the standard 
food database information of Compeat Pro 5 diet analysis software (Nutrition Systems, 
UK). This programme utilises a UK integrated database based upon McCance and 
Widdowson’s 6th Edition of The Composition of Foods (McCance et al., 2002).  
 Total energy intake and the percentage of energy intake from carbohydrates, 
fats, protein and alcohol were calculated. Additionally, the proportion of 
carbohydrates in participants’ diets composed of sugars and starch were calculated as 
well as the proportion of saturated fat. Diets were analysed for each 24 hour period 
and also for pre- and post- 12:00. For analysis of feeding frequency, meals were 
defined as > 300 kcal intake, and distinct from another meal by > 45 minutes, with 
snacks defined as other feeding occasions (de Castro, 1994a).   
It is reasonably well established that food records are liable to error, 
particularly underreporting (Poslusna et al., 2009). While there is much literature 
pertaining to the assessment of dietary records for feasibility (Black, 2000b; Goldberg 
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et al., 1991), in the present work previously proposed cut offs were not employed. 
While this may introduce some error due to unidentified underreporting, Black (2000) 
has identified that cut offs have little application on an individual basis. Additionally, 
weight change is one of the potential outcomes in the current work; therefore 
excluding dietary records on the basis that long term weight stability would not be 
maintained is not appropriate as this may be an outcome of the intervention period. 
       
2.7.2 Continuous Glucose Monitoring Systems 
  
Continuous glucose monitors (CGMS) were used to assess free-living glucose 
concentrations (CGMS® iPro, Medtronic MiniMed, USA). The device chosen has 
been previously shown to provide acceptable clinical accuracy in ≥ 95 % of 
measurements in type 1 diabetics (Sachedina and Pickup, 2003; Gross et al., 2000) as 
defined by the Clarke error grid which classifies the agreement between a glucose 
measure and a reference value (Clarke et al., 1987). Using this methodology, the two 
values are plotted to establish if the two measures are considered clinically accurate 
(Zone A-within 20% of criterion) or the difference is a benign error (Zone B) that 
would not result in the absence of necessary clinical intervention or inappropriate 
treatment. Anything outside of these two zones are not considered clinically 
acceptable. In a pilot study of accuracy in healthy subjects during daily activities it has 
been suggested that there was no statistically significant difference between CGMS 
and fingerprick data (Derosa et al., 2009), although this does not necessarily indicate 
good agreement.  
One of the main differences between measured interstitial glucose 
concentrations and blood glucose is a lag in changes of interstitial glucose (Dye et al., 
2010; Mazze et al., 2009). Indeed, lag of interstitial glucose concentrations has been 
reported in type 1 diabetics consuming two liquid meals over an 8 hour period (Boyne 
et al., 2003). Cheyne and colleagues (2002) investigated controlled hypoglycaemia 
(2.5 mmol∙l-1) in healthy individuals and reported that the detection of the return to 
euglycaemia after hypoglycaemia was delayed by an average of 26 minutes, although 
the overall agreement with blood glucose was good with a mean absolute error of 7 ± 
15 %.  
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The reproducibility and validity of the device for identifying hypoglycaemia 
in free-living type 1 diabetics has been described by Hoi-Hansen and colleagues 
(2005). They report that in participants fitted with two CGMS devices that when one 
device was recording a hypoglycaemic episode (≤ 2.2 mmol∙l-1) in 91 % of occasions 
the other device was either also registering an episode (54 %) or interstitial glucose of 
>2.2-3.5 mmol∙l-1 (37 %). When comparing CGMS results with a limited number of 
self-monitored blood glucose readings of hypoglycaemia 94 % were again either 
registering hypoglycaemia (53 %) or in the range of >2.2-3.5 mmol∙l-1 (41 %).         
 
Due to the nature of the device, the CGMS device has been predominantly 
validated in type 1 diabetics and with a focus on clinical accuracy (as described above). 
There is a lack of validity and reliability data in normal populations during free-living. 
In particular, there is a paucity of data in healthy, obese populations describing the use 
of this device and reliability and validity in obese individuals. Future research should 
also focus on establishing normal ranges in obese, healthy individuals as has been 
established in normal weight individuals (Juvenile Diabetes Research Foundation 
Continuous Glucose Monitoring Study Group, 2010; Hill et al., 2011). 
Devices were employed as follows; electrochemical sensors utilising glucose 
oxidase were inserted into the subcutaneous abdominal tissue of participants using a 
lancing device provided by the manufacturer. This was then connected to a monitor 
secured in place by adhesive plasters (IV3000, Smith and Nephew, UK). The CGMS 
monitor took measures of interstitial glucose every 5 minutes, and was worn for 3-4 
days. The indwelling sensor and monitor were replaced at this point, with a total wear 
time of 7 days. The monitors were retrospectively calibrated against capillary 
fingerprick glucose readings (Freestyle Lite, Abbott Diabetes, UK) obtained 4 times a 
day prior to meals using software provided by the manufacturer (Solutions Software 
for CGMS iPro version 2.2a, Medtronic Minimed USA). This is relevant as 
Buckingham et al (2006) report lower accuracy of calibration during periods of high 
rates of blood glucose change potentially due to the lag in interstitial blood glucose  
(Dye et al., 2010; Boyne et al., 2003). Participants were blinded to the readings of the 
fingerprick glucose monitors to prevent any behavioural adaptation to the perception 
of blood glucose level acceptability.  
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Participants maintained logs of waking and sleeping times during the two 
weeks of free-living monitoring, the results obtained from these logs were used to 
divide the day into periods from waking to 12:00, 12:00 to sleeping and sleeping. For 
these defined periods as well as the day as a whole, CGMS data for glucose was 
analysed for mean, standard deviation and coefficient of variation.  
 
2.7.3 Combined Heart Rate Accelerometry  
  
For the measurement of physical activity energy expenditure a combined heart 
rate-accelerometry monitor was used (Actiheart®, Cambridge Neurotechnology, UK). 
The Actiheart® is a non-invasive monitor, weighing less than 8g. Participants wore 
the monitors for 9 days (providing 7 full days of measurement) mounted on the chest 
using adhesive electrode pads (3M, UK) and were informed to wear the monitors 
continuously, only removing the monitors for washing or water based activities. This 
device has been shown to be reliable and valid (Brage et al., 2005) and able to 
accurately estimate energy expenditure in low to moderate intensity activities 
(Thompson et al., 2006). The monitor was used in the group calibration setting using 
participants’ sleeping heart rate and gender (Brage et al., 2007). Due to the intensive 
nature of the experimental protocols involved for participants and substantive time 
commitment it was not feasible to include an individual calibration of these devices. 
This was primarily as for some participants the exercise involved in individual 
calibration would have been unaccustomed and as participants began their 
measurement of physical activity intervention immediately after their baseline visit, 
and therefore some modification of physical activity habits during this period may 
have occurred as a result. Due to the already heavy participant burden it was not 
deemed practical to include an additional laboratory visit for an exercise test to be 
conducted prior to beginning the free-living intervention.      
  Unlike many hip mounted accelerometers this device allows for greater wear 
time and therefore a more accurate picture of physical activity as there is less error due 
to bias from imputing of data (Catellier et al., 2005). Participants also maintained 
physical activity diaries, providing contextual information about patterns of wear. 
Where participants removed the monitor and reported increased physical activity (i.e 
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swimming) energy expenditure was interpolated using the Compendium of Physical 
Activities (Ainsworth et al., 2011).  
 
2.7.4 Data Handling 
 Whilst the use of physical activity monitors is widespread in research settings, 
there have not been clear guidelines set out for many parameters such as duration of 
monitor wear (Matthews et al., 2012) or in fact what constitutes a valid day of 
measurement (Paul et al., 2008). This is in some respects understandable, as decisions 
relating to these key outcomes will be study specific (Heil et al., 2012). A particular 
weakness of the literature pertaining to the use of Actiheart® is a lack of information 
relating to the handling of data after collection. Considered in detail subsequently are 
the methods and rationales for dealing with the processing of physical activity traces 
obtained.   
During wear there are occasions that the Actiheart® temporarily loses heart 
rate signal. During these occasions the monitor uses “recovered” HR observations and 
gives a 75% weighting to accelerometry based estimates of energy expenditure. While 
this is a pragmatic and practical approach to obtaining the greatest number of measures 
possible there are two main issues associated with this approach. Firstly, experiences 
from our laboratory indicate the “recovered” HR would seem to underestimate HR 
compared with what would be expected based upon the corresponding accelerometry 
data and activity diaries (see Figure 2.2 below). It would seem to follow that electrical 
conduction with the chest is reduced potentially when the unit is knocked, or during 
periods when the electrode pads may be less secure (i.e sweating). Therefore, the HR 
based component of energy expenditure would tend to be underestimated.  
The strength of the energy expenditure estimates made by the device is based 
upon the combination of both the measures of heart rate and accelerometry (Brage et 
al., 2004). It is also particularly pertinent that investigations using Actiheart® have 
found that the accelerometry only based estimates when compared with other 
prediction models were the least predictive of energy expenditure (Crouter et al., 2008; 
Spierer et al., 2011). Therefore, in the present work it was decided that due to the 
potential modification of the energy expenditure estimates using this data that a criteria 
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of no greater than 22.5% of a given 24-hour period could be comprised of “recovered” 
data. 
 
Figure 2.2: Example of “recovered” HR data from the Actiheart® device. Measured 
acceleration is displayed as the black bars, while heart rate is displayed as the red trace, 
“recovered” HR data is displayed in blue. The estimated energy expenditure is 
displayed as green bars in the bottom panel.   
Due to the convenient nature of the device, potential wear time of the monitor 
is high relative to accelerometers. Therefore, for a day of wear to be classified as valid 
the percentage of time not lost (i.e through non-wear not including time accounted for 
in water based activity) was set at 90% of a 24 hour period. This figure was selected 
to minimise the potential error by imputation of data (Catellier et al., 2005). For each 
day where there was a proportion of lost data, the measured data was transformed to a 
24 hour equivalent energy expenditure estimate. 
The determination of the number of days required to assess physical activity 
in accelerometers has been considered at length by Matthews et al (2002). The authors 
propose a monitoring period of 3-4 days to achieve 80% reliability in activity counts. 
In the present work an acceptable number of valid (as defined by fulfilling of the two 
criteria set out above) days of monitoring was ≥4 days, to include one weekend day, 
due to potential for differences in weekday to weekend activity patterns (Matthews et 
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al., 2002). Participants were only included in the physical activity analysis if both 
weeks of recording met the criteria outlined. The criteria for inclusion in data analysis 
are summarised in Figure 2.3. 
 
Figure 2.3: Schematic of the data analysis process for physical activity data. 
 The physical activity data obtained was analysed for total physical activity 
energy expenditure, as well as energy expenditure according to intensity for both pre- 
and post-12:00. This was classified as energy expenditure expressed as multiples of 
measured resting metabolic rate ((i.e metabolic equivalents, METs (Ainsworth et al., 
2000)). These intensity domains for physical activity were based upon previously 
established cutoffs (Haskell et al., 2007; Pate et al., 2008). 
  
2.7.5  Lifestyle Maintenance Data 
Lifestyle maintenance/monitoring was applied to any willing participant 
eligible for randomisation into the breakfast/fasting treatment groups (thus broadly 
equivalent to the main study population) but unable to commit to the main study for 
other reasons (e.g. impossible to schedule trials in the required time-frame, unwilling 
Actiheart monitor worn for 7 days
Traces checked visually for sensor malfunction 
Data inputted for active periods of non-wear (i.e swimming)
Days excluded if exceeding either 10 % "lost" or 22.5 % 
"recovered" data 
Physical activity measurement periods with ≥4 days remaining 
(including a weekend day) included in analysis
Energy expenditure for remaining days converted to 24-hour 
equivalent estimates 
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to provide tissue samples, etc.). Monitoring free-living responses in the absence of any 
intervention therefore provides context regarding the extent to which those free-living 
measures alone (i.e. dietary and physical activity monitoring) may impact typical 
energy intake (2391  626 kcal·d-1), physical activity levels (1230  603 kcal·d-1) and 
change in body mass body mass over 6 weeks (-0.09 kg; 95% CI = -0.8, 0.6) under 
conditions where diet and physical activity are monitored as applied in the main 
experiment. 
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Chapter 3: Morning fasting is incompletely 
compensated for at an ad libitum lunch and causes 
altered second meal metabolism during the 
afternoon in lean adults 
 
3.1  Introduction 
Regular breakfast omission is associated with many negative health outcomes, 
including greater risk of obesity (Ma et al., 2003; Horikawa et al., 2011),  prospective 
weight gain (Purslow et al., 2008), type 2 diabetes (T2D) (Mekary et al., 2013; Mekary 
et al., 2012) and coronary heart disease (Cahill et al., 2013b). These detrimental 
associations are particularly relevant as Reeves et al. (2013) have suggested that 30% 
of British adults occasionally skip breakfast. As increased adiposity is due to chronic 
positive energy balance; laboratory studies have understandably explored a possible 
role of daily breakfast in regulating energy intake (EI) and associated metabolic 
responses. However, the major focus of previous research on this topic has been to 
contrast breakfasts of varied quantity or composition, for example by manipulating 
macronutrient (Clegg and Shafat, 2010), fibre (Hamedani et al., 2009; Kim et al., 2009; 
Levine et al., 1989; Liljeberg et al., 1999), energy content (Martin et al., 2000) and/or 
glycaemic index (Rosen et al., 2011; Nilsson et al., 2008). In contrast, far less attention 
has been given to comparing the effects of breakfast consumption versus morning 
fasting upon acute energy intake. 
   
Studies that have compared energy intake following morning fasting with a 
variety of breakfasts have yielded equivocal results, with both reduced (Gonzalez et 
al., 2013; Levitsky and Pacanowski, 2013) and similar (Astbury et al., 2011) daily 
energy intakes observed with several permutations of fixed intake and ad libitum 
feedings throughout the day. While some research has attempted to address the impact 
of morning fasting upon acute energy intake, to the authors’ knowledge, only two 
studies have measured the hormonal and appetite responses to morning fasting and 
breakfast consumption followed by an ad libitum lunch (Astbury et al., 2011; 
Gonzalez et al., 2013). Whilst these studies provide valuable information regarding 
regulatory hormones and energy intake at an ad libitum lunch in response to breakfast 
omission, both of these designs employed a mid-morning preload (250 and 358 kcal) 
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that was consumed in both trials prior to the provision of the lunch. As a result, in both 
breakfast skipping conditions the participants had not undertaken unbroken fasting 
prior to eating the ad libitum lunch. The aforementioned design therefore provides an 
appropriate analogy with an individual that has skipped breakfast but then “snacked” 
prior to eating lunch, yet the hormonal and metabolic responses following an ad 
libitum lunch after unbroken morning fasting are yet to be determined.        
 
The current study examines acute energy intake, appetite regulatory hormones 
and metabolic responses after extended morning fasting relative to a standardised 
breakfast. We hypothesise that morning fasting will result in incomplete EI 
compensation (i.e increased intake at lunch but not of an equivalent magnitude as 
breakfast intake) but greater appetite sensations and orexigenic hormone responses 
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3.2  Participants and Methods 
 
3.2.1 Participants 
Thirty five healthy, lean men (n = 14) and women (n = 21) aged 22-56 y took 
part in this study. Participants were recruited via local advertisement from South West 
England and were initially assessed for eligibility based upon a body mass index of 
18-25 kg·m-2 and then later classified as lean based upon DEXA-derived fat mass 
indices of ≤7.5 kg·m-2 (men) and ≤11 kg·m-2 (women) (Kelly et al., 2009). The study 
was part of a wider randomised controlled trial (the Bath Breakfast Project). In 
accordance with the full eligibility criteria set out in Chapter 2, participants reported 
being weight stable ( 2% body mass within past 6 months) and adhered to a standard 
sleep-wake cycle (e.g no shift workers) and did not anticipate any change in lifestyle 
during the study period. Participants were free of metabolic disorders, with pre-
menopausal female participants either menstruating regularly, or following their 
chosen contraceptive method (i.e pill, implant) for >6 months. Within the study cohort 
there was a mix of regular breakfast consumers (classified as >50 kcal intake within 2 
hours of waking on ≥4 days of the week) and non-consumers. Characteristics of 
participants are presented in Table 3.1. 
 Written informed consent was obtained from all participants, with the Ethical 
Approval for the study obtained from the NHS Bristol Research Ethics Committee. 
The study is registered with Current Controlled Trials [ISRCTN31521726]. 
Table 3.1: Participant characteristics 
*Fat mass index calculated as DEXA derived total fat mass divided by height squared. 
Data presented are Mean with (SD) 
Characteristic 
n 35 
Age (y) 36 (11) 
Body Mass (kg) 67.9 (9.2) 
Body Mass Index (kg/m2) 22.7 (2.5) 
Fat Mass Index (kg/m2)* All 5.7 (2.2) 
Female 6.7 (2.0)  
Male 4.1 (1.4) 
Habitual Breakfast Consumers (n) 27 
Female (n) 21 
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3.2.2 Study Design 
 Each participant undertook a randomised, counterbalanced crossover design 
involving two laboratory based feeding trials in the Human Physiology Laboratories 
at the University of Bath. These trials were separated by 3-28 days where participants 
resumed their habitual routine, with eumenorrheic women undergoing testing during 
the follicular phase of the menstrual cycle (3-10 days after the onset of menses) to 
standardise any effects of phase upon appetite hormones and energy intake between 
trials (Buffenstein et al., 1995; Lissner et al., 1988). 
3.2.3 Protocol for Laboratory Visits 
 The protocol during experimental visits is displayed in Figure 3.1. Upon arrival 
at the laboratory at 08:00  1 h, adherence to standardisation measures as described in 
Chapter 2 was confirmed verbally. Participants then voided and had body mass 
measured in light clothing (Seca 873, Vogel and Halke). On their first visit to the 
laboratory, following 20 minutes of quiet rest, resting metabolic rate was assessed in 
a supine position by repeated 5 minute expired gas samples over ~30 minutes, 
according to best practice (Compher et al., 2006). During the second visit to the 
laboratory, another resting sample was obtained for comparison with energy 
expenditure during that trial and to confirm the previously measured value from the 
first visit. A cannula was then inserted into an antecubital vein, with a baseline sample 
of 15 mL blood obtained and further samples acquired at regular intervals throughout 
the day. Participants were then provided with either a breakfast (to be consumed within 
15 minutes) or asked to rest for the same duration, with blood samples taken at 15 
minutes, 30 minutes and an hour post completion of the breakfast period. One hour 
after the breakfast/rest period, an expired gas sample was obtained for assessment of 
diet-induced thermogenesis. Blood and gas samples were then obtained hourly until 3 
h post breakfast, at which point an ad libitum lunch was provided. The lunch period 
was of 30 minute duration. Samples of blood and expired gas were obtained hourly 
after completion of the lunch period for a further 3 hours, with the first samples 
obtained an hour after lunch was finished. Participants also completed visual analogue 
scales relating to hunger and appetite throughout the day. During the day participants 
remained sedentary and completed quiet activities such as reading, watching television 
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and typing. Full details of techniques and measurements employed are described in 
Chapter 2. 
Figure 3.1: Schematic of experimental protocol. RMR=Resting Metabolic Rate, 
B=Breakfast consumption, F=Fasting, L=Ad libitum lunch  
3.2.4 Breakfast 
 The breakfast consisted of Corn Flakes (Kellogg’s), 2% Fat Milk 
(Sainsbury’s), toasted white bread (Braces), margarine (I can’t believe it’s not butter) 
and fresh orange juice (Sainsbury’s) and was based upon the breakfast provided by 
Chryssanthopoulos and colleagues (2004). Participants were given the choice of either 
white sugar added to cornflakes, or seedless raspberry jam (Sainsbury’s) on their toast, 
or an iso-caloric combination of both. The overall percentages of energy from 
macronutrients in the breakfast were 70 % carbohydrate, 17 % fat and 13% protein. 
The breakfast was provided in quantities that contained 0.06 g carbohydrate per kcal 
of each individual participant’s measured daily resting metabolic rate, resulting in an 
energy intake of 469  57 kcal. Quantities of the items provided for a typical breakfast 
are illustrated in Appendix 1. Participants were first provided with cereal, then at 5 
minute intervals toast and finally orange juice, with all of the breakfast consumed 
within 15 minutes to standardise any effects of eating rate upon appetite hormones 
(Kokkinos et al., 2010). During the fasting trial participants sat quietly for a matched 
time period. 
3.2.5 Ad Libitum Lunch 
 Three hours post-breakfast participants were provided with an ad libitum lunch 
test meal consisting of 1 kg cooked (i.e wet weight) penne pasta (Sainsbury’s) and 
tomato sauce (Ragu); prepared at a ratio of 1:1 uncooked mass. The overall 
percentages of energy from macronutrients for the lunch were 79 % carbohydrate, 14 
Chapter 3  Lean Phase 1: Acute Crossover Study  
96 
% fat and 7 % protein. During their first trial participants were allowed ad libitum 
intake of plain water during lunch, this volume was subsequently replicated on their 
second visit. Participants were left alone during the lunch, with a recorded message 
played prior to beginning consumption “We ask that you continue eating until you 
have satisfied your hunger.  The lunch will remain in front of your for at least 30 
minutes, at which point the post-lunch timer will be started, although you will be 
allowed to continue eating if you are still hungry.” Pasta was provided in a large bowl 
containing 1 kg of cooked pasta which was replenished every 10 minutes during the 
lunch period to minimise any visual feedback relating to consumption volumes, and 
prevent any tendency to completely finish the portion provided. The mass of pasta 
consumed during the lunch was recorded and energy intake was calculated using 
manufacturer’s nutritional information.    
3.2.6 Statistical Analysis 
 For single comparisons of two means (e.g energy intake at lunch), paired t-
tests were employed. For comparison of time series variables that were measured over 
the course of the day in each treatment (e.g appetite hormones), repeated measures 
ANOVA were employed to identify interactions independent of deviations from a 
normal distribution (Maxwell and Delaney, 1990) but with Greenhouse-Geisser 
corrections applied to intra-individual contrasts for ɛ < 0.75, and the Huynh-Feldt 
correction applied for less severe asphericity (Atkinson, 2002). ANOVA results are 
described using the following terms: a main effect of trial refers to a difference of the 
overall means between the two conditions (i.e breakfast consumption and fasting trial 
days, irrespective of the time course within each day); a main effect of time refers to 
significant differences over the course of the testing day (i.e a change between time 
points within a trial day, irrespective of condition); and an interaction effect indicates 
that the time course of the measure was different dependent upon the trial being 
undertaken (i.e the time course varies between trial days).  
 
For ANOVA, significant interaction effects were explored with post-hoc t-tests 
that compared the difference between specific time points in the two trials. Where 
multiple comparisons for a measure were conducted, these were corrected for potential 
inflation of type 1 error rate by using a Holm-Bonferroni stepwise adjustment 
(Ludbrook, 1998). For all statistical analyses, significance was accepted at p ≤ 0.05. 
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Data are presented in text as mean ± standard deviation, figures display mean with 
normalised confidence intervals (nCI). These confidence intervals do not represent the 
variance around the mean for each time point (as would SD) but represent the 
comparison between the two trials, removing the inter-individual variation due to the 
fully paired nature of the experimental design (Loftus and Masson, 1994). In general, 
where these confidence intervals do not overlap by more than half the distance of one 
side of a confidence interval, these contrasts are likely to be deemed statistically 
significant using conventional hypothesis testing. All statistical analyses were 
















Figure 3.2: Energy intake during trials. In the fasting trial an asymmetric error bar is 
plotted. The positive portion of the error bar reflects the comparison between total 
intake during the fasting trial (i.e lunch only) and total intake on the breakfast trial, 
with the negative portion reflecting the comparison between lunches. An asterisk 
above a bar represents the comparison between the sum of the components of the bars, 
an asterisk between the bars represents the comparison between the specific 
component. * p < 0.01   
 
3.3.1 Energy Intake 
 During the breakfast trial, participants consumed a prescribed breakfast of 469 
± 57 kcal (i.e variance proportionate to inter individual differences in RMR). During 
the ad libitum lunch, participants consumed 776 ± 349 kcal following breakfast but 
significantly more in the fasting trial (929 ± 317 kcal; p <0.01). However, when the 
absolute energy intake during the breakfast trial was calculated (i.e breakfast + lunch), 
this was significantly more than during the fasting trial (1246 ± 380 vs 929 ± 317 kcal; 
p <0.001). When comparing the energy intake at lunch in the two conditions, the 
additional energy intake at lunch of 153 kcal during the fasting trial accounted for 
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Figure 3.3: Glucose responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p < 0.03 versus corresponding time point in other trial 
 
3.3.2 Glucose  
 
There were main effects of time, trial and a trial x time interaction for plasma 
glucose concentrations (all p < 0.01). Baseline glucose concentrations were not 
different between trials (p = 0.80, Figure 3.3), but were significantly greater following 
breakfast consumption until 2 hours post-breakfast (all p < 0.03). By 3 hours post-
breakfast there was no difference in plasma glucose concentrations between trials (p 
= 0.30). Glucose concentrations were significantly greater 1 hour post-lunch in the 
fasting trial (p < 0.01). There was a strong tendency for greater concentrations in the 
fasting trial at 2 hours post-lunch (Breakfast Trial, 5.99 ± 0.75 mmol·l-1 vs Fasting 
Trial, 6.49 ± 1.02 mmol·l-1; p = 0.06) but no difference between trials 3 hours after 
lunch (p = 0.63).          
Time
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Figure 3.4: Insulin responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 




There were main effects of time, trial and a trial x time interaction for serum 
insulin concentrations (all p < 0.01). Insulin concentrations were not different between 
trials at baseline (p = 0.45) but following breakfast consumption were significantly 
greater during the morning than during the fasting trial (all p < 0.01, Figure 3.4). 
Following lunch, insulin concentrations were significantly greater in the fasting trial 
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Figure 3.5: NEFA responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 




There were main effects of time, trial and a trial x time interaction for plasma 
NEFA concentrations (all p < 0.01). There was no difference in baseline NEFA 
concentrations in the two trials (p = 0.25, Figure 3.5). NEFA concentrations were 
lower for the 3 hour period following breakfast consumption (all p < 0.01). Following 
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Figure 3.6: Acylated Ghrelin responses during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 
fasting trial. L= Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in 
other trial 
Figure 3.7: Total Ghrelin responses during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 
fasting trial. L= Ad libitum pasta lunch. * p ≤ 0.05 versus corresponding time point in 
other trial 
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3.3.5  Acylated and Total Ghrelin 
 
There were main effects of time and a trial x time interaction for plasma 
acylated ghrelin (both p < 0.01). Baseline concentrations of acylated ghrelin were not 
different between trials (p = 0.79). Breakfast consumption suppressed acylated ghrelin 
concentrations such that these were significantly lower 1 and 2 hours post-breakfast 
relative to the fasting trial (both p < 0.01, Figure 3.6) but there was no difference 
between trials at 3 hours post-breakfast (Breakfast Trial, 145 ± 83 pg·ml-1 vs Fasting 
Trial, 143 ± 73 pg·ml-1; p = 0.72). Acylated ghrelin concentrations were significantly 
greater than the fasting trial throughout the afternoon in the breakfast trial (all p < 
0.01), with concentrations remaining above pre-lunch values during the breakfast trial, 
but lower than pre-lunch during the fasting trial.   
 
There were main effects of time, trial and a trial x time interaction for plasma 
total ghrelin concentrations (all p < 0.01). Total ghrelin concentrations were not 
different between trials at baseline (p = 0.57). Following breakfast consumption, total 
ghrelin concentrations were suppressed resulting in significantly lesser concentrations 
than the fasting trial at all time points prior to lunch (p < 0.01, Figure 3.7). Following 
lunch, there was limited suppression of ghrelin in the breakfast trial such that total 
ghrelin concentrations at 1 hour post lunch were 85 % of baseline concentrations and 
rose throughout the afternoon reaching 94 % of baseline concentrations at 3 hours 
post-lunch. There was greater suppression of total ghrelin in the fasting trial after 
lunch, such that concentrations were significantly lower than breakfast throughout the 
afternoon (all p ≤ 0.05).  
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Figure 3.8: PYY responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 




 There were main effects of time, trial and a trial x time interaction for plasma 
PYY concentrations (all p < 0.01). Baseline PYY concentrations were not different 
between trials (p = 0.35, Figure 3.8). Significant differences between the trials at all 
time points prior to lunch were apparent for PYY concentrations (p < 0.01). At 1 hour 
post-lunch in the fasting trial PYY concentrations had returned to baseline levels of 
79 ± 37 pg·ml-1, whilst in the breakfast trial, PYY concentration peaked at 97 ± 46 
pg·ml-1, resulting in a significant difference between the two trials (p < 0.01). PYY 
concentrations remained greater in the breakfast trial than the fasting trial throughout 
the rest of the afternoon (p < 0.05).       
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Figure 3.9: GLP-1 responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 




 There was a tendency for a main effect of time (F = 2.27, p = 0.08), but no 
effect of trial (F = 2.89, p = 0.1) for plasma GLP-1 concentrations. There was a trial x 
time interaction (F = 3.09, p = 0.03) for GLP-1 concentrations which are displayed in 
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Figure 3.10: Leptin responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial  
 
3.3.8 Leptin   
 
 Serum leptin concentrations in both trials are displayed in Figure 3.10. There 
were main effects of time, trial and a trial x time interaction for leptin (all p < 0.02). 
Baseline leptin concentrations were not different between trials (p = 0.83). In the 
breakfast trial, leptin concentrations were reduced from baseline at 3 hours post- 
breakfast, but this reduction was greater in the fasting trial, such that there was a trend 
for lower leptin concentrations in the fasting trial (Breakfast Trial, 7859 ± 7282 pg·ml-
1 vs Fasting Trial, 6792 ± 6632 pg·ml-1; p = 0.07). Three hours post-lunch, leptin 
concentrations had increased in the breakfast trial to a greater extent than in the fasting 
trial, resulting in a significantly greater concentration of leptin in the breakfast trial (p 
























Chapter 3  Lean Phase 1: Acute Crossover Study  
107 
 
Figure 3.11: Adiponectin responses during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 




 There was a main effect of time for serum adiponectin concentrations (F = 
5.60, p < 0.01). There were no main effects of trial (F = 1.86, p = 0.18) or an interaction 
effect apparent (F = 0.47, p = 0.62), such that adiponectin concentrations displayed 
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Figure 3.12: Desire to eat during trials. B=Breakfast period, in which participants ate 
a prescribed breakfast during the breakfast trial and rested during the fasting trial. L= 
Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial 
Figure 3.13: Hunger during trials. B=Breakfast period, in which participants ate a 
prescribed breakfast during the breakfast trial and rested during the fasting trial. L= 
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Figure 3.14: Fullness during trials. B=Breakfast period, in which participants ate a 
prescribed breakfast during the breakfast trial and rested during the fasting trial. L= 
Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial 
Figure 3.15: Prospective consumption during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 
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Figure 3.16: Appetite score during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial 
 
3.3.10 Subjective Appetite Ratings 
 
 Results from the hedonic scales provided to participants throughout the day 
are displayed in Figures 3.12-16. There were no differences at baseline for any of the 
measures (all p > 0.2). Desire to eat, hunger and prospective consumption all followed 
very similar patterns throughout the day. Immediately after breakfast consumption 
there was a reduction in all three measures such that there was a highly significant 
difference between all three measures compared with the fasting trial (all p < 0.01). 
Immediately prior to lunch these appetite sensations were greater in the fasting than 
breakfast trial (all p < 0.01). Following the consumption of the ad libitum lunch all 
three measures decreased to a nadir with no significant difference between trials (all p 
> 0.4). Three hours after completion of lunch there was no difference between trials 
for any of the measures (all p ≥ 0.1). The sensations of fullness followed a similar, but 





























Chapter 3  Lean Phase 1: Acute Crossover Study  
111 
combining the hedonics described above shows a similar pattern as desire to eat, 
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Figure 3.17: Diet induced thermogenesis during trials. The morning and afternoon 
periods were both of 3 h duration.  * p ≤ 0.04 versus other trial 
 
3.3.11 Diet Induced Thermogenesis  
 
 Diet induced thermogenesis during the two trials is displayed in Figure 3.17. 
Increases in energy expenditure above rest were greater in the morning during the 
breakfast trial (29.8 ± 13.0 kcal·3h-1) than the fasting trial (9.6 ± 15.2 kcal·3h-1, p < 
0.01). After lunch there was no difference between the energy expenditure in either 
trial (Breakfast Trial, 36.5 ± 22.4 kcal·3h-1 vs Fasting Trial, 39.3 ± 18.1 kcal·3h-1; p = 
0.47). When the morning and afternoon periods were combined; total expenditure was 
greater (p = 0.04) in the breakfast trial (66.4 ± 33.2 kcal·6h-1) than the fasting trial 


































Chapter 3  Lean Phase 1: Acute Crossover Study  
113 
3.4 Discussion 
The aim of the present study was to investigate energy intake at an ad libitum 
lunch meal as well as hormonal, metabolic and subjective appetite responses 
throughout the day to morning fasting in contrast with a carbohydrate rich breakfast 
in lean individuals. In this study, energy intake at the ad libitum lunch meal was greater 
following fasting than breakfast consumption. However, this increased intake at lunch 
was not sufficient to compensate for the intake from the breakfast meal, resulting in a 
greater net intake in the breakfast trial. However, following lunch consumption, there 
were contrasting responses from appetite hormones with some indicative of satiety 
(PYY, Leptin) greater with breakfast but no evidence of ghrelin suppression in the 
breakfast trial. Subjective appetite three hours after lunch was not different between 
conditions; indicating that morning fasting does not cause greater appetite in the late 
afternoon despite limited energy compensation at an ad libitum meal. 
  
Despite many experiments that have examined various compositions of 
breakfast upon subsequent energy intake within a laboratory setting; there have been 
very few studies in adults investigating the simple comparison of breakfast vs morning 
fasting upon subsequent energy intake at an ad libitum lunch. Levitsky and 
Paconowski (2012) have reported that energy intake at an ad libitum lunch was 
unaffected by breakfasts of ~350 kcal and reduced by ~150 kcal following ad libitum 
breakfast consumption of ~624 kcal. In both cases, the combined energy intake of 
breakfast and lunch was greater following breakfast consumption in contrast with 
morning fasting. However, while these feeding occasions were in a laboratory 
environment, participants were permitted to leave the laboratory between feedings, 
leading to potential issues with control of extraneous variables and fidelity of the 
participants to the experimental designs. This work contrasts with Astbury et al (2011) 
who established that increased energy intake at lunch completely compensated for a 
missed 200 kcal breakfast in male habitual breakfast consumers. However, it has to be 
considered that these participants were also provided with a 250 kcal pre-load between 
the breakfast and lunch and therefore the ad libitum lunch in the no breakfast trial was 
not consumed in a fasted state (i.e the responses to lunch are the interactive effects of 
the breakfast/fasting and the pre-load). Using a similar preload design, Gonzalez et al 
(2013) reported no difference in energy intake at lunch in individuals who either 
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consumed a 444 kcal breakfast or fasted but were then provided with a 358 kcal 
preload of chocolate milk 90 minutes prior to the ad libitum meal.  
 
As described in Chapter 1, cross sectional evidence is mixed as to whether 
those that omit breakfast have lower (Cho et al., 2003; Deshmukh-Taskar et al., 2010b; 
Nicklas et al., 1998) or similar energy intake (Mekary et al., 2013; Mekary et al., 2012; 
Wyatt et al., 2002). However, this cross sectional data cannot establish cause and 
effect. In an intervention in which morning meals were prescribed, but delayed by ~3 
hours in the no breakfast group and subsequent feeding patterns in the 
afternoon/evening were structured in both groups, individuals reported lower total 
daily energy intake during the breakfast intervention (Farshchi et al., 2005b). It would 
not be realistic to expect in the present study that a ~470 kcal breakfast would be 
compensated within the one ad libitum meal provided. It seems more plausible that 
the effects of morning fasting may be manifested in greater consumption of snacks 
and intake at meals later in the day. Future investigations should include greater 
duration of measurement into the evening and designs that incorporate and quantify 
the impact of self-initiated feedings. However, emerging evidence in free-living 
humans suggests that without any dietary restrictions placed upon participants 
throughout the rest of the day, reported energy intake is similar (Halsey et al., 2012) 
or greater (Reeves et al., 2014) in those consuming breakfast. 
 
PYY has been shown to reduce food intake (Batterham et al., 2002) with 
increased caloric load increasing PYY concentrations (Chandarana et al., 2009). In 
this study, PYY increased in response to breakfast and remained higher than in the 
fasting trial throughout the afternoon despite increased energy intake at lunch in the 
fasting trial. This is consistent with the accumulated difference in energy intake over 
the day and is supported by findings of no difference in PYY concentrations in 
participants after an ad libitum lunch at which participants in the fasting trial ate 
significantly more, therefore accumulating similar energy intake over the testing day 
(Astbury et al., 2011). These results therefore indicate that PYY is more a reflection 
of nutritional status over the entire day rather than in response to the most recent 
feeding occasion, consistent with PYY peaking 1-2 hours after feeding followed by a 
lengthy elevation lasting several hours (Adrian et al., 1985).  
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Leptin concentrations were also higher 3 hours after lunch in the breakfast trial. 
This finding is consistent with the relatively slow response of leptin to feeding, such 
that the increased concentrations of leptin ~6 hours after consumption of breakfast are 
a product of the postprandial responses of glucose and insulin from the breakfast and 
lunch (Saad et al., 1998b). It would be probable that increases in leptin during the 
fasting trial may have been delayed and were more likely to occur in the evening, as 
delaying food intake from 07:00 to 13:30 has previously been shown to concomitantly 
shift the rise in leptin levels later in the day, further towards the normal late evening 
zenith (Schoeller et al., 1997). 
 
The increased PYY and leptin concentrations should contribute towards 
feelings of greater satiety at the end of the trial, although there was no appreciable 
difference in subjective appetite at the end of the day between the breakfast and fasting 
trials. This may partly be a product of the complete lack of suppression of ghrelin 
following lunch in those that had already consumed breakfast. This is a particularly 
unusual result that to our knowledge has not been reported previously. As it has 
previously been shown that increasing energy content of liquid breakfasts with 
increased carbohydrate content causes greater reductions in ghrelin (Blom et al., 
2005), it is particularly puzzling that the ad libitum meal had no impact upon ghrelin 
concentrations whatsoever as the lunch intake was high energy/simple carbohydrate. 
Ghrelin has been associated with meal initiation (Cummings et al., 2001) and as such 
it would be unexpected for this hormone to be elevated following the second meal of 
the day. However, work by Foster-Schubert and colleagues (2008)  has demonstrated 
that after feeding with an 80% carbohydrate breakfast drink (providing 20% of daily 
energy requirements) that ghrelin was initially suppressed but then subsequently 
rebounded above fasting levels after 3 hours, remaining elevated for the majority of 
the following 3 hours. An obvious distinction in the present study is that at the point 3 
hours after initial feeding the participants received another carbohydrate rich meal. 
This indicates that participants in the breakfast trial had a completely abolished ghrelin 
response to subsequent feeding, with ghrelin following the established time course of 
a similar carbohydrate load without a second feeding occasion.  
 
While not universal (Caixas et al., 2002; Gottero et al., 2003; Schaller et al., 
2003), there have been some reports that insulin may play an important role in ghrelin 
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suppression (Blom et al., 2005; Flanagan et al., 2003; Murdolo et al., 2003; Saad et 
al., 2002). Therefore, it is interesting to note that after lunch when participants had 
consumed breakfast, the glucose and insulin responses to the meal over the afternoon 
were significantly diminished relative to the fasting trial. It is conceivable that the 
substantial reduction in insulin concentrations in the afternoon following breakfast 
may have contributed to the absence of ghrelin suppression after lunch. Indeed, this 
hypothesis is supported by the work of Teff and colleagues (2004) in demonstrating 
limited suppression of ghrelin by high fructose meals that induced a lesser insulin 
response than equivalently energetic high glucose meals.  
However, this lack of ghrelin suppression needs confirmation and it remains 
to be seen whether elevated ghrelin concentrations following a lunchtime meal 
translate to increased hunger and energy intake throughout the rest of the day. It has 
been previously been suggested in a time-blinded study in men that ghrelin 
concentrations need to reach a “threshold” (reported as 93% of fasting concentrations) 
prior to meal requests (Blom et al., 2009). As ghrelin concentrations in the fasting trial 
had returned to fasting concentrations 3 hours after lunch (the point at which hunger 
was assessed in the afternoon) this may explain why there was no difference in hunger 
detected despite greater concentrations of ghrelin in the breakfast trial. Alternatively, 
ghrelin concentrations following repeated meals may not be as relevant in signalling 
hunger as prior to the first/second meal of the day.            
 
Whilst the reduction in insulin/glucose concentrations after lunch may be 
partly explained by the slight reduction in energy intake at lunch following breakfast 
of ~150 kcal, this is also potentially representative of a second meal effect on glucose 
(Hamman and Hirschmann, 1919), with an associated reduction of insulin 
concentration and potentiation of its effects (Bonuccelli et al., 2009). Evidence that 
this is a “real” reduction in insulin concentrations due to a prior meal and not due to 
differences in energy intake at lunch is demonstrated in the 11 individuals who ate 
similar amounts in both trials (either more or <80 kcal less in the breakfast trial relative 
to the fasting trial). Ten of these individuals had reduced insulin concentrations 60 
minutes after lunch during the breakfast trial, with insulin concentrations on average 
68 ± 25 % of those in the fasting trial, providing evidence of acutely reduced insulin 
sensitivity following extended morning fasting.  
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 In a UK population of breakfast consumers, the most frequently (~50% of 
adults) reported food products consumed during weekdays were cereals and 
bread/toast (Reeves et al., 2013). This lends some external validity to our choice of 
breakfast, as although there may be some benefits of higher protein breakfasts (Leidy 
et al., 2011; Leidy et al., 2013), the majority of the UK population still consume 
breakfasts that are predominantly rich in carbohydrates.  
 
In summary, while breakfast consumption was incompletely compensated for 
at an ad libitum lunchtime meal, there were increased concentrations of some satiety 
hormones but no suppression of ghrelin following lunch eaten after breakfast 
consumption. This may be mediated through reduced insulin concentrations in 
response to a second meal and result in similar hunger after lunch independent of 
breakfast consumption/morning fasting. Further work should focus on investigating 
these responses in obese individuals and using designs that allow greater food choices 
and self-selected feeding frequency in the afternoon and evening.  
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Chapter 4: Effect of six weeks of daily morning 
fasting upon components of energy balance and 




As discussed in Chapter 1, epidemiology has associated infrequent breakfast 
consumption with increased risk of adiposity (Ma et al., 2003; Horikawa et al., 2011; 
Purslow et al., 2008; Barton et al., 2005; Kant et al., 1995), diabetes (Mekary et al., 
2013; Mekary et al., 2012) and cardiovascular risk (Cahill et al., 2013b; Smith et al., 
2010).  However, it is also pertinent that breakfast consumers have also been found to 
exhibit other healthful behaviours including consumption of less fat and alcohol (van 
der Heijden et al., 2007), are more likely to be non-smokers (van der Heijden et al., 
2007; Smith et al., 2010) and, crucially, are more physically active (Duval et al., 2008). 
Therefore, despite numerous studies examining associations between breakfast and 
health, causality cannot be inferred from cross sectional studies. It remains to be 
established if breakfast is causally linked to health or is instead a marker of a healthy 
lifestyle. 
 One of the possible benefits of breakfast consumption is a compensatory 
reduction in energy intake throughout the rest of the day. However, epidemiological 
evidence is mixed, with some authors reporting no difference (Song et al., 2005; Wyatt 
et al., 2002)  and others greater intake in those who consume breakfast (Cho et al., 
2003; Nicklas et al., 1998). Acute laboratory studies contrasting morning fasting with 
breakfast have reported both similar (Astbury et al., 2011) and reduced energy intake 
with the omission of breakfast (Levitsky and Pacanowski, 2013; Gonzalez et al., 
2013). Evidence from longer duration randomised controlled trials comparing 
extended fasting and breakfast consumption is inconsistent, with both greater 
(Farshchi et al., 2005b), unchanged (Halsey et al., 2012) and lower (Reeves et al., 
2014) energy intake when omitting breakfasts in free-living conditions. It is therefore 
inconclusive whether individuals who extend their morning fast subsequently 
consume additional calories to compensate throughout the rest of the day.          
As well as the potential for reduced energy intake, the other key malleable 
component of energy balance that may respond to breakfast consumption/morning 
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fasting is energy expenditure. The studies that have been completed in adults 
specifically contrasting a daily breakfast regimen with morning fasting have either not 
measured energy expenditure (Farshchi et al., 2005b; Schlundt et al., 1992) or have 
used partial records of physical activity assessed via pedometers and heart rate 
monitoring (Halsey et al., 2012), which limits the sensitivity of the physical activity 
measurement undertaken (Butte et al., 2012). Halsey and colleagues (2012) report 
when individuals skipped or consumed breakfast for a week, there were no  differences 
in physical activity between conditions, but as well as issues with their choice of 
measurement device, the choice of monitoring period also limits the validity of their 
observations. Physical activity as assessed by these instruments was only measured 
during the hours between 09:00 and 17:00 in campus based university students. 
Therefore, the levels of physical activity observed will be predominantly dictated by 
the schedule of activities associated with studying. 
Results from a previous randomised controlled trial examining 2 weeks of 
extended fasting in comparison with breakfast consumption in lean women has 
revealed a negative impact of the extended fasting intervention upon fasting lipids and 
insulin sensitivity (Farshchi et al., 2005b). These findings agree with several 
prospective studies implicating omission of breakfast with greater incidence of 
diabetes (Mekary et al., 2013; Mekary et al., 2012), coronary heart disease events 
(Cahill et al., 2013b) and development of overall metabolic risk (Odegaard et al., 
2013). The work of Farshchi and colleagues (2005) was of a relatively short duration 
with experimenter prescription of feeding frequency and food items consumed. It 
remains to be established if a less externally regulated intervention manipulating 
morning energy intake has similar effects.                   
In studies that have compared breakfast consumption with extended fasting, 
all have involved experimenter prescription of either feeding frequency (Farshchi et 
al., 2005b), or breakfast composition (Halsey et al., 2012) or a combination of both 
factors with a target energy deficit (Schlundt et al., 1992), or weight stability (Stote et 
al., 2007). In a less prescriptive study, only diet was examined in response to an 
extended morning fasting intervention (Reeves et al., 2014). A randomised study 
examining the “natural” responses of free-living individuals to a morning fasting 
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intervention that has quantified all components of energy balance is yet to be 
conducted.    
 The aim of the current study is to examine the impact of daily morning 
fasting/breakfast interventions on energy balance and selected markers of health in 
lean individuals. On the basis of previous investigations we hypothesise that energy 
intake will be lower in individuals fasting during the morning but that blood lipids and 
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Thirty-three healthy, lean men (n = 12) and women (n = 21) aged 22-56 y 
volunteered to take part in this study. Participants were deemed suitable for 
participation based upon full eligibility criteria outlined in Chapter 2. Participants were 
recruited via local advertisement from South West England and were initially assessed 
for eligibility based upon a body mass index of 18-25 kg·m-2 and then later classified 
as lean based upon DEXA-derived fat mass indices of ≤7.5 kg·m-2 (men) and ≤11 
kg·m-2 (women) (Kelly et al., 2009). Participants reported being weight stable ( 2% 
body mass within past 6 months) and adhered to a standard sleep-wake cycle (e.g no 
shift workers) and did not anticipate any change in lifestyle during the study period. 
Participants were free of metabolic disorders, with pre-menopausal female participants 
either menstruating regularly, or following their chosen contraceptive method (i.e pill, 
implant) for >6 months. These individuals were randomly assigned to one of two 
intervention groups; either a group prescribed 700 kcal∙d-1 before 11:00 with at least 
half of intake within 2 hours of waking or a group that extended their overnight fast 
until 12:00 daily for 6 weeks. Characteristics of the two experimental groups are 
presented in Table 4.1. 
Written informed consent was obtained from all participants, with the Ethical 
Approval for the study obtained from the NHS Bristol Research Ethics Committee. 
The study is registered with Current Controlled Trials [ISRCTN31521726]. 
Table 4.1: Participant characteristics 
*Fat mass index calculated as DEXA derived total fat mass divided by height squared. 
Data presented are Mean with (SD) 
Characteristic Breakfast Group Fasting Group 
n 16 17 
Age (y) 36 (11) 36 (11) 
Body Mass (kg) 67.0 (8.3) 66.5 (7.8) 
Body Mass Index (kg/m2) 22.0 (2.2) 22.8 (2.3) 
Fat Mass Index (kg/m2)* All 5.4 (2.2) 5.9 (2.3) 
Female 6.5 (2.1) 6.8 (2.0) 
Male 3.6 (1.0) 4.1 (1.6) 
Habitual Breakfast Consumers (n) 11 15 
Female (n) 10 11 
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4.2.2 Study Design  
The study employed an independent measures comparison of 2 randomly 
assigned parallel groups. Participants were randomised using a block randomisation 
plan, with stratification to facilitate an equal distribution of habitual consumers 
(defined as the ingestion of ≥50 kcal∙d-1 within two hours of waking on most days of 
the week) and non-consumers in the two groups. Following two days of diet and 
activity standardisation both groups had baseline measures of body composition and 
insulin sensitivity (OGTT) assessed. Subsequently, the breakfast group were 
prescribed 700 kcal∙d-1 before 11:00 (with at least half within two hours of waking) 
whilst the fasting group extended their overnight fast until 12:00 daily for 6 weeks. 
During the first and last week of the intervention participants had measures of physical 
activity energy expenditure, energy intake and glucose variability assessed under free-
living conditions. Following repetition of the standardisation procedures, participants 
had body composition and insulin sensitivity assessed again upon completion of the 6 
week intervention. A schematic representation of the experimental design is provided 
in Figure 4.1. 
 
Figure 4.1: Schematic representation of study design. The top half represents the 
normal schedule, the bottom half for a menstruating female. 
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4.2.3 Prescribed Breakfast 
 As the first study to have quantified all elements of energy balance, the two 
interventions that the groups undertook were designed to maximise the discrepancy 
between the experimental conditions. As such, the fasting group was to abstain from 
energy until 12:00 each day and those participants that were allocated to the breakfast 
consumption group were required to consume ≥700 kcal by 11:00 daily as part of their 
intervention period. This quantity of breakfast was selected as it was deemed a realistic 
energetic target as a breakfast of this size has been employed previously in a free-
living intervention (Martin et al., 2000). In addition, this energy content fits within the 
previously suggested theoretical energy content of what constitutes a breakfast (i.e 20-
35% of daily EI) of Timlin and Pereira (2007). Participants were allowed to consume 
self-selected foods to reach this energy content. In order to assist this process, 
participants were provided with an example booklet of common foodstuffs and their 
energy content such that they could estimate the energy content of foods consumed.     
 
4.2.4 Laboratory Experimental Protocol            
Participants reported to the laboratory overnight fasted and having followed 
standardisation procedures as described in Chapter 2. Participants were asked to void 
and were subsequently weighed in light clothing (Body Composition Monitor BC-
543, Tanita, Japan) and underwent a DEXA scan. Participants were then fitted with an 
indwelling cannula in an antecubital vein with a 10 mL resting venous sample 
obtained. A small (~0.5 g) subcutaneous adipose tissue biopsy was then obtained 
under local anaesthetic. Following a period of applied pressure to the biopsy site (~10 
min), participants received a 75 g oral glucose load in a 300 mL total volume. 
Commencing upon complete ingestion of the fluid volume, 5 mL blood samples were 
obtained at 15 minute intervals with the final sample at 120 minutes post-ingestion. 
Full details of all measurements and analyses are provided in Chapter 2. 
 
4.2.5 Free-Living Experimental Protocol 
On the day prior to commencement of the assigned 6 week free-living 
intervention (which commenced immediately after the baseline laboratory measures 
in men and non-menstruating women but was delayed by two weeks in menstruating 
women to ensure follow-up testing occurred in the same point in the menstrual cycle; 
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Figure 4.1) participants were fitted with a continuous glucose monitor (iPro®), a 
physical activity monitor (Actiheart®) and provided with a food/activity record and 
scales. Participants then wore these measurement devices for a continuous period of 7 
days excluding the day of fitting, while concurrently recording a weighed food intake 
and completing a physical activity diary.  
At this point it was emphasised to participants that the design of the experiment 
was not to place any other restrictions upon any element of their lifestyle other than 
the consumption/omission of breakfast. As such their recording diary during this 
period contained the following text. 
 
“Your lifestyle choices during this free-living monitoring period are central to this 
study. We are interested in any natural changes in your diet and/or physical activity 
habits, which you may or may not make in response to the intervention. This 
monitoring period has been carefully scheduled to avoid any pre-planned changes in 
these habits, such as a holiday or diet/exercise plan. You should inform us immediately 
if unforeseen factors external to the study may influence your lifestyle.” 
 
Following this initial observation period, participants continued with their 
assigned intervention with no further measurements until ten days prior to completion 
of their 6 week intervention. At that point, participants were fitted with the same 
measurement devices as week 1, with the same duration of 7 days of continuous 
measurement. This final period of measurement was followed by two days of exact 
replication of the standardisation practices that preceded each participant’s initial 
laboratory visit to assess baseline laboratory measures. Following these two days of 
standardisation participants then repeated the laboratory protocol outlined previously. 
Further details on the methods used are provided in Chapter 2. 
 
4.2.6 Statistical Analysis     
                
 For repeated measurements in both groups (i.e Physical activity energy 
expenditure, energy intake) 2-way mixed model ANOVA were employed. For 
comparisons of means, either paired or independent measures t-testing was conducted 
as appropriate. Data are presented in text as means with standard deviations, in tables 
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change scores are presented with 95 % confidence intervals and error bars displayed 
on graphs are standard error of the mean. Statistical significance was accepted at p ≤ 


















4.3.1 Body Composition 
  
There was no significant difference in mass between the fasting and breakfast 
groups at baseline (66.5  7.8 kg vs 67.0  8.3 kg, respectively; F = 0.05, p = 0.8). 
While there was a trend towards reduced mass in both groups from pre- to post-
intervention (F = 3.602, p = 0.07), the pre-planned contrast for change in mass within 
each group revealed significant weight-loss in the fasting group only (0.43  0.73 kg; 
p = 0.03) Weight change was more variable across individuals in the breakfast group, 
resulting in no significant changes in body mass over time (0.19  1.16 kg; p = 0.5).   
 
Table 4.2: Anthropometric measures 
Measure  Breakfast Fasting 
 Pre Change Pre Change 
Total Mass             (kg)  67.0 (8.3) -0.2  
(-0.8, 0.4) 
66.5 (7.8) -0.4  
(-0.8, -0.1) 
Lean Mass             (kg) 47.7 (9.4) -0.08  
(-0.72, 0.57) 
46.4 (8.1) -0.08  
(-0.65, 0.49) 
Fat Mass                (kg) 16.2 (5.7) -0.21  
(-0.76, 0.34) 
16.9 (6.2) -0.21  
(-0.91, 0.49) 
Waist:Hip ratio 0.77 (0.06) -0.01 
(-0.02, 0.00) 
0.80 (0.07) -0.01  
(-0.02, 0.00) 
Sagittal Abdominal 
Diameter                (cm) 
18.3 (1.7) -0.5 
(-1.0, -0.0) 
18.6 (1.4) -0.5  
(-0.9, -0.0) 
Values represent mean with (SD) and change scores from baseline with (95 % CI)   
  
There were no significant differences between the groups for either fat or lean 
mass (p > 0.6) and neither did fat (F = 0.970, p = 0.3) nor lean mass (F = 0.144, p = 
0.7) vary significantly with respect to time. Measures of central adiposity were not 
different between groups and did not respond differently to the intervention for any 
measure between groups (all p > 0.2). Across both groups, sagittal abdominal diameter 
decreased as a result of the intervention (both p < 0.01).  
  
Chapter 4  Lean Phase 2: Free-Living Intervention 
127 
 
Figure 4.2: Reported energy intake during intervention. *lower daily energy intake in 
fasting than breakfast group (p < 0.01)  
  
4.3.2 Energy Intake 
  
The fasting group had a significantly lower reported mean energy intake during 
the measurement period relative to the breakfast group (2191  494 kcal∙d-1 vs 2730  
573 kcal∙d-1; p < 0.01). Energy intake was stable (within 50 kcal∙d-1) between the first 
and last week of the intervention. 
Comparisons of percentage macronutrient composition of diets are provided in 
Table 4.3. Analysis of relative macronutrient content for the whole day between the 
two groups indicated no main effects of time or group, apart from a lower relative 
protein intake in the breakfast group (F = 5.152, p = 0.03). The percentage protein 
intake was 15.6  3.3 % and 15.6  2.7 % for the fasting group, and 14.1  2.0 % and 
13.5  1.7 % for the breakfast group in the first and last weeks, respectively.    
 When comparing equivalent time periods during which both groups had 
unrestricted access to foods (i.e 12:00 onwards); there was a strong tendency for the 
mean energy intake of both weeks to be greater in those fasting (2193 kcal∙d-1 vs. 1852 
kcal∙d-1; p = 0.06). There were no differences between the post 12:00 relative 
carbohydrate or fat intake, either between groups or with respect to time (all p > 0.7). 
Relative protein intake was not different between groups (Fasting Group, 15.6  2.8 
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 In the breakfast group there were no differences between the pre 12:00 total 
energy intakes for the first and last week of the intervention (867  110 kcal∙d-1 vs. 
880  149 kcal∙d-1) or any differences in macronutrient intake between the two weeks 
of monitoring. When comparing the pre vs post 12:00 relative macronutrient 
composition of those consuming breakfast, relative carbohydrate intake was 
significantly higher in the morning than after 12:00 (57.3  9.5 % vs 45.0  7.3 %; p 
< 0.01). There was a strong tendency for fat intake to be lower in the morning (29.8  
8.2 vs 34.6  5.4 %, p = 0.06), but relative protein intake was not significantly different 
(p = 0.1).  
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Table 4.3: Percentage composition of diets during intervention  
 Breakfast Group Fasting Group 
 First Week Last Week First Week Last Week 
 Pre 12:00 Post 12:00 Total Pre 12:00 Post 12:00 Total Post 12:00 Post 12:00 
Energy Intake (kcal∙d-1) 867 (112) 1849 (487) 2715 (565) 889 (147) 1856 (564) 2745 (658) 2169 (490)* 2218 (587)* 
Protein % 13.2 (2.9) 14.5 (2.0) 14.2 (2.1) 12.7 (2.4) 13.9 (1.9) 13.5 (1.7) 15.6 (3.3)# 15.6 (2.7)# 
Carbohydrate % 57.9 (9.0)† 45.3 (7.3) 48.5 (6.2) 56.7 (10.9)† 44.7 (8.0) 47.7 (7.2) 45.5 (6.4) 46.4 (6.8) 
Fat % 29.0 (8.3) 34.5 (5.5) 33.5 (4.6) 30.6 (9.4) 34.8 (5.6) 34.5 (4.5) 34.4 (4.6) 34.3 (4.3) 
Alcohol % n/a 5.7 (6.1) 3.8 (4.6) n/a 6.6 (6.4) 4.4 (4.0) 4.5 (3.7) 3.5 (3.5) 
Values represent mean with (SD) 
* Denotes main effect of group (p < 0.01), with reduced energy intake in fasting group. 
# Denotes main effect of group (p = 0.03), with higher relative intake in fasting group. 
†  Denotes significantly higher (p < 0.01) pre 12:00 versus post 12:00 in breakfast group.  
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Figure 4.3: Daily macronutrient intake during the intervention *significantly lower 
carbohydrate intake in fasting than breakfast group (p < 0.01). Figures on stack 
represent mean intake, with figures in brackets representing standard deviation. 
 
Comparisons of the mean daily macronutrient intakes during the intervention 
indicated that carbohydrate intake was lower in the fasting group (p < 0.01, Figure 
4.3). There was a tendency for lower fat intake with fasting (p = 0.08), but protein and 
alcohol intake was not different between groups (both p > 0.3). Total sugar intake was 
lower in the fasting group than the breakfast group (96  38 g∙d-1 vs. 149  51 g∙d-1; p 
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Figure 4.4: Daily feeding frequency, *fewer eating occasions in fasting group (p = 
0.03) # fewer meals in fasting group (p < 0.001)     
 
4.3.3 Feeding Frequency 
  
Analysis of daily feeding frequency showed that total eating occasions were 
greater in the breakfast group relative to the fasting group (5.22  0.93 vs.4.49  0.77; 
p = 0.03). This was primarily driven by the increased daily meal frequency (3.18  
0.46 vs. 2.38  0.33; p < 0.01), consistent with and directly proportional to the 
breakfast that was prescribed/omitted in each groups. In contrast, daily snacking 
frequency was similar in the breakfast (2.05  0.74) and fasting groups (2.11  0.77; 
p = 0.8).       
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Figure 4.5: Physical Activity Energy Expenditure *lower in fasting than breakfast 
group (p = 0.03). 
 
4.3.4 Physical Activity Energy Expenditure 
 
The mean physical activity energy expenditure averaged over the intervention 
was significantly lower in the fasting group (1007  370 kcal∙d-1) relative to those in 
the breakfast group (1449  666 kcal∙d-1; F = 5.054, p = 0.03). There was ≤ 50   kcal∙d-
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Figure 4.6: AM/PM split of physical activity energy expenditure *lower in fasting 
than breakfast group (p = 0.01).  
 
 The data for energy expenditure split by time of day are presented in Figure 
4.6 and Table 4.4. Total energy expenditure in the AM period was significantly lower 
in the fasting group (311  124 kcal∙d-1 vs. 492  227 kcal∙d-1; p = 0.01). There was 
also a trend (p = 0.08) towards lower energy expenditure in the PM period in those 
fasting (680  301 kcal∙d-1) compared with those consuming breakfast (938  457 
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Figure 4.7: Physical activity energy expenditure split by time of day and intensity 
* significantly lower in fasting than breakfast group (p = 0.03) 
 
 Data for energy expenditure split both by time of day and intensity thresholds 
are presented in Figure 4.7. Energy expenditure classified as of light intensity was 
significantly lower in those fasting during the AM period than those consuming 
































Breakfast Group Fasting Group
Sedentary <1.5 MET
Light   1.5-2.9 MET
Vigorous   >5.9 MET
Sedentary <1.5 MET
Light   1.5-2.9 MET
Vigorous   >5.9 METModerate 3.0-5.9 MET
Moderate 3.0-5.9 MET
Sedentary <1.5 MET
Light   1.5-2.9 MET
Vigorous   >5.9 MET
Moderate 3.0-5.9 MET
Sedentary <1.5 MET
Light   1.5-2.9 MET




a.m. p = 0.01
p = 0.08
Chapter 4  Lean Phase 2: Free-Living Intervention 
135 
 
Table 4.4: Physical activity energy expenditure split by intensity and time of day  
 
Values represent mean with (SD) 
* Denotes significantly lower in fasting than breakfast group (p < 0.05)
 Breakfast Group Fasting Group 
Energy Expenditure (kcal∙d-1) AM PM 24h AM PM 24h 
Sedentary (<1.5 MET)  27 (12) 40 (12) 67 (22) 32 (20) 48 (22) 80 (40) 
Light (1.5-2.9 MET) 161 (41) 324 (99) 486 (133) 114 (41)* 274 (96) 387 (131) 
Moderate (3.0-5.9 MET) 182 (111) 411 (320) 593 (423) 109 (61) 245 (134) 353 (186) 
Vigorous (6.0-10.1 MET) 76 (59) 95 (60) 171 (103) 33 (22) 57 (72) 90 (88) 
Very Vigorous (≥10.2 MET) 46 (61) 68 (83) 114 (131) 24 (47) 57 (109) 80 (155) 
Total 492 (227) 938 (457) 1431 (657) 311 (124)* 680 (301) 990 (415)* 
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Figure 4.8: Resting metabolic rate before and after the intervention. 
 
4.3.5 Resting Metabolic Rate 
 
 Both the groups had similar resting metabolic rates prior to the intervention 
(Breakfast Group, 1449  195 kcal∙d-1 vs. Fasting Group, 1402  149 kcal∙d-1, Figure 
4.8). These values were stable in response to the intervention with a <15 kcal∙d-1 
difference from pre- to post-intervention and no difference in response between groups 
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Figure 4.9. Diet induced thermogenesis during the intervention, * significantly lower 
in fasting than breakfast group (p < 0.05)  
 
4.3.6 Diet Induced Thermogenesis 
 Based on the established thermogenic effect of ingested macronutrients, diet 
induced thermogenesis was lower in the fasting group than in the breakfast group (180 
 39 kcal∙d-1 vs. 221  49 kcal∙d-1; p < 0.05, Figure 4.9). The group difference in energy 
intake of 539 kcal∙d-1 equated to a difference in DIT of 41 kcal∙d-1. There was less than 
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Figure 4.10: Energy Balance Summary. An asterisk above a bar represents the 
comparison between the sum of the bars, an asterisk between the bars represents the 
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4.3.7 Oral Glucose Tolerance Test 
 
Figure 4.11: Insulinaemic response to an Oral Glucose Tolerance Test 
 
There were no significant differences either between groups (F = 0.00, p = 0.9), 
from pre-post (F = 0.0, p = 0.9) or an interaction effect (F = 0.86, p = 0.36) upon the 
incremental area under the curve calculated for the insulinaemic response to the oral 
glucose tolerance test. 
Figure 4.12: Glycaemic response to an Oral Glucose Tolerance Test  
  
 There was no difference between the groups (F = 0.01, p = 0.9) or in response 
to the intervention (F = 2.2, p = 0.15) for the glycaemic response to an oral glucose 
tolerance test. The fasting and breakfast groups did not differ in their response to the 
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Table 4.5: Insulin sensitivity measures  
Measure Breakfast Group Fasting Group 
 Pre Change Pre Change 
Fasting Insulin   (pmol.l-1) 20.2 (12.9) 2.1 
(-1.9, 6.0) 
20.6 (8.6) 1.9 
(-4.0, 7.8) 
Peak Insulin       (pmol.l-1) 364 (210) 37  
(-62, 136) 
357 (182) 36  
(-14, 87) 
Fasting Glucose (mmol.l-1) 5.25 (0.31) 0.06 
(-0.15, 0.27) 
5.36 (0.31) 0.07 
(-0.10, 0.24) 
Peak Glucose     (mmol.l-1) 8.73 (1.27) -0.2  
(-1.02, 0.60) 
9.00 (1.57) -0.04 
(-0.92, 0.83) 
HOMA-IR 0.79 (0.52) 0.10  
(-0.06, 0.26) 
0.83 (0.36) 0.10  
(-0.16, 0.36) 
C-ISI 12.1 (6.6) -1.0  
(-3.7, 1.8) 
11.1 (8.0) 0.4  
(-1.3, 2.1) 
Values represent mean with (SD) and change scores from baseline with (95 % CI)   
 
4.3.8 Insulin Sensitivity Measures 
 
A summary of the measures obtained from the OGTT’s are presented in Table 
4.5. There were no effects of group (p > 0.9), or any interaction effects (p > 0.9) for 
either peak or fasting insulin. Neither measure was different following the intervention 
(p > 0.14). For both peak and fasting glucose there were no significant effects of group, 
time or any interaction effects (all p > 0.3). Additionally, there were no main effects 
(p > 0.2) or interactions (p > 0.3) for either HOMA-IR or the C-ISI indices of insulin 
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Table 4.6: Fasting lipids and inflammatory markers 
Measure Breakfast Group Fasting Group 
 Pre Change Pre Change 
Total Cholesterol (mmol.l-1) 4.98 (1.15) 0.13  
(-0.23, 0.48) 
5.00 (0.59) 0.22 
(-0.06, 0.50)  
HDL Cholesterol (mmol.l-1) 1.37 (0.32) 0.12 
(0.03, 0.22) 
1.28 (0.27) 0.11  
(0.05, 0.18) 
LDL Cholesterol (mmol.l-1) 3.22 (0.92) 0.01  
(-0.25, 0.27) 
3.34 (0.64) 0.14 
(-0.08, 0.35) 
Total:HDL Cholesterol 3.71(0.79) -0.21 
(-0.39, -0.04) 
4.07 (1.02) -0.18 
(-0.37, 0.02) 
Triglycerides       (mmol.l-1) 0.86 (0.37) -0.01 
(-0.14, 0.11) 
0.84 (0.19) -0.06 
(-0.18, 0.06) 
NEFA                  (mmol.l-1) 0.55 (0.19) 0.06 
(-0.08, 0.19)  
0.61 (0.30) -0.07 
(-0.22, 0.07) 
CRP                     (mg.l-1) 0.79 (0.82) -0.13  
(-0.46, 0.21) 
0.53 (0.50) -0.10  
(-0.36, 0.16) 
Values represent mean with (SD) and change scores from baseline with (95 % CI)   
  
4.3.9 Cardiovascular Disease Risk Factors 
 
There were no significant differences between any of the fasting lipids or CRP 
concentrations measured between the groups (all p > 0.2). For all of the parameters 
measured there was no evidence of any interaction effects in response to the 
intervention (all p > 0.17).  HDL cholesterol concentration was significantly increased 
across both groups from pre- to post-intervention (F = 17.22, p < 0.01) (Table 4.6). 
The Total:HDL cholesterol ratio was significantly reduced across both groups as a 
result of the interventions (F = 9.99, p < 0.01). None of the other lipids or inflammatory 










Chapter 4  Lean Phase 2: Free-Living Intervention 
142 
 
Figure 4.13: Glucose variability from waking until 12:00 (left hand side) and from 
12:00 until sleeping (right hand side) during the first and last week of the intervention.  
 
4.3.10 Continuous Glucose Monitoring 
Continuously measured glucose indicated that from waking until 12:00 the 
mean (5.4 ± 0.5 mmol.l-1 vs 5.1 ± 0.5 mmol.l-1) and peak (7.6 ± 1.2 mmol.l-1 vs 6.5 ± 
1.0 mmol.l-1) glucose concentrations were greater (p < 0.04) in the breakfast group, 
with no effects of time or interaction effects (p ≥ 0.1). The coefficient of variation 
(CV) for glucose indicated greater glucose variability in the morning in the breakfast 
group (F = 4.90 p = 0.04; Figure 4.13). The fasting group exhibited greater glucose 
variability from 12:00 to sleeping across both weeks (F = 4.29, p = 0.05). The greatest 
difference between the groups was during week 6 (3.9%, 95% CI: 0.1%, 7.8%). Other 
results indicated there were no main effects or interactions (all p > 0.1) for peak, mean 
or glucose variability during the morning, from 12:00 until sleep, during sleep and 















































































 The current study has examined all elements of energy balance, as well as 
metabolic control and markers of cardiovascular disease risk in response to both daily 
morning fasting and breakfast consumption for 6 weeks in healthy lean individuals. 
Energy intake was significantly lower in those that extended their fast until 12:00, with 
limited compensation for the omission of intake in the morning relative to the breakfast 
consumption group. However, daily physical activity energy expenditure was lower 
in those that extended their fast through the morning, which may cause negative health 
implications.  Markers of metabolic control and cardiovascular health were mostly 
unaffected by either intervention, although there was tentative evidence that daily 
fasting may result in increasing glucose variability during the afternoon and evening. 
Contrary to cross-sectional evidence, daily morning fasting did not cause increased 
weight. 
The present data indicate significantly lower energy intake in free living 
individuals who fasted until 12:00 each day relative to those with a prescribed 700 ≥ 
kcal∙d-1 energy intake by 11:00 but otherwise completely self-selected meal 
composition and feeding frequency. This is in contrast to the previous work of 
Farshchi and colleagues (2005) who report greater total energy intake in those omitting 
breakfast relative to those consuming breakfast. However, in the aforementioned study 
during the omission condition participants actually consumed the same “breakfast” in 
two stages as during the breakfast consumption condition but ~2 hours later. In 
addition, feeding frequency was then fixed throughout the remainder of the day. In 
contrast, two studies with less prescription of diet outside the morning period have 
resulted in similar (Halsey et al., 2012) and lower (Reeves et al., 2014) daily energy 
intakes in those fasting during the morning.        
Many studies within the literature utilise an acute laboratory-based 
experimental paradigm to investigate feeding behaviours, with elements of this 
approach also incorporated into this work. This allows accurate characterisation of 
physiological parameters and tight control of external influences. However, the key 
difference between laboratory and free-living work is (by design) the interaction of 
participants’ environment with the basic physiological signals thought to dictate eating 
behaviours. This is particularly relevant as it has been suggested that in fact eating can 
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be seen as a behaviour more strongly influenced by environment than the individual 
(Cohen and Farley, 2008). During this intervention, analysis of feeding patterns 
indicates no differences between treatment groups in snacking or meal frequency 
(once the allotted morning breakfast is accounted for). As feeding occasions are 
seemingly unaffected by the exclusion of morning food intake it may be that those 
consuming breakfast subsequently ate “automatically” at perceived meal/snack times 
rather than in response to physiological cues to eat (Cohen and Farley, 2008). Previous 
work in free living individuals asked to record reasons for the initiation of feeding 
occasions showed that whilst hunger was reported on 21% of occasions, the statements 
“It was mealtime” and “Because of regular lifestyle” accounted for 46% of feeding 
occasions (Tuomisto et al., 1998), indicating a strong influence of habits upon feeding 
frequency. 
 The difference in physical activity energy expenditure between groups is in 
contrast to the best evidence previously available (Halsey et al., 2012). It is therefore 
important to note some of the key methodological differences between these studies. 
Crucially, Halsey and colleagues (2012) provided breakfast within the laboratory, 
where subsequently physical activity measurement commenced following completion 
of this meal at ~09:00 and was terminated at 17:00 each day. Not only does this method 
place restrictions upon the movements of participants but the limited recording period 
may reduce the sensitivity of the instruments to detect differences within different 
periods of the day. This is particularly relevant as the present results not only indicate 
lower overall (i.e. 24 h) physical activity energy expenditure but also highlight that 
the greatest impact was apparent during the morning.  
 Whilst there has been much attention given to the effect of physical activity 
upon energy intake, the opposite (i.e the effect of energy intake upon physical activity) 
has received very little attention. Previous studies that have measured energy 
expenditure with altered feeding frequency have failed to detect any differences in 
energy expenditure but have not been truly free-living due to the use of room 
calorimeters (Smeets and Westerterp-Plantenga, 2008; Verboeket-van de Venne et al., 
1993; Dallosso et al., 1982; Taylor and Garrow, 2001) or incomplete/restrictive 
periods of measurement (Halsey et al., 2012).  
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Previous work in both rodent models and anorexia nervosa sufferers have 
reported elevated physical activity levels during severe energy deficit, termed 
starvation induced hyperactivity (Hebebrand et al., 2003). More recent results 
contradict these findings as long term calorie restricted diets between 10-30 % of 
energy needs were associated with reduced activity energy expenditure at follow up 
between 6-12 months of the interventions (Martin et al., 2011). While the impact of 
chronic energy restriction upon physical activity is receiving research attention, the 
impact of transient periods of energy restriction upon self-selected physical activity is 
yet to be fully investigated in humans. Whilst the current work can contribute to 
answering the fundamental question of whether acute periods of energy restriction are 
related to energy expenditure, future work should attempt to provide further 
information as to why this may be the case. For example, use of subjective scales of 
vitality given over the course of an intervention may further elucidate the impact of 
altered feeding patterns upon energy expenditure.  
 When comparing three versus seventeen feeding occasions a day, it has been 
reported that fasting total and HDL cholesterol concentrations were reduced in 
response to two weeks of the high feeding frequency pattern (Jenkins et al., 1989). At 
the other end of the feeding frequency spectrum, Stote et al. (2007) have reported 
increases in all measures of cholesterols when comparing individuals eating once 
(dinner) relative to three times a day. Additionally, two studies from the same group 
indicate that irregular feeding occasions and the omission of breakfast negatively 
affect fasting cholesterol concentrations (Farshchi et al., 2004b; Farshchi et al., 
2005b). These changes have been speculated to be due to lower insulin levels resulting 
in less activation of the enzyme hydroxymethylglutaryl-coenzyme A, the rate limiting 
of cholesterol synthesis in the liver (Bhutani et al., 2010). These findings were not 
mirrored in our work. Extended daily fasting did not negatively impact fasting 
cholesterol levels, with no changes in response to the intervention apart from increased 
HDL cholesterol in both groups.  
 Insulin sensitivity measures calculated at baseline and following the 6 week 
intervention indicate that neither extended fasting nor daily breakfast consumption 
altered the response to an OGTT. For those participants in the breakfast group this is 
not unexpected, as for the majority of this group the intervention they were following 
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would not have been particularly dissimilar from their usual lifestyle. However, in 
those individuals fasting, the lack of impairment is a novel finding within the literature. 
Farshchi and colleagues (2005) have demonstrated a greater insulin response to a high 
carbohydrate test meal following two weeks of shifting the commencement of daily 
feeding back from 8am ~2-3 hours for two weeks. While the authors attribute stable 
fasting and postprandial glucose responses to the short term nature of the study the 
authors provide no potential mechanisms for the reported effects on insulin. However, 
they do suggest that the response may be specific to meal ingestion, so future 
investigations examining the response to meal ingestion following extended morning 
fasting interventions may reveal an impact upon postprandial insulin sensitivity.   
 In addition to the laboratory based measurements of insulin sensitivity, free-
living measurements of glycaemic control were obtained during the intervention. 
While the majority of parameters obtained were not different between groups, it was 
observed that afternoon glucose variability was greater in the fasting than breakfast 
group despite no difference in eating occasions between the two groups from 12:00 
onwards. This effect will potentially be partly attributable to the noted tendency for 
greater energy intake after 12:00 in the fasting group (341 kcal), and to the increase 
from a lower fasted concentration during the morning. However, it is interesting to 
note that this difference in afternoon/evening glucose variability was increased from 
week 1 to 6 of the intervention. This might suggest that chronic adherence to morning 
fasting may cause greater systemic glucose appearance or reduce disposal upon eating. 
It could be suggested that this may be a result of repeated exposure to greater 
glucose/insulin concentrations during the afternoon because of the absence of the 
associated reductions in these two metabolites to lunch following morning feeding (as 
demonstrated in Chapter 3). A further extension of this work to control any potential 
for confounding based upon energy intake/feeding patterns between groups would be 
to use continuous glucose monitors in laboratory settings with fixed 
composition/energy repeated feeding occasions to establish if either chronic breakfast 
consumption or morning fasting alters the glycaemic responses to repeated meals.   
               There are some limitations of the present work that must be considered when 
interpreting our findings. The nature of our study design for the free living 
measurements obtained during the study (i.e physical activity, energy intake) allowed 
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a simple between groups comparison. However, there was no assessment of these 
parameters of the two groups prior to commencement of the intervention. This was 
primarily due to practical considerations such as lab time/visits required and the 
potential for measurement fatigue in participants. This means it is not definitively 
possible to rule out that baseline differences between the groups account for the 
observed differences. However, whilst a “true” matched groups design was not 
feasible due to the rolling recruitment of participants; our two groups were very similar 
for all characteristics (i.e age, body composition, gender split, metabolic 
characteristics) measured at baseline. As such, there should be no reason to suspect 
such marked differences in free living outcomes as observed in the present work. 
Additionally, the most marked difference in this parameter was during the morning, 
coincident with the time of day that the conditions were implemented.    
The choice to not dictate the foods consumed in the morning during the 
breakfast condition could be perceived as a potential drawback of the present work. 
However, this was deliberate as it was deemed that the least prescriptive intervention 
would give the best representation of “natural” compensatory responses. In addition, 
as the first study utilising certain measurement tools (i.e combined heart 
rate/accelerometry) to investigate a direct comparison of breakfast versus fasting, the 
largest practical dose was deemed the most appropriate to maximise the discrepancy 
between the two conditions. Within the context of the UK population where breakfast 
consumption is the norm (Reeves et al., 2013), the fasting condition can be seen as the 
“intervention”, whereas the breakfast condition is closer to a “control”. Whilst there 
is little scope for variation in what constitutes a morning fast, there are potentially 
limitless possibilities for a breakfast. Future work should focus on more prescriptive 
breakfasts to attempt to establish if specific permutations of macronutrient 
composition, morning feeding frequency or energy intake are necessary to confer 
health benefits.  
The current finding of reduced body mass in those extending their fast is in 
contradiction to the majority of cross sectional associations and prospective studies. It 
is difficult to make meaningful comparisons with randomised trials in the extant 
literature, as most studies investigating altered feeding frequency have either been in 
the context of weight loss interventions (Schlundt et al., 1992; Keim et al., 1997) or 
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have deliberately attempted to maintain stable weight (Stote et al., 2007). In studies 
where weight change was neither prescribed nor prevented, no alterations in weight or 
body composition have been reported over 2 weeks (Farshchi et al., 2005b; Farshchi 
et al., 2005a). A recent 16 week study advising either breakfast skipping or 
consumption in overweight individuals did not result in differences in weight change 
between the two intervention groups (Dhurandhar et al., 2014a).  
The observed mean weight change in those extending their morning fast over 
6 weeks was modest (~400 g). It is well established that chronic energy deficit results 
in weight loss that slows over time due to changes in body composition, as the amount 
of body tissue that needs to be supported metabolically both at rest and during 
movement is reduced (Hall et al., 2011). It may be that the modest weight loss 
occurring over the current study period is not sufficient to induce compensatory 
mechanisms designed to protect (fat) mass, such as a reduction in leptin (Thong et al., 
2000). Further studies over longer periods in lean individuals could provide 
information as to whether sustained weight loss is achieved through daily morning 
fasting, or if behavioural/hormonal modification over greater time results in differing 
weight change outcomes.          
       In summary, we conclude that in lean adults daily energy intake but also 
physical activity energy expenditure is lower in individuals extending their fast until 
12:00 daily. Neither resting metabolic rate nor markers of cardiovascular health or 
metabolic control were substantially affected by either intervention. Contrary to 
epidemiological evidence, omission of breakfast did not lead to weight gain, but 
reduced physical activity associated with morning fasting may have negative longer 
term implications for health. 
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Chapter 5: Morning fasting for 6 weeks does not 
cause increased appetite, acute energy intake or 
negative metabolic consequences to feeding relative 
to daily breakfast consumption in lean adults 
 
5.1 Introduction 
Infrequent or insufficient breakfast consumption is associated with greater risk 
of overweight and obesity (Bazzano et al., 2005; Kant et al., 2008; Song et al., 2005). 
Cross-sectional evidence associating breakfast consumption and energy intake is 
equivocal, with some reports indicating no difference between breakfast consumers 
and skippers (Song et al., 2005; Wyatt et al., 2002) and others reporting increased 
energy intake in those that consume breakfast (Cho et al., 2003; Nicklas et al., 1998).  
Some evidence from randomised controlled trials is beginning to suggest that 
breakfast skipping leads to reduced energy intake (Reeves et al., 2014). Indeed, in 
Chapter 4 of this thesis we have reported lower free-living energy intake in those 
extending their morning fast, with evidence of stable energy intake over a 6 week 
intervention. However, the impact of interventions manipulating morning fasting upon 
acute energy intake, appetite and regulatory hormones has not been established. It 
remains to be seen whether chronic assignment to differing daily morning feeding 
regimens can affect short term appetite regulation (i.e whether prolonged exposure to 
daily morning fasting/feeding causes adaptation of responses measured acutely within 
a day). 
A previous morning fasting intervention (Farshchi et al., 2005b) as well as the 
work described in Chapter 4 have examined health markers, and postprandial insulin 
sensitivity using a mixed macronutrient test drink (Farshchi et al., 2005b). In the study 
of Farshchi, Taylor and MacDonald (2005), the authors report reduced insulin 
sensitivity following a 2 week breakfast skipping intervention in lean women. In 
addition, the results from the intervention study reported in Chapter 4 have indicated 
some evidence for increased free-living glucose variability during the afternoon and 
evening in those that fasted daily from week 1 to 6 of the intervention. Whilst this was 
not associated with differences in glucose or insulin responses to an OGTT or changes 
in calculated indices of insulin sensitivity, it is important to establish if the morning 
Chapter 5  Lean Phase 3: Acute Interaction Study 
150 
fasting regimen alters glycaemic control in response to repeated meals, as this is more 
similar to free-living feeding.      
Neither of the aforementioned studies have examined if the appetite hormone 
responses to feeding are altered by adherence to either a daily breakfast or extended 
morning fasting regimen. Evidence from previous studies characterising appetite 
hormone responses to chronic (8 week) interventions based upon manipulating feeding 
frequency (but not the presence or absence of breakfast) (Cameron et al., 2010; 
Carlson et al., 2007) and macronutrient composition of diet (Ellis et al., 2012) have 
reported no adaptation of appetite hormone responses after the interventions.    
The present study aims to investigate whether chronic (6-week) exposure to 
either a morning fasting or daily breakfast regimen can cause adaptations in acute 
appetite regulation and metabolic responses throughout the day, and energy intake at 
an ad libitum lunch in lean individuals. We hypothesise that appetite hormones will 
be unaffected by either morning feeding pattern but that postprandial insulin 
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 Thirty one healthy, lean men (n = 12) and women (n = 19) aged 22-56 y took 
part in this study. Participants were recruited via local advertisement from South West 
England and were initially assessed for eligibility based upon a body mass index of 
18-25 kg·m-2 and then later classified as lean based upon DEXA-derived fat mass 
indices of ≤7.5 kg·m-2 (men) and ≤11 kg·m-2 (women)(Kelly et al., 2009). The study 
was part of a larger randomised controlled trial entitled the Bath Breakfast Project. In 
accordance with full eligibility criteria set out in Chapter 2, participants reported being 
weight stable ( 2% body mass within past 6 months) and adhering to a standard sleep-
wake cycle (e.g no shift workers) and not anticipating any change in lifestyle during 
the study period. Participants were free of metabolic disorders, with pre-menopausal 
female participants either menstruating regularly, or following their chosen 
contraceptive method (i.e pill, implant) for >6 months. Within the study cohort there 
was a mix of regular breakfast consumers (classified as >50 kcal intake within 2 hours 
of waking on ≥4 days of the week) and non-consumers. Characteristics of participants 
are presented in Table 5.1. 
 
Written informed consent was obtained from all participants, with the Ethical 
Approval for the study obtained from the NHS Bristol Research Ethics Committee. 
The study is registered with Current Controlled Trials [ISRCTN31521726]. 
 
Table 5.1: Participant characteristics 
*Fat mass index calculated as DEXA derived total fat mass divided by height squared. 
Values represent mean with (SD)  
Characteristic Breakfast Group Fasting Group 
n 15 16 
Age (y) 36 (12) 35 (10) 
Body Mass (kg) 66.6 (8.4) 66.0 (7.9) 
Body Mass Index (kg/m2) 21.6 (1.7) 22.7 (2.3) 
Fat Mass Index (kg/m2)* All 5.1 (1.9) 5.7 (2.3) 
Female 6.1 (1.8) 6.7 (2.1) 
Male 3.6 (1.0) 4.1 (1.6) 
Habitual Breakfast Consumers (n) 11 14 
Female (n) 9 10 
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5.2.2 Study Design 
 
 Each participant first undertook a laboratory based breakfast feeding trial in 
the Human Physiology Laboratories at the University of Bath. Following these visits 
participants then commenced one of two morning feeding interventions (breakfast 
consumption or morning fasting for a 6 week period-described in more detail below) 
and then returned to the laboratory to repeat their laboratory based breakfast 
consumption trial (Figure 5.1). Here, we report the effect of the participants’ assigned 
intervention upon their energy intake, appetite and hormonal responses to the acute 
breakfast consumption trial.  
 
 
Figure 5.1: Schematic showing study design. In menstruating women the 6 week 
intervention commenced 2 weeks after the baseline assessments so that the 
intervention follow up visit was conducted in the luteal phase (3-10 days after onset 
of menses). In some cases the first breakfast feeding trial occurred after this baseline 
assessment but prior to the intervention beginning such that it was also within the 
luteal phase. The 48 h food diary completed prior to the first breakfast feeding trial 
and repeated prior to the follow up breakfast feeding trial conformed to the 
participants’ assigned intervention.    
     
5.2.3 Intervention 
 
 During the 6-week intervention, participants were randomised (1:1 allocation 
ratio) into either a group prescribed an energy intake of ≥700 kcal before 11:00 daily, 
with at least half consumed within 2 h of waking (Breakfast Group) or a group to 
extend their overnight fast by abstaining from ingestion of energy-providing nutrients 
(i.e. plain water only) until 12:00 each day (Fasting Group). Beyond the morning 
period all other lifestyle choices were allowed to vary naturally. The effect of this 
intervention upon components of energy balance and other health measures has been 
reported in Chapter 4. The randomisation of participants was stratified according to 
baseline breakfast habits to facilitate a more even distribution of habitual breakfast 
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5.2.4 Standardisation of Participants Prior to Second Feeding Trial 
 Between the two laboratory visits, participants undertook their assigned dietary 
intervention for 6 weeks with pre- and post-intervention visits to assess body 
composition changes and glycaemic control (OGTT). Following this post-intervention 
visit, within 3-7 days, participants returned to the laboratory for their second breakfast 
feeding trial. During this intervening period participants continued to follow their 
assigned intervention dietary regime (i.e daily ≥700 kcal energy intake by 11:00 or 0 
kcal until 12:00) such that any chronic adaptations to their feeding regime were not 
affected by a change of dietary practices before their follow up breakfast feeding trial 
(Figure 5.1).      
5.2.5 Protocol for Laboratory Visits 
 The protocol during experimental visits is displayed in Figure 5.2. Participants 
reported to the laboratory at 08:00  1 h, upon which adherence to standardisation 
measures as described in Chapter 2 were confirmed verbally. Participants then voided 
and had body mass measured in light clothing (Seca 873, Vogel and Halke). On their 
first visit to the laboratory prior to commencement of their intervention, following 20 
minutes of quiet rest, resting metabolic rate was assessed in a supine position by 
repeated 5 minute expired gas samples over ~30 minutes, as according to best practice 
(Compher et al., 2006). Following their intervention on the second feeding trial, this 
procedure was repeated. A cannula was then inserted into an antecubital vein, with a 
baseline sample of 15 mL obtained and further samples acquired at regular intervals 
throughout the day. Participants were then provided with a breakfast, with blood 
samples taken at 15, 30 minutes and an hour post completion of the breakfast period. 
One hour after the breakfast period finished an expired gas sample was also obtained 
for assessment of dietary induced thermogenesis and substrate oxidation. Blood and 
gas samples were then obtained hourly until 3 h post breakfast, at which point an ad 
libitum lunch was provided. Upon completion of the lunch period (30 minutes), 
samples of blood and expired gas were obtained each hour for a further 3 hours. 
Participants also completed visual analogue scales relating to hunger and appetite 
throughout the day. During the day participants remained sedentary and completed 
quiet activities such as reading, watching television and typing. Full details of 
techniques and measurements employed are described in Chapter 2. 
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Figure 5.2: Schematic of experimental protocol. RMR=Resting Metabolic Rate, 
B=Breakfast consumption, L=Ad libitum lunch  
5.2.6 Breakfast 
 The breakfast consisted of Corn Flakes (Kellogg’s), 2% Fat Milk 
(Sainsbury’s), toasted white bread (Braces), margarine (I can’t believe it’s not butter) 
and fresh orange juice (Sainsbury’s) and was based upon the breakfast provided by 
Chryssanthopoulos and colleagues (2004). For provision of additional sugar, 
participants were given the choice of either white sugar added to cornflakes, or 
seedless raspberry jam (Sainsbury’s) on their toast, or an iso-caloric combination of 
both. The overall percentages of energy from macronutrients in the breakfast were 70 
% carbohydrate, 17 % fat and 13 % protein. The breakfast was provided in quantities 
that contained 0.06 g carbohydrate per kcal of each individual participants measured 
daily resting metabolic rate, resulting in energy intake of 472 ± 67 kcal and 460 ± 47 
kcal in the breakfast and fasting groups, respectively. Quantities of the items provided 
for a typical breakfast are illustrated in Appendix 1. Participants were first provided 
with cereal, then at 5 minute intervals toast and finally orange juice, with all of the 
breakfast consumed within 15 minutes to standardise any effects of eating rate upon 
appetite hormones (Kokkinos et al., 2010).  
5.2.7 Ad Libitum Lunch 
 Three hours post-breakfast participants were provided with an ad libitum lunch 
test meal consisting of 1 kg cooked (i.e wet weight) penne pasta (Sainsbury’s) and 
tomato sauce (Ragu); prepared at a ratio of 1:1 uncooked mass. The overall 
percentages of energy from macronutrients for the lunch were 79 % carbohydrate, 14 
% fat and 7 % protein. During their first trial participants were allowed ad libitum 
intake of plain water during lunch, this volume was subsequently replicated on their 
second visit. Participants were left alone during the lunch, with a recorded message 
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played prior to beginning consumption “We ask that you continue eating until you 
have satisfied your hunger.  The lunch will remain in front of your for at least 30 
minutes, at which point the post-lunch timer will be started, although you will be 
allowed to continue eating if you are still hungry.” Pasta was provided in a large bowl 
containing 1 kg of cooked pasta which was replenished every 10 minutes during the 
lunch period to minimise any visual feedback relating to consumption volumes, and 
prevent any tendency to completely finish the portion provided. The weight of pasta 
consumed during the lunch was recorded and energy intake was calculated using 
manufacturer’s nutritional information.    
5.2.8 Statistical Analysis 
 
 For comparison of time series variables that were measured over the course of 
the day (e.g appetite hormones), 3-way mixed model ANOVA were employed to 
identify interactions independent of deviations from a normal distribution (Maxwell 
and Delaney, 1990) but with Greenhouse-Geisser corrections applied to intra-
individual contrasts for ɛ < 0.75, and the Huynh-Feldt correction applied for less 
severe asphericity (Atkinson, 2002). ANOVA results are described using the 
following terms: a main effect of trial refers to a difference of the overall means from 
pre- to post-intervention (i.e across both intervention groups, irrespective of the time 
course within each day); a main effect of time refers to significant differences over the 
course of the testing day (i.e a change between time points within the day, irrespective 
of groups and trials); and a main effect of group indicates that the mean of both trials 
is different between the two experimental intervention groups (i.e the breakfast and 
fasting groups).  
 Where relevant, to provide a fuller appreciation of any potential changes in 
response to the interventions, time courses were also expressed as peak, nadir and 
fasting concentrations specific to each participant (e.g the average of the peak 
concentrations within each participant, irrespective of when this occurred), with these 
summary statistics subsequently analysed by 2-way ANOVA. For all statistical 
analysis, significance was accepted at p ≤ 0.05. Data are presented in text as mean ± 
standard deviation, figures display mean with error bars representing the standard error 
of the mean (SEM). All statistical analyses were conducted using IBM SPSS statistics 
version 22 (IBM, New York). 




5.3.1 Mass and RMR 
From their pre-intervention to post-intervention breakfast trial both groups 
body mass was stable within 0.35 kg. Resting metabolic rates prior to the intervention 
were similar between the fasting and breakfast groups (1402 ± 149 kcal∙d-1 vs 1452 ± 
201 kcal∙d-1) and were not differently affected by the intervention, such that the values 
after intervention for the fasting (1417 ± 129 kcal∙d-1) and breakfast (1421 ± 187 
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Figure 5.3: Energy intake during the feeding trial before and after 6-weeks of daily 
breakfast or fasting. Breakfast intake was prescribed, with the breakfast provided for 
both groups based on RMR similar (Breakfast Group, 472 ± 67 kcal vs Fasting Group, 
460 ± 47 kcal; p = 0.56) and did not change from pre to post-intervention. The error 
bars on the grey portion of the stack represent the SEM of the energy intake at lunch, 
and the error bars on the white portion the SEM of the energy intake of the whole day. 
5.3.2 Energy Intake 
 
 Energy intake at lunch was not different between groups or trials and there was 
no evidence of a group x trial interaction (all p > 0.2). Lunch intake was stable within 
80 kcal in both groups. Overall intake including the prescribed breakfast was 1150 ± 
341 kcal pre-intervention and 1177 ± 422 kcal post-intervention in those that fasted 
for 6 weeks. In those consuming breakfast for 6 weeks, intake was 1291 ± 377 kcal 
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Figure 5.4: Glucose responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch 
5.3.3 Glucose 
 There was a main effect of time (F = 22.2, p < 0.01; Figure 5.4), but no main 
effects for group or trial and no interactions evident for blood glucose concentrations 
(all p > 0.2). Individual peak glucose concentrations were not different between groups 
or trials (Breakfast Group, 7.50 ± 0.73 mmol·l-1 vs 7.38 ± 0.85 mmol·l-1; Fasting 
Group, 7.67 ± 1.27 mmol·l-1 vs 7.36 ± 1.30 mmol·l-1) and there was no interaction 
effect (all p > 0.2). Similarly there were no main effects or interactions for individual 
nadir glucose (all p > 0.3), which remained stable in response to the intervention 
(Breakfast Group, 4.64 ± 0.59 mmol·l-1 vs 4.54 ± 0.76 mmol·l-1; Fasting Group, 4.40 
± 0.59 mmol·l-1 vs 4.36 ± 0.62 mmol·l-1). Fasting glucose was not different between 
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Figure 5.5: Insulin responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch 
 5.3.4 Insulin 
 
Serum insulin concentrations displayed a main effect of time (F = 41.0, p < 
0.01; Figure 5.5), but no effect of trial (F = 0.18, p = 0.68) or group (F = 2.6, p = 0.12). 
There were no interactions for the insulin response over the day (all p > 0.1). Individual 
peak insulin concentrations were not different between groups or trials (Breakfast 
Group, 401 ± 221 pmol·l-1 vs 374 ± 211 pmol·l-1; Fasting Group, 336 ± 181 pmol·l-1 
vs 352 ± 130 pmol·l-1) and there was no interaction effect (all p > 0.3). Fasting insulin 
concentrations were not different between groups and there was no interaction effect 
(both p > 0.6) but there was a main effect of trial (F = 5.05, p = 0.03). Fasting insulin 
increased, across both groups, in response to the intervention (Breakfast Group, 23 ± 
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Figure 5.6: NEFA responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch 
5.3.5 NEFA 
 
  There was a main effect of time (F = 42.4, p < 0.01, Figure 5.6) for plasma 
NEFA concentrations throughout the day, with no effect of group, trial or any 
interactions (all p ≥ 0.1). Fasting NEFA concentrations were not different between 
groups (F = 0.12, p = 0.7) but there was a main effect of trial (F = 4.24, p = 0.05) and 
a trial x group interaction (F = 4.33, p = 0.05). This interaction for fasting NEFA was 
primarily driven by a reduction in the fasting group (0.45 ± 0.29 mmol·l-1 vs 0.35 ± 
0.20 mmol·l-1; p = 0.04), with the breakfast group remaining stable (0.41 ± 0.19 
mmol·l-1 vs 0.43 ± 0.21 mmol·l-1; p = 0.98). Individual peak NEFA concentrations 
were similar between groups and trials (Breakfast Group, 0.43 ± 0.18 mmol·l-1 vs 0.47 
± 0.24 mmol·l-1; Fasting Group, 0.48 ± 0.26 mmol·l-1 vs 0.38 ± 0.19 mmol·l-1), and 
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Figure 5.7: Acylated ghrelin responses to feeding before and after a 6 week 
intervention in the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad 
libitum lunch  
Figure 5.8: Total ghrelin responses to feeding before and after a 6 week intervention 
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5.3.6 Acylated and Total Ghrelin 
 
Plasma acylated and total ghrelin concentrations are displayed in Figures 5.7 
and 5.8. There was a significant effect of time (F = 40.7, p < 0.01) for acylated ghrelin 
concentrations over the day. There was no difference between groups or trials, and no 
interaction effects (all p > 0.3). Fasting acylated ghrelin was not significantly different 
between groups (F = 0.6, p = 0.46) but there was a tendency for a main effect of trial 
(F = 3.53, p = 0.07) as both groups had slightly increased fasting concentrations 
(Breakfast Group, 150 ± 86 pg·ml-1 vs 153 ± 89 pg·ml-1; Fasting Group, 126 ± 55 
pg·ml-1 vs 130 ± 57 pg·ml-1) but without any interaction effect (F = 0.37, p = 0.55).  
Individual peak acylated ghrelin concentrations were not significantly different 
between groups or trials (Breakfast Group, 192 ± 96 pg·ml-1 vs 192 ± 106 pg·ml-1; 
Fasting Group, 168 ± 77 pg·ml-1vs 166 ± 74 pg·ml-1) with no interaction effect (all p 
> 0.4). Individual nadir acylated ghrelin concentrations were not significantly different 
between groups and there was no interaction effect (both p > 0.6). However, there was 
a main effect of trial (F = 4.7, p = 0.04) for nadir acylated ghrelin, such that 
concentrations increased in response to both breakfast consumption (76 ± 43 pg·ml-1 
vs 82 ± 45 pg·ml-1) and fasting interventions (67 ± 45 pg·ml-1 vs 76 ± 44 pg·ml-1).  
  
There was a main effect of time (F = 32.0, p < 0.01) but no effect of group or 
any other interaction effects (all p > 0.2) for total ghrelin.  Individual peaks of total 
ghrelin concentrations were not significantly different between groups or trials 
(Breakfast Group, 489 ± 206 pg·ml-1 vs 459 ± 211 pg·ml-1; Fasting Group, 435 ± 168 
pg·ml-1 vs 422 ± 177 pg·ml-1) with no interaction effect (all p > 0.2). Similarly, there 
were no main effects or interactions evident (all p > 0.3) for individual nadirs of total 
ghrelin concentrations (Breakfast Group, 241 ± 110 pg·ml-1 vs 240 ± 108 pg·ml-1; 
Fasting Group, 208 ± 87 pg·ml-1 vs 206 ± 73 pg·ml-1). Fasting total ghrelin was 
unaffected by the intervention and was not different between groups (Breakfast Group, 
420 ± 156 pg·ml-1 vs 424 ± 213 pg·ml-1; Fasting Group, 400 ± 174 pg·ml-1 vs 376 ± 
146 pg·ml-1) with no interaction effect (all p > 0.1).   
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Figure 5.9: PYY responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch 
5.3.7 PYY 
 
PYY concentrations varied over the course of the testing day (F = 5.98, p < 
0.01; Figure 5.9). There was no effect of trial or group (both p > 0.1). A trial x time 
interaction was evident (p = 0.04) but no other interactions were apparent (all p > 0.5). 
There was no difference between groups or trials in fasting PYY (Breakfast Group, 68 
± 29 pg·ml-1 vs 61 ± 25 pg·ml-1; Fasting Group, 81 ± 34 pg·ml-1 vs 83 ± 29 pg·ml-1) or 
an interaction effect (all p > 0.1). Individual peak PYY was not different between 
groups (F = 2.22, p = 0.15) but there was a tendency for a main effect of trial (F = 
3.93, p = 0.06), with peak PYY concentrations decreasing after the intervention in both 
groups (Breakfast Group, 97 ± 31 pg·ml-1 vs 92 ± 29 pg·ml-1; Fasting Group, 124 ± 58 
pg·ml-1 vs 107 ± 37 pg·ml-1) but no interaction effect (F = 1.22, p = 0.28). Individual 
nadir PYY concentrations were not different between groups or trials (Breakfast 
Group, 58 ± 18 pg·ml-1 vs 53 ± 20 pg·ml-1; Fasting Group, 71 ± 34 pg·ml-1 vs 68 ± 24 
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Figure 5.10: GLP-1 responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch 
5.3.8 GLP-1 
There were no main effects of trial, group or time for GLP-1 (all p ≥ 0.1; Figure 
5.10). A trial x group interaction was apparent (F = 4.17, p = 0.05) but no other 
interaction effects were detected (all p > 0.1). Individual peak GLP-1 concentrations 
were not different between groups or trials (both p > 0.3) but there was an interaction 
effect (F = 4.85, p = 0.04) with an increase in the breakfast group (9.1 ± 6.4 pg·ml-1 vs 
10.4 ± 6.2 pg·ml-1) and a reduction in the fasting group (12.9 ± 8.0 pg·ml-1 vs 10.1 ± 
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Figure 5.11: Leptin responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad Libitum lunch 
5.3.9 Leptin    
 
   Leptin concentrations are displayed in Figure 5.11. A main effect of time was 
evident for leptin concentrations over the day (F = 18.6, p < 0.01) but no other main 
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Figure 5.12: Adiponectin responses to feeding before and after a 6 week intervention 
in the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch  
 
5.3.10 Adiponectin 
 Main effects of trial (F = 4.65, p = 0.04) and time (F = 8.37, p < 0.01) were 
apparent but groups were not significantly different for adiponectin concentrations (F 
= 0.54, p = 0.47, Figure 5.12). There were significant interactions of trial x group (F 
= 4.17, p = 0.05) and trial x time (F = 3.37, p = 0.04) but no other interactions (both p 
> 0.6).  A main effect of trial for fasting adiponectin (F = 6.4, p = 0.02) was apparent 
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Figure 5.13: Desire to eat during feeding trials before and after a 6 week intervention 
in the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch  
Figure 5.14: Hunger during feeding trials before and after a 6 week intervention in 
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Figure 5.15: Fullness during feeding trials before and after a 6 week intervention in 
the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch  
Figure 5.16: Prospective consumption during feeding trials before and after a 6 week 
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Figure 5.17: Appetite Score during feeding trials before and after a 6 week 
intervention in the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad 
libitum lunch  
5.3.11 Appetite Sensations 
 Appetite sensations are shown in Figures 5.13-17. There was a significant 
effect of time (F = 96.7, p < 0.01) but no main effect of trial or difference between 
groups (both p ≥ 0.3) for desire to eat over the course of the day. There was a tendency 
for a time x group interaction (p = 0.09) but no other interaction effects (all p > 0.1). 
There were no main effects or interactions for fasting desire to eat (all p > 0.2). For 
hunger across the day, a main effect of time (F = 85.6, p < 0.01) but no difference 
between trials or groups (both p ≥ 0.2) or any interactions were significant (all p ≥ 
0.1). There were no main effects or interactions for fasting hunger (all p> 0.1). Fullness 
varied over time (F = 138.9, p < 0.01), with no main effects of trial or group (both p > 
0.5). A significant trial x group interaction (F = 4.50, p = 0.04) and a tendency for a 
trial x time (F = 2.57, p = 0.06) interaction were apparent, with no other interactions 
(p > 0.2). Fasting fullness was unaffected by trial, was not different between groups 
and there was no evidence of an interaction effect (all p > 0.1). There was a main effect 
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interactions (p > 0.2). Similarly, no effects were apparent for fasting prospective 
consumption (all p > 0.3). The composite appetite score calculated from these 
sensations indicates that appetite varied over time (F = 142.3, p < 0.01) but there were 
no other main effects or interactions (p > 0.1). Fasting appetite scores were not 












Figure 5.18: Diet induced thermogenesis during feeding trials before and after 6-
weeks of daily breakfast or fasting. Error bars reflect SEM. Asymmetric error bars are 
plotted on the morning section of each stack. The negative portion of these error bars 
reflects the SEM of the morning period and the positive portion the SEM of the whole 
day.  
 
5.3.12 Diet Induced Thermogenesis 
 
 There were no main effects of trial or group or an interaction of trial x group 
for morning DIT (all p ≥ 0.2). Afternoon DIT was not different between trials or 
groups with no evidence of an interaction effect (all p > 0.1). When DIT was compared 
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5.4 Discussion 
The present study aimed to investigate acute energy intake, metabolic and 
appetite responses in a laboratory based protocol following a 6 week intervention of 
morning fasting or daily breakfast consumption in lean individuals. It was found that 
following a standardised breakfast, there was no adaptation of energy intake at an ad 
libitum lunch meal as a result of either daily fasting or breakfast consumption. As 
hypothesised, most appetite hormone responses were not differently regulated by 
either the fasting or feeding interventions. Contrary to our hypothesis, glycaemia and 
insulinaemia following feeding was not negatively affected by the fasting intervention. 
The present study indicates that a prolonged daily morning fasting intervention does 
not stimulate increased hunger, energy intake or negative metabolic consequences to 
acute feeding. 
It has previously been reported that a 2 week period of breakfast eating in lean 
women reduced the insulin AUC to a mixed macronutrient drink whereas delaying the 
first feeding of the day until 11:00 h resulted in a significantly greater insulin profile 
following a test drink (Farshchi et al., 2005b). These findings have not been replicated 
in the current work. We found no evidence of either a significant reduction with 
breakfast consumption or detrimental increases in insulin response to feeding 
following 6 weeks of morning fasting. This is particularly interesting as the changes 
observed in the aforementioned work were induced in only 2 weeks of intervention, 
compared to the 6 weeks in the present study. These discrepancies in outcomes may 
centre upon differences in the cohorts studied (young women vs a mixed age and 
gender cohort in the current work). Additionally, there was a greater level of dietary 
control placed on participants, with a prescribed pattern of meals and snacks 
throughout the day that may contribute to the divergent findings. 
The current work also examined the response to a second self-regulated 
feeding occasion. Although these meals were not identical pre- vs post-intervention, 
the magnitude of difference in both groups was an increase in EI of <80 kcal and as 
such allows a valid comparison of insulin response to relatively equivalent meals. 
Again, following this second meal there was no appreciable difference in insulin 
response during the afternoon. This confirms the postprandial insulin responses are 
not increased in individuals who followed a daily morning fasting intervention either 
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at the first meal of the day or having already eaten. It has previously been reported that 
acutely elevated NEFA concentrations can cause reduced insulin sensitivity due to 
impaired insulin signalling (Dresner et al., 1999), therefore it is interesting to note that 
NEFA concentrations throughout the testing day were also not increased following the 
fasting intervention. 
To the best of the authors’ knowledge, no study to date has investigated the 
effect of a sustained morning fasting intervention on hormonal factors regulating, and 
metabolic responses to, acute feeding (i.e if prolonged exposure to morning fasting 
causes adaptation of appetite responses examined within a day). With some authors 
having reported putative benefits for acute appetite regulation with breakfast 
consumption (Astbury et al., 2011; Leidy et al., 2013) our findings do not corroborate 
these previous reports as exposure to a morning fasting intervention did not lead to 
significantly increased intake at the ad libitum lunch. It could be contended that the 
nature of an ad libitum meal promotes overconsumption and therefore the test meal 
employed may not be sensitive to alterations in hunger. However, two pieces of 
evidence in combination lend credence to the lack of efficacy of the interventions in 
changing intake. Firstly, appetite ratings were not different prior to lunch following 
either intervention. Secondly, reported free-living energy intake in participants during 
the intervention reported in Chapter 4 were not different between weeks 1 and 6 of 
their assigned intervention; indicating no evidence of free-living dietary adaptation 
over time. This would seem to indicate that neither daily self-selected breakfast or 
more interestingly (as it was unaccustomed in more participants) morning fasting over 
a 6 week period induces any adaptations in acute energy intake or subjective appetite 
in lean individuals.  
The absence of altered acute energy intake to either intervention is consistent 
with the stability of appetite hormone responses before and after the interventions. 
There have been few studies that have examined acute appetite hormone responses to 
feeding following a chronic dietary intervention. These investigations have examined 
the effect of interventions manipulating feeding frequency (Cameron et al., 2010; 
Carlson et al., 2007) and macronutrient composition of diet (Ellis et al., 2012) upon 
acute appetite hormone responses to feeding. In concordance with the current work, 
none of these prior investigations has reported alterations in acute appetite hormone 
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responses from pre- to post- chronic intervention. Although it has been reported that 
exercise programme (Martins et al., 2010) and diet induced (Cummings et al., 2002) 
weight loss interventions can modify postprandial appetite hormone concentrations, it 
appears that these responses are relatively resistant to change in the context of altered 
feeding patterns without substantial weight change.  
One appetite hormone that has been suggested to be modifiable through altered 
feeding patterns is the orexigenic hormone ghrelin. Frecka and Mattes (2008) have 
suggested that ghrelin concentrations are entrained to habitual feeding patterns, with 
peaks coordinated with the expected time of feeding. Kim and colleagues (2012) have 
reported that when shifting breakfast intake from 07:00 to 09:00 for two weeks that 
the peak in ghrelin concentrations followed the change in eating time. Following this 
line of reasoning, it might be expected that ghrelin would peak later in the morning 
and/or be reduced at the start of the day following a fasting intervention but this was 
not the case in the current intervention. This may well be due to the duration of the 
overnight fast resulting in a “maximal” drive to eat independent of habitual patterns 
and potentially due to expectancy of feeding in the lab environment. A future line of 
enquiry would be to establish in time blinded individuals if the pattern of ghrelin 
release in the morning is altered following a morning fasting regimen. 
Adiponectin concentrations significantly increased as a result of the fasting 
intervention, a finding that was not replicated in the breakfast group. It has previously 
been shown that adiponectin is inversely related to weight (Matsubara et al., 2002) and 
that weight loss via changes to diet and physical activity increase adiponectin 
concentrations (Esposito et al., 2003). However, when reviewing the evidence 
pertaining to caloric restriction interventions resulting in weight loss, Klempel and 
Varady (2011) have not reported a consistent increase in adiponectin. Studies of short 
duration involving moderate energy restriction for 4 days (Imbeault et al., 2004) or 
acute fasting for 48 hours (Gavrila et al., 2003) also do not increase adiponectin levels. 
In contrast with these findings are reports adiponectin increases in response to short 
term (5-7 days) overfeeding (Cahill et al., 2013a; Walhin et al., 2013; Brons et al., 
2009), with some authors suggesting that this increase may be a counter regulatory 
response to counter insulin resistance in the short term (Brons et al., 2009; Cahill et 
al., 2013a). It may be that in the fasting group an increase in adiponectin reflects a 
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similar response to attempt to preserve insulin sensitivity. It should also be 
acknowledged that the fasting group had lower initial adiponectin concentrations and 
therefore the increase in this group could also represent some regression to the mean. 
 This study has found that a 6 week period of daily morning fasting does not 
cause adaptation of acute appetite regulation or increase acute energy intake. Appetite 
hormone responses to morning and lunch feeding were mainly unchanged by either a 
morning fasting or breakfast consumption regimen, indicating relative stability of 
responses in the absence of weight change as observed in this context. In conclusion, 
this work provides no evidence for a detrimental impact of daily morning fasting upon 
acute appetite regulation and metabolic responses to feeding in lean adults.   
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Chapter 6: Morning fasting does not stimulate 
increased energy intake at a lunchtime meal, but 
causes differing metabolic and hormonal responses 
relative to a typical breakfast in obese adults 
 
6.1 Introduction 
 In Chapter 3 we characterised the energy intake, metabolic and appetite 
responses to acute breakfast consumption and morning fasting followed by an ad 
libitum feeding occasion in lean individuals. Whilst there is a relative lack of literature 
comparing these conditions in lean individuals, to the best of the authors knowledge 
no studies have compared the appetite hormone and metabolic responses to extended 
morning fasting versus breakfast consumption in obese individuals.  
It cannot be assumed that the responses of lean individuals will be the same as 
obese individuals. The clearest indication that this should not be the case is that excess 
adiposity in obese individuals is not simply a physiological status but the result of a 
process of energy imbalance that has not been reversed over time. In contrast, lean 
individuals have demonstrated that they are able to manage long term energy balance 
effectively. 
Previous studies contrasting obese individuals with lean counterparts have 
highlighted several relevant differences that might be expected to contribute to 
divergent findings in the two groups. It has been reported that obese individuals have 
delayed satiation to feeding, with greater energy intake before reaching maximum 
satiation (Delgado-Aros et al., 2004). This discrepancy in satiation may partly be 
influenced by differences in appetite hormones.  
 
It has been established that several appetite hormones are either present in 
different concentrations in obese individuals or respond differently to feeding 
compared with lean individuals. Batterham and colleagues (2003) have reported that 
PYY concentrations were lower postprandially in obese than normal weight 
individuals despite greater intake during an ad libitum buffet meal. This attenuation of 
PYY release has been implicated in the reduced satiety induced by meals in obese 
individuals (le Roux et al., 2006). Ghrelin concentrations are lower in obese than lean 
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individuals (Tschop et al., 2001b; Shiiya et al., 2002). Additionally, the suppression 
of ghrelin in response to feeding has been reported to be both reduced (le Roux et al., 
2005) and not present at all in obese individuals (English et al., 2002), with some 
evidence to suggest that nadir ghrelin concentrations after feeding are delayed in obese 
men (Carroll et al., 2007).  
When reviewing relationships between insulin, glucose and appetite regulation 
in test meal studies by meta-analysis, Flint and colleagues (2007) have reported 
inverse associations between insulin and both hunger and energy intake in lean but not 
overweight individuals. In addition, they also report a significant correlation between 
appetite sensations and energy intake at ad libitum meals in normal weight but not 
obese individuals. 
With these pertinent differences between obese and lean individuals in mind, 
the aim of the present study is to examine the appetite, metabolic and hormonal 
responses to acute morning fasting and breakfast consumption in obese individuals. 
Due to previous reports of reduced satiety hormone concentrations and lesser 
suppression of ghrelin following feeding, it is hypothesised that breakfast 
consumption will not reduce intake at a subsequent feeding occasion in obese 
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6.2 Participants and Methods 
 
6.2.1 Participants  
Twenty four healthy, obese men (n = 8) and women (n = 16) aged 25-58 y took 
part in this study. Participants were recruited via local advertisement from South West 
England and were initially assessed for eligibility based upon a body mass index of ≥ 
30 kg·m-2 and then later classified as obese based upon DEXA-derived fat mass indices 
of ≥9 kg·m-2 (men) and ≥13 kg·m-2 (women) (Kelly et al., 2009). The study was part 
of a wider randomised controlled trial (the Bath Breakfast Project). In accordance with 
full eligibility criteria outlined in Chapter 2, participants reported being weight stable 
( 2% body mass within past 6 months) and adhered to a standard sleep-wake cycle 
(e.g no shift workers) and did not anticipate any change in lifestyle during the study 
period. Participants were free of metabolic disorders, with pre-menopausal female 
participants either menstruating regularly, or following their chosen contraceptive 
method (i.e pill, implant) for >6 months. Within the study cohort there was a mix of 
regular breakfast consumers (classified as >50 kcal intake within 2 hours of waking 
on ≥4 days of the week) and non-consumers. Characteristics of participants are 
presented in Table 6.1. 
 Written informed consent was obtained from all participants, with the Ethical 
Approval for the study obtained from the NHS Bristol Research Ethics Committee. 
The study is registered with Current Controlled Trials [ISRCTN31521726]. 
Table 6.1: Participant characteristics 
*Fat mass index calculated as DEXA derived total fat mass divided by height squared. 




Age (y) 44 (10) 
Body Mass (kg) 96.7 (19.0) 
Body Mass Index (kg/m2) 33.5 (4.7) 
Fat Mass Index (kg/m2)* All 13.4 (3.9) 
Female 15.1 (3.7) 
Male 9.8 (1.0) 
Habitual Breakfast Consumers (n) 14 
Female (n) 16 
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6.2.2 Study Methodology 
  
 The study design, experimental protocols and approach to statistical analysis 
for this investigation were identical to those outlined in Chapter 3 of this thesis. The 
only difference in this study was the quantity of breakfast provided. The breakfast was 
again provided in quantities that contained 0.06 g carbohydrate per kcal of each 
individual participant’s measured daily resting metabolic rate and due to the greater 
body mass (and therefore correspondingly greater RMR) of the obese participants in 
this study, this resulted in an energy intake of 521  94 kcal.  
.           
  




Figure 6.2: Energy intake during trials. In the fasting trial an asymmetric error bar is 
plotted. The positive portion of the error bar reflects the comparison between total 
intake during the fasting trial (i.e lunch only) and total intake on the breakfast trial, 
with the negative portion reflecting the comparison between lunches. * p < 0.01 for 
difference between total energy intake of breakfast versus fasting trial. Equivalent 
figure for lean individuals on page 98 
 
6.3.1 Energy Intake 
 
The energy content of the breakfast provided to participants was 521 ± 94 kcal 
(i.e variance proportionate to inter-individual differences in RMR). Energy intake at 
the ad libitum lunch was 817 ± 325 kcal in the breakfast trial and was not significantly 
different in the fasting trial (869 ± 354 kcal; p = 0.1). The additional intake at lunch 
during the fasting trial accounted for 10% of the intake provided with breakfast, 
resulting in a greater absolute intake over the testing day of 469 kcal (p < 0.01) during 
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Figure 6.3: Glucose responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial. 




There were main effects of trial and time, and an interaction of trial x time for 
blood glucose (all p < 0.01). Blood glucose was greater following breakfast 
consumption until 2 hours post breakfast (all p < 0.01; Figure 6.3) but was not different 
3 hours after consumption (p = 0.26). Following lunch consumption, blood glucose 
concentrations were greater in the fasting trial 1 hour after lunch (p < 0.01) but not 
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Figure 6.4: Insulin responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p ≤ 0.05 versus corresponding time point in other trial. 




Similar to glucose concentrations, there were main effects of time, trial and a 
trial x time interaction for insulin (all p < 0.02). Insulin concentrations were greater 
throughout the morning following breakfast consumption (all p < 0.02, Figure 6.4). 
After the ad libitum lunch, insulin concentrations were greater in the fasting trial (all 
p = 0.05). 
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Figure 6.5: NEFA responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p ≤ 0.05 versus corresponding time point in other trial. 




Main effects of time and trial were evident for NEFA as well as a time x trial 
interaction (all p < 0.01). NEFA concentrations were reduced in the breakfast trial 
compared with the fasting trial from 15 minutes after breakfast (p = 0.05) and 
throughout the rest of the morning (all p < 0.01, Figure 6.5). There were no differences 
(both p > 0.1) between NEFA concentrations in the two trials at 1 and 3 hours after 
lunch consumption. There was a statistically significant but quantitatively small 
difference 2 hours after lunch consumption (Breakfast; 0.08 ± 0.06 mmol·l-1 vs 
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Figure 6.6: Acylated ghrelin responses during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 
fasting trial. L= Ad libitum pasta lunch. * p ˂ 0.01 versus corresponding time point in 
other trial. Equivalent figure for lean individuals on page 102 
 
 
6.3.5 Acylated Ghrelin 
 
A main effect of time and a trial x time interaction (both p < 0.01) were 
apparent for acylated ghrelin concentrations. Acylated ghrelin concentrations were 
lower following breakfast consumption until 2 hours post-breakfast (both p < 0.01; 
Figure 6.6) with no difference between the trials immediately prior to the ad libitum 
lunch (p = 0.47). Following lunch consumption, acylated ghrelin was suppressed 
below baseline concentrations throughout the afternoon in the fasting trial but 
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Figure 6.7: Total ghrelin responses during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 
fasting trial. L= Ad libitum pasta lunch. * p ˂ 0.04 versus corresponding time point in 
other trial. Equivalent figure for lean individuals on page 102 
 
6.3.6 Total Ghrelin 
 
There were main effects of trial, time and and a trial x time interaction (all p < 
0.01) for total ghrelin concentrations. Total ghrelin concentrations were significantly 
lower than the fasting trial following breakfast consumption throughout the morning 
(all p < 0.04, Figure 6.7). Following lunch consumption there was no difference 
between total ghrelin concentrations in the two trials.  
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Figure 6.8: PYY responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p ˂ 0.02 versus corresponding time point in other trial. 




 PYY concentrations differed over time, between trials and there was a trial x 
time interaction evident (all p < 0.01; Figure 6.8). PYY concentrations were not 
different at baseline (p = 0.25) but from 1 hour after breakfast until 2 hours after lunch, 
PYY concentrations were greater in the breakfast trial (all p < 0.02). Three hours after 
lunch consumption, the difference between trials was reduced such that there was only 
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Figure 6.9: Leptin responses during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p ˂ 0.01 versus corresponding time point in other trial. 




For leptin concentrations there were main effects of trial, time and a significant 
trial x time interaction (all p < 0.04; Figure 6.9). Leptin concentrations were not 
different at baseline (p = 0.5) and decreased pre-lunch in both groups, but with a 
tendency for lower concentrations following fasting (Breakfast Trial, 24133 pg·ml-1 
vs Fasting Trial, 21252 pg·ml-1, p = 0.06). Three hours after lunch consumption, leptin 
concentrations were significantly greater in the breakfast consumption trial (29059 ± 
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Figure 6.10: Adiponectin responses during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 





 Adiponectin concentrations over the day displayed a main effect of time  
(F = 6.47, p < 0.01). No other main effects or interactions were apparent (all p > 0.2, 
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Figure 6.11: Desire to eat during trials. B=Breakfast period, in which participants ate 
a prescribed breakfast during the breakfast trial and rested during the fasting trial. L= 
Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial 
Figure 6.12: Hunger during trials. B=Breakfast period, in which participants ate a 
prescribed breakfast during the breakfast trial and rested during the fasting trial. L= 
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Figure 6.13: Fullness during trials. B=Breakfast period, in which participants ate a 
prescribed breakfast during the breakfast trial and rested during the fasting trial. L= 
Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial 
Figure 6.14: Prospective consumption during trials. B=Breakfast period, in which 
participants ate a prescribed breakfast during the breakfast trial and rested during the 
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Figure 6.15: Appetite score during trials. B=Breakfast period, in which participants 
ate a prescribed breakfast during the breakfast trial and rested during the fasting trial. 
L= Ad libitum pasta lunch. * p < 0.01 versus corresponding time point in other trial. 
Equivalent figures for appetite ratings for lean individuals on pages 108-110 
 
6.3.10 Subjective Appetite Ratings 
 
 Subjective appetite ratings are displayed in Figures 6.11-15. Main effects of 
time and trial and a time x trial interaction were apparent for desire to eat (all p < 0.01). 
During the morning desire to eat was greater in those fasting than those who ate 
breakfast both immediately after consumption and prior to lunch (both p < 0.01). There 
was a tendency for greater desire to eat in the breakfast trial at the end of the day (40 
± 20 vs 31 ± 24; p = 0.06). 
For prospective consumption effects of time, trial and a trial x time interaction 
were apparent (all p < 0.05). Following breakfast consumption prospective 
consumption was reduced and was less than in the fasting trial (p < 0.01). There was 
a tendency for the pre-lunch prospective consumption to be lower in the breakfast trial 
than the fasting trial (Breakfast, 58 ± 15 vs Fasting, 67 ± 20; p = 0.06). Lunch 
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of the day there was a tendency for higher prospective consumption in the breakfast 
(41 ± 19) than fasting trial (33 ± 20; p = 0.06).  
For hunger there were main effects apparent for time and trial as well as a time 
x trial interaction (all p < 0.01). Hunger was lower throughout the morning during the 
breakfast trial (both p < 0.01). There were no differences in perceived hunger 
throughout the afternoon between trials (both p > 0.18).  
Results for fullness indicated main effects of trial, time and a trial x time 
interaction (all p < 0.03). Fullness was increased after breakfast consumption and was 
greater than in the fasting trial (71 ± 18 vs 29 ± 21; p < 0.05). Prior to lunch, there was 
a tendency for greater fullness in the breakfast trial (33 ± 19 vs 20 ± 18; p = 0.06). 
Immediately after lunch and at the end of the day, there was no detectable difference 
in fullness (both p > 0.1). 
For the composite appetite score calculated there was a main effect of trial, 
time and a trial x time interaction (all p < 0.03). Appetite was reduced following 
breakfast consumption and although it rebounded to baseline levels prior to lunch, it 
was still lower than in the fasting trial (both p < 0.01). There was no difference in 
appetite after lunch consumption (p = 0.15) but there was a tendency for greater 
appetite at the end of the testing day in the breakfast trial (41 ± 17 vs 35 ± 17; p = 
0.09).  
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Figure 6.16: Diet induced thermogenesis during trials. The morning and afternoon 
periods were both of 3 h duration. * p < 0.01 versus other trial. Equivalent figure for 
lean individuals on page 112 
 
6.3.11 Diet Induced Thermogenesis 
 
 Energy expenditure above rest was greater (p < 0.01) in the breakfast (31 ± 15 
kcal·3h-1) than fasting (8 ± 13 kcal·3h-1) trial during the morning. Following lunch 
consumption there was a tendency (p = 0.08) for greater energy expenditure in the 
breakfast trial (37 ± 17 kcal·3h-1) when compared with the fasting trial (32 ± 16 
kcal·3h-1). When energy expenditure above rest was combined for the trial as a whole, 
there was greater energy expenditure in the breakfast than fasting trial (Breakfast, 68 
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6.4 Discussion       
  
The current study aimed to characterise the metabolic, hormonal and appetite 
responses to morning fasting compared with a typical high carbohydrate breakfast in 
obese individuals. There was no evidence of altered energy intake at an ad libitum 
lunch when participants fasted, resulting in greater net intake in the breakfast trial. 
Following lunch consumption there was limited suppression of ghrelin in the breakfast 
trial, but greater PYY and leptin concentrations. Subjective ratings did not indicate 
greater appetite after lunch consumption in the fasting trial, despite less energy intake 
over the testing day. These results indicate that obese individuals do not compensate 
for missed breakfast energy intake at a lunchtime meal and that neither hormonal nor 
subjective measures of appetite are increased during the afternoon following fasting.  
 The finding of incomplete energy compensation in a single meal following 
morning fasting has been reported previously in lean individuals (Levitsky and 
Pacanowski, 2013) and was also observed in Chapter 3 of this thesis. Previous studies 
using morning preloads have reported both increased (Astbury et al., 2011) and 
unaffected lunchtime intake (Gonzalez et al., 2013) following fasting. However, all of 
these published studies have been completed in lean, young participants. To the best 
of our knowledge, this is the first study to specifically examine a contrast of acute 
morning fasting against breakfast consumption in obese individuals. Although it has 
been suggested that energy intake is increased with breakfast skipping (Farshchi et al., 
2005b) there is accumulating evidence from randomised controlled trials that energy 
intake is either unaffected (Halsey et al., 2012) or lower in individuals who skip 
breakfast (Reeves et al., 2014). This latter finding of reduced energy intake with 
omission of breakfast was also replicated in free-living lean individuals in Chapter 4. 
Therefore, the effects of morning fasting upon total energy intake are yet to be 
conclusively established. It would seem that any potential compensation for omitted 
energy intake through breakfast skipping is not strongly manifested through energy 
intake at the lunchtime meal in obese individuals. However, it is plausible that energy 
intake in a natural environment would be discrepant from the results obtained in the 
laboratory due to self-regulation of feeding patterns and food choices. This is also 
particularly relevant as obese individuals display elevated neural responses to 
palatable and energy dense foods (Burger and Berner, 2014) and are suggested to be 
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more susceptible to environmental cues to eat than hormonal regulation (Schachter, 
1968; Mela, 2001). Studies investigating free-living energy intake with morning 
fasting and lab studies utilising buffet designs or permitting volitional feeding 
frequency are warranted in obese individuals. 
The current work replicates our findings in lean individuals that consuming a 
typical carbohydrate rich breakfast results in blunted ghrelin response to a second meal 
(i.e a lack of suppression after feeding) despite similar lunch energy intake in this 
obese group. This finding is also similar to a previous study reporting absence of 
ghrelin suppression in obese individuals following food intake (English et al., 2002).  
Similar to the responses observed in lean individuals, this limited suppression of 
ghrelin may be linked to reduced glucose and insulin responses to the lunchtime meal 
following breakfast consumption that is putatively due to the second meal effect 
(Bonuccelli et al., 2009). Whether this effect persists with breakfast and lunchtime 
meal combinations inducing less pronounced differences in glucose and insulin 
relative to morning fasting is an interesting area of future study.  
 
Similarly to the lean individuals previously studied using the same design in 
Chapter 3, leptin and PYY were greater in the afternoon during the breakfast trial. 
Therefore, in individuals consuming breakfast there were both hormonal responses 
generally indicative of satiety (PYY/leptin) as well as others that may signal hunger 
(ghrelin). In contrast to the lean individuals previously studied, and within the context 
of these contrasting hormonal responses, there was some tentative evidence of 
increased perceptions of hunger at the end of the day in the breakfast trial. Future work 
extending laboratory investigations into the evening would provide interesting 
information as to the time course of these hormones/subjective perception of appetite 
into the evening and if there are any resultant effects upon energy intake. 
Immediately prior to lunch, as would be expected, subjective ratings of 
appetite indicated greater hunger during the fasting trial. However, despite marked 
differences in subjective ratings of appetite there was no difference in lunchtime 
energy intake between the two trials. This is not completely unexpected as the 
correlation between pre-lunch appetite ratings and ad libitum lunch energy intake in 
lean men has been reported as only in the range of 0.25 to 0.38 indicating a weak to 
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moderate relationship (Flint et al., 2000) and a further meta-analysis has indicated that 
sensations of hunger and satiety did not correlate with energy intake in obese 
individuals (Flint et al., 2007).  
There are several plausible explanations for this lack of relationship between 
pre-lunch appetite ratings and energy intake. Firstly, that the relationship between 
appetite and intake are disrupted in obese individuals (Flint et al., 2007). Secondly, 
that subjective appetite measures do not adequately capture the various dimensions of 
appetite (Mattes et al., 2005). Thirdly, that there is another factor that potentially led 
to termination of the meal in participants who were still hungry. Meal termination may 
have arisen due to feelings other than satiation (i.e boredom and reduced liking for the 
food provided due to the homogeneity of the meal provided) as provision of a variety 
of foods delays satiation (Hetherington et al., 2006) and promotes greater intake (Rolls 
et al., 1981b; Spiegel and Stellar, 1990).    
The present study shows morning fasting does not result in energy 
compensation at an ad libitum lunch meal compared with consuming a carbohydrate 
rich breakfast in obese individuals. Breakfast consumption limited the suppression of 
ghrelin following the lunchtime meal as was also previously observed in lean 
individuals, with this response possibly mediated through reduced insulin responses 
to lunch. There was no evidence of increased hunger in the late afternoon when 
individuals fasted throughout the morning. This work suggests that any compensation 
for missed energy intake is not apparent at the next meal in obese individuals, although 
the possibility that this may occur through greater meal/snack frequency and food 
choices should be investigated in free-living settings.  
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Chapter 7: Effect of six weeks of daily morning 
fasting upon components of energy balance and 
associated health markers in obese individuals 
 
7.1 Introduction  
  
As discussed in Chapter 1, epidemiology has associated infrequent breakfast 
consumption with increased risk of adiposity (Ma et al., 2003; Horikawa et al., 2011; 
Purslow et al., 2008; Barton et al., 2005; Kant et al., 1995), diabetes (Mekary et al., 
2013; Mekary et al., 2012) and cardiovascular risk (Cahill et al., 2013b; Smith et al., 
2010). However, it is also pertinent that breakfast consumers have been found to 
exhibit other healthful behaviours including consumption of less fat and alcohol (van 
der Heijden et al., 2007), are more likely to be non-smokers (van der Heijden et al., 
2007; Smith et al., 2010) and, crucially, are more physically active (Duval et al., 2008). 
Therefore, despite numerous studies examining associations between breakfast and 
health, either the existence or direction of causality cannot be inferred from cross 
sectional studies. It remains to be established if breakfast is causally linked to health 
or is instead a marker of a healthy lifestyle. 
 While previous laboratory studies have contrasted breakfasts of varied quantity 
or composition, for example by manipulating macronutrient (Clegg and Shafat, 2010), 
fibre (Hamedani et al., 2009; Kim et al., 2009; Levine et al., 1989; Liljeberg et al., 
1999) or energy content (Martin et al., 2000; Hubert et al., 1998) and/or glycaemic 
index (Rosen et al., 2011; Nilsson et al., 2008). Few studies have contrasted energy 
intake with a no breakfast condition (Gonzalez et al., 2013; Astbury et al., 2011; 
Levitsky and Pacanowski, 2013). Two of these studies utilised a preload (i.e a mid-
morning snack) and as such were not specifically examining unbroken morning fasting 
(Gonzalez et al., 2013; Astbury et al., 2011). We have investigated the acute appetite 
responses to morning fasting versus a typical carbohydrate rich breakfast in both lean 
(Chapter 3) and obese (Chapter 6) individuals. In both cohorts, lunch intake was not 
increased sufficiently to compensate for the intake at breakfast (i.e net energy intake 
was greater in the breakfast consumption trial). While these studies provide useful 
insight into mechanisms of short-term appetite regulation, free-living studies are 
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required to provide an ecologically valid reflection of how morning fasting can impact 
upon both energy intake and overall energy balance. 
     If breakfast consumption can favour a more negative net energy balance, 
one mechanism may be a reduction in energy intake throughout the rest of the day. 
However, epidemiological evidence is mixed, with some authors reporting no 
difference (Song et al., 2005; Wyatt et al., 2002) and others greater intake in those 
who consume breakfast (Cho et al., 2003; Nicklas et al., 1998). Consistent with the 
latter, emerging findings from randomised controlled trials in free-living adults 
indicate greater intake with breakfast consumption (Reeves et al., 2014). 
In Chapter 4 of this thesis we have also observed lower free-living energy 
intake in those fasting during the morning. However, as discussed in Chapter 6, there 
are several differences between appetite regulation of lean and obese individuals that 
may affect their responses to a free-living intervention. Therefore, it is important to 
establish how observed responses in lean individuals undergoing a morning 
fasting/daily breakfast intervention may differ in obese individuals. 
 In addition to the potential for reduced energy intake, another key malleable 
component of energy balance that may respond to breakfast consumption/morning 
fasting and therefore explain a more negative net energy balance with breakfast 
consumption is greater energy expenditure. The studies that have contrasted daily 
breakfast with morning fasting in adults have either not measured energy expenditure 
(Farshchi et al., 2005b; Schlundt et al., 1992) or have used partial (~8 h) records of 
physical activity assessed via pedometers and heart rate monitoring (Halsey et al., 
2012), which limits the sensitivity of the physical activity measurement undertaken 
(Butte et al., 2012). The lack of difference between conditions in individuals 
undertaking both breakfast consumption and morning fasting observed by Halsey and 
colleagues (2012) in lean individuals contrasts with the findings from Chapter 4 of this 
thesis; where greater energy expenditure was apparent in those lean individuals 
assigned the daily breakfast consumption intervention. It therefore remains to be 
established if physical activity energy expenditure is affected by morning feeding 
patterns. 
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 In addition to differences between those fasting and consuming daily breakfast 
in several elements of energy balance in lean individuals, we have also reported the 
responses of several markers of health during and following the interventions. We 
found no detrimental metabolic impact of morning fasting, apart from increased 
afternoon/evening glucose variability from weeks 1 to 6 of the intervention. Prior work 
by Farshschi and colleagues (2005) reported a negative impact upon fasting lipids and 
insulin iAUC to a mixed macronutrient test drink of extending the morning fast until 
11am in lean women. While we have not observed such pronounced negative 
implications of morning fasting in lean individuals, studies have yet to determine the 
effect of a morning fasting intervention upon health markers in free-living obese 
individuals. 
 The aim of the current study is to examine the impact of daily morning 
fasting/breakfast interventions on energy balance and selected markers of health in 
obese individuals. On the basis of prior published work and our free-living study in 
lean individuals described in Chapter 4, we hypothesise that both energy intake and 
physical activity expenditure will be lower in individuals fasting during the morning 
but that adherence to this regimen will not cause significant deterioration of health 
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7.2 Participants and Methods 
 
7.2.1 Participants 
 A total of 23 healthy, obese men (n = 8) and women (n = 15) aged 25-58 y 
volunteered to take part in this study. Participants were initially assessed for eligibility 
based upon the general criteria outlined in Chapter 2. In this study participants were 
recruited with a body mass index of ≥ 30 kg·m-2 and then later classified as obese 
based upon DEXA-derived fat mass indices of ≥9 kg·m-2 (men) and ≥13 kg·m-2 
(women) (Kelly et al., 2009). Participants were required to report being weight stable 
( 2 % body mass fluctuation within past 6 months). Participants adhered to a standard 
sleep-wake cycle (e.g no shift workers) and did not anticipate any change in lifestyle 
during the study period. Participants were free of metabolic disorders, with pre-
menopausal female participants either menstruating regularly, or following their 
chosen contraceptive method (i.e pill, implant) for >6 months. These individuals were 
randomly assigned to one of two intervention groups, either a breakfast consumption 
group prescribed ≥ 700 kcal by 11:00 daily (at least half of which was consumed 
within two hours of waking), or a fasting group prescribed abstinence from energy 
providing nutrients (i.e plain water only) until 12:00 daily. Characteristics of 
participants in the two groups are presented in Table 7.1. 
Written informed consent was obtained from all participants, with the Ethical 
Approval for the study obtained from the NHS Bristol Research Ethics Committee. 
The study is registered with Current Controlled Trials [ISRCTN31521726]. 
Table 7.1: Participant characteristics 
*Fat mass index calculated as DEXA derived total fat mass divided by height squared. 
Values represent mean with (SD)  
 
Characteristic Breakfast Group Fasting Group 
n 11 12 
Age (y) 44 (10) 44 (10) 
Body Mass (kg) 103.9 (24.0) 92.4 (11.2) 
Body Mass Index (kg/m2) 35.4 (6.1) 32.0 (2.2) 
Fat Mass Index (kg/m2)* All 14.8 (5.0) 12.0 (2.3) 
Female 16.9 (4.5) 13.5 (1.8) 
Male 9.9 (1.4) 9.8 (0.8) 
Habitual Breakfast Consumers (n) 7 7 
Female (n) 7 8 
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7.2.2 Study Methodology  
The study design, experimental protocols and approach to statistical analysis 
for this investigation were identical to those outlined in Chapter 4 of this thesis. The 
only difference from procedures employed for lean individuals described in Chapters 
2 and 4 was for the analysis of physical activity data. Due to a tendency for reduced 
wear time and heart rate data quality in obese participants, the criteria for Actiheart® 
monitoring were relaxed slightly to maximise included participant numbers without 
significantly compromising data quality. As such, a valid day of measurement for 
obese individuals was considered as 85% wear time for a day and no more than 30% 
comprising “recovered data”. This contrasts with corresponding criteria of 90% wear 
time and 22.5% maximum for “recovered data” in lean individuals. The impact of 
these changes upon the data obtained is presented in further detail in Appendix 2. 
Other inclusion criteria for physical activity monitoring data remained the same as 
lean individuals as described in Chapter 2.       
  




7.3.1 Body Composition 
 
 Body mass increased across both groups in response to the intervention (F = 
6.293, p = 0.02). There was no difference between groups (F = 2.23, p = 0.15) or an 
interaction effect (F = 2.29, p = 0.15). Pre-planned contrasts for change in body mass 
within each group revealed significantly increased body mass in the breakfast group 
(0.96 kg ± 1.10 kg; p = 0.02) but not in the fasting group (0.24 ± 1.13 kg; p = 0.5).   
 
Table 7.2: Anthropometric measures 
Measure  Breakfast Fasting 
 Pre Change Pre Change 




92.4 (11.2) 0.2  
(-0.5, 1.0) 
Lean Mass               (kg) 52.5 (7.0) 0.2  
(-1.7, 2.1) 
54.7 (11.0) -0.2  
(-1.3, 0.8) 
Fat Mass                  (kg) 41.8 (12.8) 0.5  
(-1.4, 2.5) 
34.1 (3.5) 0.6  
(-0.4, 1.5) 
Waist:Hip ratio 0.87 (0.10) 0.01 
(-0.01,0.03) 
0.91 (0.07) -0.01 
(-0.03, 0.00) 
Sagittal Abdominal 
Diameter                (cm) 
26.4 (3.2) 0.0 
(-0.4, 0.4) 
25.2 (2.0) -0.4  
(-1.0, 0.2) 
Values represent mean with (SD) and change scores from baseline with (95 % CI). 
Equivalent table for lean individuals on page 126   
 
Lean mass estimated by DEXA was not different between groups, over time 
and there was no interaction effect of time x group (all p > 0.6). Fat mass did not differ 
over time (F = 1.38, p = 0.25), and groups did not respond differently to the 
intervention (F = 0.00, p = 0.98). There was a tendency for a difference between 
groups, with greater fat mass in the breakfast group (F = 3.93, p = 0.06). It should be 
noted that one individual in the breakfast group could not be scanned due to their size 
and body mass (167 kg) exceeding the maximum capacity of the scanner, so it is likely 
that this group difference would be greater were data available for this individual. 
Measures of central adiposity were not different between groups, or over the course 
of the intervention (all p > 0.2). Groups did not respond differently to the intervention 
for any measure (both p > 0.1), apart from a tendency for an interaction effect for 
Waist:Hip ratio (F = 3.166, p = 0.09).    
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Figure 7.2: Reported energy intake during the first and last week of the intervention. 
Equivalent figure for lean individuals on page 127   
 
7.3.2 Energy Intake 
 
 Reported daily energy intake during the intervention was not different between 
groups (F = 1.173, p = 0.29), with the mean energy intake of the two weeks of 
monitoring 2719 ± 683 kcal·d-1 in the breakfast group and 2382 ± 234 kcal·d-1 in the 
fasting group. There was a main effect of time for reported energy intake from the first 
to the last week of the intervention (F = 4.886, p = 0.04), this decrease was -202 kcal·d-
1 (95% CI,-526, 122) in the breakfast group and -156 kcal·d-1 (95% CI, -315, 3) in the 
fasting group.    
There were no differences (all p > 0.1) between groups for percentage 
macronutrient composition for the whole day (Table 7.3) or total intake of 
macronutrients (Figure 7.3). There were main effects of time for total and saturated 
fat intake (both p < 0.05), and a tendency for a time x group interaction (p = 0.06) for 
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Table 7.3: Percentage composition of diets during intervention  
 Breakfast Group Fasting Group 
 First Week Last Week First Week Last Week 
 Pre 12:00 Post 12:00 Total Pre 12:00 Post 12:00 Total Post 12:00 Post 12:00 
Energy Intake (kcal∙d-1) 885 (197) 1934 (538) 2820 (595) 891 (214) 1727 (742) 2618 (833) 2459 (779) 2303 (792) 
Protein % 15.7 (4.6) 15.8 (3.2) 15.7 (2.4) 14.4 (3.4) 17.1 (3.9) 16.1 (3.4) 14.3 (2.2)  15.2 (3.2) 
Carbohydrate % 51.2 (14.9) 41.6 (4.4) 44.3 (6.2) 50.3 (14.5) 44.0 (5.7) 45.5 (7.6) 44.0 (8.6) 43.6 (7.5) 
Fat % 33.1 (11.9) 38.7 (4.4) 37.4 (5.5) 35.3 (12.0) 34.4 (5.5) 35.2 (6.4) 35.0 (7.2) 35.8 (6.0) 
Alcohol % n/a 3.9 (4.2) 2.7 (2.8) n/a 4.6 (4.7) 3.2 (3.4) 6.7 (8.4) 5.4 (6.3) 
Values represent mean with (SD). Equivalent table for lean individuals on page 129  
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Figure 7.3: Daily macronutrient intake during the intervention. Figures on stack 
represent mean intake, with figures in brackets representing standard deviation. 
Equivalent figure for lean individuals on page 130 
 
 
 When comparing pre- and post-12:00 percentage macronutrient composition 
in the breakfast group, there were no differences (all p ≥ 0.1) between any of the 
macronutrients. However, there was a greater proportion of energy intake from sugars 
prior to 12:00 relative to post 12:00 (23 ± 8 % ± vs 16 ± 4%, p = 0.02).  
Once both groups were permitted unrestricted feeding (i.e 12:00 onwards) 
there was a tendency towards greater energy intake in the fasting group (2381 ± 777 
kcal∙d-1) relative to the breakfast group (1831 ± 612 kcal∙d-1; p = 0.08). There was 
greater intake of sugars in the fasting group after 12:00 (108 ± 45 g vs 75 ± 27 g; p = 
0.05) but no other differences between groups were apparent for macronutrient intakes 
after 12:00 (all p > 0.1). There was reduced reported intake (F = 6.05, p = 0.02) in the 
last week relative to the first week of recording. For total fat and saturated fat intake 
there was a main effect of time, with reductions across both groups (both p < 0.03). A 
trial x group interaction was apparent for total fat intake (F = 4.58, p = 0.05), with a 
significant reduction in the breakfast group from the first (85 ± 28 g) to last week (66 
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Figure 7.4: Physical activity energy expenditure. Equivalent figure for lean 
individuals on page 132  
 
7.3.4 Physical Activity Energy Expenditure 
Daily energy expenditure between the two groups was not different (Breakfast 
Group, 1221 ± 261 kcal·d-1 vs Fasting Group, 949 ± 709 kcal·d-1; F = 1.17, p = 0.29). 
There was no difference in energy expenditure between the two weeks of physical 
activity monitoring, and the groups did not respond differently between the first and 
last week of monitoring (both p > 0.3). There was no difference between the two weeks 
of measurement, with both groups stable within 100 kcal·d-1 between weeks and no 
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Figure 7.5: Physical activity energy expenditure split by time of day and intensity. 
Equivalent figure for lean individuals on page 134 
 
Analysis of the timing/intensity of energy expenditure is displayed in Figure 
7.5 and Table 7.4. This indicated that energy expenditure prior to 12:00 was greater in 
the breakfast group (435 ± 132 kcal·d-1) than the fasting group (247 ± 171 kcal·d-1; p 
= 0.03). After 12:00 there was no significant difference in energy expenditure between 
the two groups (Breakfast Group, 756 ± 135 kcal·d-1 vs Fasting Group, 676 ± 540 
kcal·d-1; p = 0.66). Activity partitioned by intensity according to metabolic equivalents 
was not different between groups, either for the day considered as a whole or for the 


































Breakfast Group Fasting Group
Sedentary <1.5 MET
Light   1.5-2.9 MET
Vigorous   >5.9 MET
Sedentary <1.5 MET




Light   1.5-2.9 MET
Vigorous   >5.9 MET
Moderate 3.0-5.9 MET
Sedentary <1.5 MET
Light   1.5-2.9 MET




a.m. p = 0.03
p = 0.65
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Table 7.4: Physical activity energy expenditure split by intensity and time of day  
 
Values represent mean with (SD). Equivalent table for lean individuals on page 135  
* Denotes significantly lower in fasting than breakfast group (p < 0.05) 
 Breakfast Group Fasting Group 
Energy Expenditure (kcal∙d-1) AM PM 24h AM PM 24h 
Sedentary (<1.5 MET) 24 (7) 48 (11) 72 (17) 26 (7) 41 (12) 67 (18) 
Light (1.5-2.9 MET) 146 (30) 284 (55) 430 (79) 103 (57) 247 (100) 350 (146) 
Moderate (3.0-5.9 MET) 208 (82) 346 (116) 554 (193) 109 (99) 327 (332) 435 (424) 
Vigorous (6.0-10.1 MET) 50 (68) 75 (56) 125 (115) 9 (16) 39 (72) 49 (85) 
Very Vigorous (≥10.2 MET) 8 (16) 3 (4) 11 (20) 1 (2) 22 (46) 23 (47) 
Total 435 (132) 756 (457) 1191 (249) 247 (171)* 676 (540) 923 (697) 
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Figure 7.6: Resting metabolic rate before and after the intervention. Equivalent 
figure for lean individuals on page 136 
 
7.3.5 Resting Metabolic Rate 
 There were no main effects of time or group (both p > 0.6) for resting metabolic 
rate. Resting metabolic rate was 1613 ± 77 kcal∙d-1 and 1679 ± 101 kcal∙d-1 for the 
fasting and breakfast groups, respectively, prior to the intervention. Following the 
intervention, RMR was stable in both groups (Fasting Group, 1605 ± 91 kcal∙d-1  vs 
Breakfast Group 1679 ± 106 kcal∙d-1) such that it was within 8 kcal from prior to the 
interventions in both groups, with no difference in response to the intervention (F = 
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Figure 7.7: Diet induced thermogenesis during the intervention. Equivalent figure 
for lean individuals on page 137 
 
7.3.6 Diet Induced Thermogenesis 
 Based on the established thermogenic effect of ingested macronutrients, diet 
induced thermogenesis based on reported energy intake from food diaries was not 
different between groups (F = 1.22, p = 0.28), with no effect of time (F = 2.36, p = 
0.14) or any interaction (F = 0.12, p = 0.73). Daily diet induced thermogenesis was 
200 ± 60 kcal∙d-1 in the fasting group, relative to 224 ± 43 kcal∙d-1 in the breakfast 
group, during the first week. In the final week of observation, diet induced 
thermogenesis was 186 ± 57 kcal∙d-1 in the fasting group relative to 215 ± 72 kcal∙d-1  
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7.3.7 Oral Glucose Tolerance Test  
Figure 7.9: Insulinaemic response to an Oral Glucose Tolerance Test. Equivalent 
figure for lean individuals on page 139 
 
Insulin concentrations varied over the course of the OGTT (F = 16.24, p < 
0.01) and this response over time varied from pre- to post-intervention (F = 3.732, p 
= 0.02). There were no other main effects or interactions (all p > 0.3) apart from a 
tendency for a trial x group interaction (F = 3.84, p = 0.07). Insulin incremental AUC 
was not different between groups or trials (both p > 0.3), but there was a significant 
trial x group interaction (F = 4.72, p = 0.05, Figure 7.9). The individual contrasts of 
the insulinaemic response to the OGTT from pre- to post-intervention within each 
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Figure 7.10: Glycaemic response to an Oral Glucose Tolerance Test. Equivalent 
figure for lean individuals on page 139 
 
Glucose concentrations varied over the course of the OGTT (F = 34.55, p < 
0.01) and this response over time varied from pre- to post-intervention (F = 4.03, p = 
0.01). No other main effects or interactions were apparent for glucose concentrations 
during the OGTT (all p > 0.17). Glucose incremental AUC was not different over time, 
between groups and the response to the intervention was not different between groups 
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Table 7.5: Insulin sensitivity measures  
Measure Breakfast Group Fasting Group 
 Pre Change Pre Change 
Fasting Insulin     (pmol.l-1) 63 (35) 2  
(-21, 25) 
54 (16) -4   
(-16, 9) 
Peak Insulin         (pmol.l-1) 872 (555) -54  
(-233, 124) 
694 (285) 101  
(-99, 303) 
Fasting Glucose   (mmol.l-1) 5.30 (0.29) 0.08  
(-0.12, 0.28) 
5.56 (0.37) 0.09  
(-0.20, 0.38) 
Peak Glucose       (mmol.l-1) 10.09 (1.40) 0.30  
(-0.53, 1.14) 
10.15 (1.00) 0.68  
(-0.08, 1.44) 
HOMA-IR 2.46 (1.31) 0.18 
(-0.84, 1.19) 
2.24 (0.72) -0.13 
(-0.71, 0.45)  
C-ISI 3.78 (2.05) 0.05 
(-0.59, 0.70) 
3.81 (1.09) -0.05  
(-1.08, 0.97) 
Values represent mean with (SD) and change scores from baseline with (95 % CI). 
Equivalent table for lean individuals on page 140 
   
7.3.8 Insulin Sensitivity Measures     
 Insulin sensitivity measures calculated from the OGTT are displayed in Table 
7.5. Fasting glucose and insulin did not respond over time (both p > 0.3), with no 
evidence of a time x group interaction (both p > 0.6). There was no difference in 
fasting insulin between groups (p = 0.27) but a difference between fasting glucose 
concentrations was apparent between groups (F = 4.44, p = 0.05). There were no main 
effects or interactions for peak glucose or insulin concentrations (all p > 0.2) apart 
from a tendency for increased peak glucose over time in both groups (F = 3.90, p = 
0.06). Both Matsuda and HOMA indices were not different over time or between 
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Table 7.6: Fasting lipids and inflammatory markers  
Measure Breakfast Group Fasting Group 
 Pre Change Pre Change 
Total Cholesterol (mmol.l-1) 5.78 (0.79) 0.14  
(-0.11, 0.39) 
4.96 (0.90) 0.25  
(0.00, 0.49) 
HDL Cholesterol (mmol.l-1) 1.25 (0.24) 0.03 
 (-0.06, 0.11) 
1.26 (0.27) -0.01  
(-0.16, 0.14)  
LDL Cholesterol (mmol.l-1) 3.91 (0.98) 0.15 
 (-0.07, 0.36) 
3.07 (0.71) 0.27 
 (0.01, 0.53) 
Total:HDL Cholesterol 4.69 (0.48) 0.03 
 (-0.18, 0.24) 
4.00 (0.70) 0.19  
(-0.29, 0.66) 
Triglycerides       (mmol.l-1) 1.87 (1.11) -0.08  
(-0.43, 0.27) 
1.38 (0.64) -0.03 
 (-0.24, 0.19) 
NEFA                  (mmol.l-1) 0.55 (0.27) -0.13 
 (-0.3, 0.04) 
0.45 (0.21) -0.00  
(-0.11, 0.11) 
CRP                     (mg.l-1) 3.10 (2.05) -0.05 
 (-0.89, 0.80) 
2.19 (1.03) 0.11  
(-0.87, 1.08) 
Values represent mean with (SD) and change scores from baseline with (95 % CI). 
Equivalent table for lean individuals on page 141 
   
7.3.9 Cardiovascular Disease Risk Factors 
 None of the cardiovascular disease risk factors presented responded differently 
between groups to the intervention (all p > 0.13). There was an increase in total and 
LDL cholesterol concentrations in both groups from pre- to post-intervention (both p 
< 0.03). Both LDL concentrations and the Total:HDL ratio were greater in the 
breakfast group (both p ≤ 0.04), with a tendency for greater total cholesterol 
concentrations in the breakfast group (p = 0.07). No other risk factors differed over 
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7.4 Discussion 
 The current study has examined all elements of energy balance, as well as 
metabolic control and selected markers of cardiovascular disease risk in response to 
both daily morning fasting and breakfast consumption for 6 weeks in healthy obese 
individuals. There was no difference in the overall energy intake reported in the two 
intervention groups, indicative of dietary compensation (i.e eating more) after 12:00 
in those that had fasted during the morning. Physical activity thermogenesis was lower 
in those fasting prior to 12:00 but was not different over the course of the day as a 
whole. Resting metabolic rate was stable in response to both interventions and blood 
lipids and CRP responses to the intervention were not different between the two 
groups. However, insulinaemic response to an OGTT displayed divergent responses 
to the interventions with a decrease in those consuming breakfast relative to an 
increase in those extending their fast. The current study establishes that in free-living 
obese adults, both breakfast and fasting result in similar overall energy intake and 
expenditure, with no clear negative impact of daily morning fasting. 
 Energy intake in those who do not consume breakfast has been reported in 
cross sectional studies to be both similar to breakfast consumers (Song et al., 2005; 
Wyatt et al., 2002) and lower than those that consume breakfast (Cho et al., 2003; 
Nicklas et al., 1998). Experimental evidence in individuals omitting breakfast and not 
prescribed weight loss has also produced conflicting results, with greater (Farshchi et 
al., 2005b), similar (Halsey et al., 2012) and lower energy intake (Reeves et al., 2014) 
in those missing breakfast daily. In our previous study described in Chapter 4, lean 
individuals undertook the same experimental manipulation as this study. It was found 
that individuals assigned to the fasting condition had lower energy intake than those 
consuming breakfast, with minimal dietary compensation throughout the rest of the 
day.  
When attempting to reconcile the present results with those in the extant 
literature, it is possible that differences in prescriptiveness of the breakfast intervention 
and weight status may account for some of the discrepancy in findings. Firstly, two of 
the studies above (Halsey/Reeves) allowed ad libitum intake of breakfast and foods 
throughout the rest of the day, whereas the work of Farshchi prescribed identical foods 
consumed at 08:00 in the breakfast condition or delayed until 11:00 in the no breakfast 
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condition and participants then followed scheduled meal patterns. In the present work, 
individuals in the breakfast group were required to reach a minimum intake of 700 
kcal by 11:00 in the breakfast condition. The impact of differing energy intake at 
breakfast during free-living is not well investigated, although work by Martin and 
colleagues (2000) has established that free-living total energy intake in young lean 
men was greater when consuming 700 kcal versus a 100 kcal breakfast. This is similar 
to our findings in lean individuals and may indicate a modifying effect of weight status 
upon energy intake during breakfast/morning fasting interventions as there was no 
difference in energy intake between the two experimental groups in these obese 
individuals. 
 Reeves and colleagues (2014) have found energy intake is lower with morning 
fasting when comparing a mixture of lean and overweight/obese individuals who both 
ate and skipped breakfast for a week. However, this was a pooled effect and the 
difference in obese individuals (~60 kcal) was much less pronounced than that in lean 
individuals (~265 kcal). This potentially indicates that, similar to the current work, 
obese individuals display greater compensation for omitted calories in the morning 
than lean counterparts. Reasons for greater reported dietary compensation in obese 
than lean individuals are not immediately apparent, although it should be taken into 
consideration that underreporting of energy intake is greater in obese individuals 
(Schoeller, 1995). Despite this, there is no reason to suspect that underreporting should 
occur to a greater extent in either experimental group (De Castro, 1994b).  
In the previous chapter we established that at an ad libitum lunch following 
morning fasting there was no difference in energy intake relative to a breakfast 
consumption condition. Therefore, it appears that while appetite and lunchtime energy 
intake is unaffected within a controlled laboratory environment in obese individuals 
following morning fasting, the response in a free-living setting is markedly different. 
This finding is in contrast with the observed consistency of effects in lean individuals 
in the two settings investigated (i.e some evidence of dietary compensation but 
relatively minimal to the “missed” energy intake through breakfast in both the 
laboratory and free-living setting). This suggests that external cues may have a more 
potent effect on obese individuals (Schachter, 1968; Mela, 2001) and that dietary 
compensation is cumulative throughout the day and not limited to single feeding 
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occasions. Future analysis of the current data set for the frequency/nature of feeding 
occasions and distribution of energy intake throughout the day will provide further 
insight into the dietary compensation stimulated by morning fasting. 
 Total physical activity thermogenesis was not different between those 
consuming breakfast and those extending their fast. This is in contrast to our previous 
findings in lean individuals presented in Chapter 4 where an overall difference 
between groups for daily physical activity energy expenditure was apparent. This 
finding is consistent with the lack of difference in energy intake in obese individuals. 
Unlike the lean group where substantive differences in energy intake and physical 
activity energy expenditure (both lower in those that fasted) occurred, the impact of 
the daily fasting intervention appears less marked on components of energy balance 
in obese individuals. However, some similarity between the lean and obese 
participants is evident as the fasting obese participants displayed lower physical 
activity energy expenditure prior to 12:00. This finding reinforces that physical 
activity energy expenditure is specifically most affected during the period in which 
energy intake is restricted.  
While it might be suggested that this could be an artefact of elevated heart rate 
due to feeding and not representative of actual physical activity, it should be 
considered that in response to feeding of 480 kcal mixed food, heart rate elevations of 
~5 bpm have been reported in lean and obese women (Matsumoto et al., 2001). Within 
the context of our choice of measurement device (i.e combined heart 
rate/accelerometry), in the absence of movement, the weighting of energy expenditure 
would be 90 % from accelerometry counts and 10 % from heart rate unless heart rate 
is substantially above rest (far beyond the magnitude induced with feeding as 
described above, in which case the split is 50:50 between accelerometry and HR). 
Therefore any potential impact of elevated heart rate solely due to feeding would be 
minimised. Additionally, in the groups observed, reported energy intake was 
substantially greater (~550 kcal) after 12:00 in the fasting group but the energy 
expenditure measured during this period was less than the breakfast group, indicating 
that energy expenditure measured using this device is not predicated on increased heart 
rate from feeding.  
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The specific reasons for lesser physical activity expenditure during the 
morning when fasting are not immediately apparent, but may be related to perceptions 
of lethargy/expectations relating to physical activity readiness with fasting. In future 
it would be instructive to utilise subjective markers of energy throughout the day (e.g 
the subjective vitality scale (Ryan and Frederick, 1997)) to establish if individuals feel 
differing levels of energy throughout the day with breakfast and fasting regimens. 
 Blood lipids were not differently affected by either intervention in this cohort, 
in opposition to the previous findings of Farshchi et al (2005) who report increased 
LDL and total cholesterol concentrations after a 2 week breakfast omission 
intervention in obese women. The previous authors had suggested that this may be due 
to reduced stimulation of hydroxyl methyl glutaryl-Co-A reductase by insulin as they 
also reported lower insulinaemic response to a mixed meal challenge following 
breakfast consumption.  
In the present study we have found that similar to the aforementioned work, 
despite composite measures of insulin sensitivity (i.e HOMA-IR, Matsuda C-ISI) 
being unchanged there was an interaction for insulin iAUC in response to the OGTT. 
Although this potentially indicates reduced insulin sensitivity in those that fasted, 
neither group displayed significantly different insulin iAUC from pre- to post-
intervention (both p > 0.1). Whilst there was no difference between groups at baseline, 
there were particularly high values for iAUC in the breakfast group at baseline such 
that this interaction may partly be influenced by some regression to the mean in this 
group. Additionally, there was a tendency for the pre-intervention iAUC in the 
breakfast group to be non-normally distributed (p = 0.06), although this should be 
mitigated as ANOVA are generally robust to such non-normality (Maxwell and 
Delaney, 1990). It is therefore prudent to consider these findings with some caution as 
various other measures of insulin sensitivity did not demonstrate similar 
responsiveness to the interventions. Future work examining the effects of meal 
ingestion upon glycaemia and insulinaemia following similar interventions may 
provide confirmatory evidence of these findings.    
Randomisation led to two groups that were mostly similar for anthropometric 
and metabolic measures prior to the intervention. However, it should be acknowledged 
that whilst the body mass of the groups was not significantly different, the breakfast 
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group was heavier but with twice the standard deviation for this measure than the 
fasting group. This was particularly attributable to one extreme outlier for body mass 
in the breakfast group (167 kg, 2.6 SD above the mean for the group). As this 
individual did not fulfil any of our stated exclusion criteria at enrolment, we included 
him in the study and in the analysis. For the majority of pre- and post- measures this 
individual will act as their own control, so any impact on findings will be accounted 
for.  
However, some salient points should be addressed with regards to their impact 
upon outcomes measured solely during the intervention and compared between groups 
(energy intake, physical activity energy expenditure). Importantly, considering the 
potential for the unusually high body mass of this individual in the breakfast group to 
affect their energy balance, it should be noted that this individual did not contribute to 
the physical activity energy expenditure (due to low wear time/lack of heart rate data) 
in the breakfast group. Therefore, the higher activity levels observed in the morning 
in the breakfast group are not skewed in the positive direction by this individual with 
exceptional body mass. Conversely, overall intake was not greater in the breakfast 
group despite this individual having an intake proportionate to his mass (2.8 SD above 
the mean for the breakfast group). As a result, the absence of a difference between 
groups would be even clearer with his exclusion.  
 
The only variable that would be changed with exclusion of this individual is 
energy intake after 12:00, which would be 716 kcal less (p = 0.01) than the fasting 
group with removal of this individual. This is compared with an intake that is 550 kcal 
(p = 0.08) less than the fasting group with this individual included. Whilst the 
statistical implications would therefore be different for this one variable, the overall 
conclusion would remain unchanged; that morning fasting and breakfast consumption 
results in no difference in overall daily energy intake due to some energy 
compensation from 12:00 onwards. The relative presence or absence of this individual 
therefore does not alter the overall interpretation of this study for any variable. Despite 
this, considering the extreme variability possible in obese populations, future work 
should either employ an upper limit for adiposity, or potentially employ minimisation 
to facilitate matching of experimental groups on baseline characteristics (Altman and 
Bland, 2005).          
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Body mass change was not a key outcome in this study due to the intervention 
duration of 6 weeks not necessarily being long enough for substantial changes in body 
mass without a prescribed energy deficit. However, in the current investigation whilst 
there was no interaction for body mass changes, some relevant conclusions can still 
be drawn. Considering the prevalent public health message that breakfast consumption 
facilitates weight management (Brown et al., 2013) it is contradictory that in this 
investigation 10 of the 11 individuals in the breakfast group gained weight (compared 
with 6 of 12 in the fasting group) as a result of the intervention (1.0 kg, 95% CI, 0.2, 
1.7). In a normal free-living setting without a specific aim of weight loss, breakfast 
consumption does not appear to confer any benefits for weight management in obese 
individuals. This may be a product of the nature of the intervention as we specified an 
energy intake target for breakfast consumers but without prescribing specific food 
types or any other dietary restrictions. In a large 16 week intervention in individuals 
interested in weight loss that utilised healthy dietary advice combined with 
instructions for daily breakfast consumption or fasting until 11:00, there was no 
difference in weight loss between the breakfast consumers or skippers (Dhurandhar et 
al., 2014a). Therefore, in relatively natural settings without high levels of dietary 
prescription, it appears that there is no additional benefit of breakfast consumption for 
weight management whether attempting to lose weight or without a specific weight 
loss objective. This study indicates that caution should be exercised in 
recommendations for breakfast consumption in obese individuals for the specific 
purpose of weight loss. However, it cannot yet be established if specific breakfast 
compositions may be necessary to facilitate better weight management. 
 In summary, we conclude that in obese individuals neither overall energy 
intake nor physical activity is different in those fasting during the morning or 
consuming a daily breakfast for 6 weeks, although differences in distribution 
throughout the day were apparent with lower physical activity during the morning in 
those fasting. Resting metabolic rate and blood lipids were not differently affected by 
either intervention but there was some indication of differing effects on insulin 
sensitivity due to the interventions. Daily morning fasting does not cause weight gain 
relative to self-selected breakfast in obese individuals. 
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Chapter 8: Morning fasting for 6 weeks does not 
cause increased appetite, acute energy intake or 
negative metabolic consequences to feeding relative 





 We have previously investigated the effect of chronic assignment (6 weeks) to 
a breakfast consumption/morning fasting regime upon acute (i.e within a day)   
appetite regulation in lean individuals in Chapter 5. As discussed in Chapter 6 there 
are several differences in hormonal regulation of appetite and metabolic responses to 
feeding in obese individuals in comparison with lean individuals. These include 
delayed satiation (Delgado-Aros et al., 2004), reduced concentrations of satiety 
hormones (Batterham et al., 2003) and limited suppression of ghrelin with feeding 
(English et al., 2002; le Roux et al., 2005). Therefore, although we found no adaptation 
of acute appetite regulatory responses in lean individuals following different morning 
feeding interventions, it is relevant to investigate if the relative stability of acute 
appetite regulation is present in obese individuals undertaking the same interventions. 
    The present study aims to investigate whether chronic (6-week) exposure to 
either a morning fasting or daily breakfast regimen can cause adaptation of acute 
appetite regulation and metabolic responses throughout the day and energy intake at 
an ad libitum lunch in obese individuals. Based upon previous interventions and the 
results from our work in lean individuals, we hypothesise that there will be no 
adaptation of acute appetite regulation and metabolic responses to feeding by either 
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 Twenty two, obese men (n = 8) and women (n = 14) aged 25-58 y took part in 
this study. Participants were recruited via local advertisement from South West 
England and were initially assessed for eligibility based upon a body mass index of ≥ 
30 kg·m-2 and then later classified as lean based upon DEXA-derived fat mass indices 
of ≥9 kg·m-2 (men) and ≥13 kg·m-2 (women) (Kelly et al., 2009). The study was part 
of a larger randomised controlled trial entitled the Bath Breakfast Project. In 
accordance with eligibility criteria set out in Chapter 2, participants reported adhering 
to a standard sleep-wake cycle (e.g no shift workers) and not anticipating any change 
in lifestyle during the study period. Participants were free of metabolic disorders, with 
pre-menopausal female participants either menstruating regularly, or following their 
chosen contraceptive method (i.e pill, implant) for >6 months. In this study 
participants were required to report being weight stable (2 % body mass fluctuation 
within past 6 months).  Within the study cohort there was a mix of regular breakfast 
consumers (classified as >50 kcal intake within 2 hours of waking on ≥4 days of the 
week) and non-consumers. Characteristics of participants are presented in Table 8.1. 
Written informed consent was obtained from all participants, with the Ethical 
Approval for the study obtained from the NHS Bristol Research Ethics Committee. 
The study is registered with Current Controlled Trials [ISRCTN31521726]. 
 
Table 8.1: Participant characteristics 
*Fat mass index calculated as DEXA derived total fat mass divided by height squared. 
Values represent mean with (SD)  
Characteristic Breakfast Group Fasting Group 
n 11 11 
Age (y) 43 (10) 44 (10) 
Body Mass (kg) 104.0 (24.0) 92.4 (11.2) 
Body Mass Index (kg/m2) 35.0 (6.1) 32.0 (2.3) 
Fat Mass Index (kg/m2)* All 14.8 (5.0) 12.0 (2.3) 
Female 16.9 (4.5) 13.2 (1.8) 
Male 9.9 (1.4) 9.8 (0.8) 
Habitual Breakfast Consumers (n) 7 6 
Female (n) 7 7 
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8.2.2 Study Methodology 
 
 The study design, experimental protocols and approach to statistical analysis 
for this investigation were identical to those outlined in Chapter 5 of this thesis. The 
only difference in this study was the quantity of breakfast provided. The breakfast was 
again provided in quantities that contained 0.06 g carbohydrate per kcal of each 
individual participant’s measured daily resting metabolic rate and due to the greater 
body mass (and therefore correspondingly greater RMR) of the obese participants in 
this study, this resulted in an energy intake of 525 ± 106 kcal and 537 ± 80 kcal in the 
breakfast and fasting groups, respectively. 
  
  




8.3.1 Mass and RMR 
 
 Body mass was relatively stable between the two trials, with both groups post-
intervention body mass on their second breakfast feeding trial within 0.9 kg of their 
pre-intervention body mass. RMR was 1613 ± 257 kcal·d-1 in the fasting group and 
1679 ± 335 kcal·d-1 in the breakfast group prior to the intervention. In response to the 
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Figure 8.3: Energy intake during the feeding trial before and after 6-weeks of daily 
breakfast or fasting. Breakfast intake was prescribed, with the breakfast provided for 
both groups based on RMR similar (Breakfast Group, 525 ± 106 kcal vs Fasting 
Group, 537 ± 80 kcal; p = 0.78) and did not change from pre to post-intervention. The 
error bars on the grey portion of the stack represent the SEM of the energy intake at 
lunch, and the error bars on the white portion the SEM of the energy intake of the 
whole day. Equivalent figure for lean individuals on page 157 
 
 
8.3.2 Energy Intake 
 
 Energy intake at lunch was not different between groups or trials (both p > 
0.1), however, there was a tendency for a group x trial interaction in lunch intake (F = 
3.92, p = 0.06). In the breakfast intervention group, lunch intake was reduced by 113 
kcal (893 ± 313 vs 779 ± 323; p = 0.05) after the intervention. Lunch intake was stable 
(735 ± 330 kcal vs 750 ± 284 kcal) before and after the intervention in the fasting 
group. Overall intake in those consuming breakfast for 6 weeks was 1418 ± 350 kcal 
prior to the intervention and 1305 ± 366 kcal following the intervention. In those who 
underwent the fasting intervention, intake was 1272 ± 331 kcal pre-intervention and 























Breakfast Group Fasting Group
Pre Post Pre Post
Chapter 8  Obese Phase 3: Acute Interaction Study 
227 
 
Figure 8.4: Glucose responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups. B= Prescribed Breakfast, L = Ad libitum lunch. 
Equivalent figure for lean individuals on page 158 
 
 
8.3.3 Glucose  
 
 For plasma glucose concentrations during the trials there was a main effect of 
time (F = 20.2, p < 0.01; Figure 8.4). There were no other main effects or interactions 
(all p > 0.2). Individual peak glucose concentrations were not different between groups 
or trials (Breakfast Group, 7.93 ± 0.72 mmol·l-1 vs 7.87 ± 1.29 mmol·l-1; Fasting 
Group, 7.81 ± 0.72 mmol·l-1 vs 7.63 ± 1.02 mmol·l-1) and there was no interaction 
effect (all p > 0.6). Similarly there were no main effects or interactions for individual 
nadir glucose (all p > 0.6), which remained stable in response to the intervention 
(Breakfast Group, 4.90 ± 1.10 mmol·l-1 vs 4.96 ± 0.89 mmol·l-1; Fasting Group, 4.82 
± 0.57 mmol·l-1 vs 4.77 ± 0.69 mmol·l-1). Fasting glucose was not different between 
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Figure 8.5: Insulin responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups. B= Prescribed Breakfast, L = Ad libitum lunch. 
Equivalent figure for lean individuals on page 159 
 
8.3.4 Insulin  
 
Serum insulin concentrations varied over time (F = 19.2, p < 0.01; Figure 8.5) 
but there were no other main effects or any other interactions (all p > 0.1). Individual 
peak insulin concentrations were not different between groups or trials (Breakfast 
Group, 813 ± 436 pmol·l-1 vs 930 ± 470 pmol·l-1; Fasting Group, 730 ± 393 pmol·l-1 
vs 803 ± 426 pmol·l-1) and there was no interaction effect (all p > 0.1). Fasting insulin 
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Figure 8.6: NEFA responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups. B= Prescribed Breakfast, L = Ad libitum lunch. 





A main effect of time was apparent for plasma NEFA concentrations (F = 52.0, 
p < 0.01; Figure 8.6) but no other main effects or interactions were evident (p > 0.2) 
apart from a tendency for a trial x group interaction (F = 3.2, p = 0.09). Peak NEFA 
concentrations amongst individuals were not different between groups or trials 
(Breakfast Group, 0.55 ± 0.27 mmol·l-1 vs 0.43 ± 0.18 mmol·l-1; Fasting Group, 0.47 
± 0.21 mmol·l-1 vs 0.49 ± 0.20 mmol·l-1) with no evidence of an interaction effect (all 
p > 0.1). Fasting NEFA concentrations were not different between groups or trials and 
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Figure 8.7: Acylated ghrelin responses to feeding before and after a 6 week 
intervention in the breakfast and fasting groups. B= Prescribed Breakfast, L = Ad 
Libitum lunch. Equivalent figure for lean individuals on page 161 
 
Figure 8.8: Total ghrelin responses to feeding before and after a 6 week intervention 
in the breakfast and fasting groups. B= Prescribed Breakfast, L = Ad Libitum lunch. 
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8.3.6 Acylated and Total Ghrelin 
 
Plasma acylated ghrelin concentrations varied over time (F = 27.6, p < 0.01; 
Figure 8.7) but were not different between trials or groups (both p > 0.3). There were 
no interactions (all p > 0.2) apart from a tendency for a trial x time interaction (F = 
3.0, p = 0.07). Individual peak acylated ghrelin concentrations were not significantly 
different between groups or trials (Breakfast Group, 80 ± 56 pg·ml-1 vs 68 ± 34 pg·ml-
1; Fasting Group, 65 ± 23 pg·ml-1 vs 65 ± 25 pg·ml-1) with no interaction effect (all p 
> 0.3). Nadir concentrations were similar, with no difference between groups or trials 
(Breakfast Group, 30 ± 19 pg·ml-1 vs 35 ± 25 pg·ml-1; Fasting Group, 28 ± 19 pg·ml-1 
vs 33 ± 29 pg·ml-1) with no evidence of an interaction effect (all p > 0.1). Fasting 
acylated ghrelin concentrations were not different between groups or trials and there 
was no interaction effect (all p > 0.3).   
Plasma total ghrelin concentrations displayed a main effect of time (F = 17.7, 
p < 0.01; Figure 8.8) but there were no other main effects or interactions (all p > 0.2). 
Individual peaks of total ghrelin concentrations were not significantly different 
between groups or trials (Breakfast Group, 407 ± 227 pg·ml-1 vs 355 ± 187 pg·ml-1; 
Fasting Group, 413 ± 134 pg·ml-1 vs 416 ± 110 pg·ml-1) with no interaction effect (all 
p > 0.2). Nadir concentrations were similar, with no difference between groups or trials 
(Breakfast Group, 213 ± 136 pg·ml-1 vs 201 ± 119 pg·ml-1; Fasting Group, 205 ± 97 
pg·ml-1 vs 226 ± 129 pg·ml-1) with no evidence of an interaction effect (all p > 0.2). 
Fasting concentrations of total ghrelin were similar between groups and trials and there 
was no evidence of an interaction effect (all p > 0.2).  
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Figure 8.9: PYY responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch. 




Plasma PYY concentrations were not different over time (F = 1.89, p = 0.17; 
Figure 8.9) or between trials or groups (both p > 0.5). No interactions were apparent 
(all p > 0.1) apart from a tendency for a trial x group interaction (F = 4.29, p = 0.06). 
Individual peaks of PYY concentrations were not significantly different between 
groups or trials (Breakfast Group, 75 ± 28 pg·ml-1 vs 65 ± 17 pg·ml-1; Fasting Group, 
72 ± 33 pg·ml-1 vs 78 ± 38 pg·ml-1) with no interaction effect (all p > 0.1). Nadir 
concentrations were similar, with no difference between groups or trials (Breakfast 
Group, 34 ± 9 pg·ml-1 vs 34 ± 10 pg·ml-1; Fasting Group, 36 ± 16 pg·ml-1 vs 40 ± 15 
pg·ml-1) with no evidence of an interaction effect (all p > 0.2). Fasting PYY was not 
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Figure 8.10: Leptin responses to feeding before and after a 6 week intervention in the 
breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad Libitum lunch. 
Equivalent figure for lean individuals on page 165 
8.3.8 Leptin 
 
Serum leptin concentrations are displayed in Figure 8.10. There was a main 
effect of time (F = 17.39, p < 0.01) but no other main effects or interactions (all p > 
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Figure 8.11: Adiponectin responses to feeding before and after a 6 week intervention 
in the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch. 
Equivalent figure for lean individuals on page 166  
8.3.9 Adiponectin 
 
Serum adiponectin concentrations varied over time (F = 12.91, p < 0.01; Figure 
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Figure 8.12: Desire to eat during feeding trials before and after a 6 week intervention 
in the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch 
Figure 8.13: Hunger during feeding trials before and after a 6 week intervention in 
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Figure 8.14: Fullness during feeding trials before and after a 6 week intervention in 
the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad libitum lunch  
Figure 8.15: Prospective consumption during feeding trials before and after a 6 week 
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Figure 8.16: Appetite Score during feeding trials before and after a 6 week 
intervention in the breakfast and fasting groups.  B= Prescribed Breakfast, L=Ad 
libitum lunch. Equivalent figures for appetite ratings for lean individuals on pages 
167-169  
 
8.3.10 Appetite Sensations 
 
 Subjective appetite sensations are displayed in Figures 8.12-16. Desire to eat 
varied over time (F = 43.5, p < 0.01; Figure 8.12) but there were no other main effects 
or interactions apparent (all p > 0.2). Fasting desire to eat was not different between 
groups or trials and there was no trial x group interaction (all p > 0.7). 
 Hunger varied over the course of the day (F = 42.5, p < 0.01; Figure 8.13) but 
there was no difference between trials or groups (both p > 0.3). A trial x group 
interaction was apparent (F = 4.39, p = 0.05), with greater hunger in the breakfast 
consumption group and lesser hunger in the fasting group across the day following the 
intervention. There were no other interactions for hunger sensations (all p > 0.2). 
Fasting hunger was not different between groups or trials and there was no trial x 
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 Fullness varied over the course of the day (F = 77.7, p < 0.01; Figure 8.14) but 
was not different between trials or groups and no interactions were evident (all p > 
0.2). Fasting fullness was not different between groups or trials and there was no trial 
x group interaction (all p > 0.1). 
 There was a main effect of time for prospective consumption (F = 49.0, p < 
0.01; Figure 8.15) but no other main effects or any interactions (all p > 0.1). Fasting 
prospective consumption was not different between groups or trials and there was no 
trial x group interaction (all p > 0.3).   
 The combined appetite score varied over time (F = 57.4, p < 0.01, Figure 8.16). 
There were no other main effects of trial, group or any other interactions (all p > 0.l). 
The fasting appetite score was not different between groups or trials and there was no 
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Figure 8.17: Diet induced thermogenesis before and after 6-weeks of daily breakfast 
or fasting. Error bars reflect SEM. Asymmetric error bars are plotted on the morning 
section of each stack. The negative portion of these error bars reflects the SEM of the 
morning period and the positive portion the SEM of the whole day. Equivalent figure 
for lean individuals on page 171 
 
8.3.11 Diet Induced Thermogenesis 
 
 Diet induced thermogenesis in the morning did not differ between trials or 
groups with no interaction effect (all p > 0.2). For the afternoon period there was no 
difference in DIT between trials, groups or a trial x group interaction (all p > 0.1). 
When these periods were combined to establish DIT for the whole day, there was no 
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 The present study aimed to investigate the impact of a 6 week intervention 
manipulating morning feeding patterns upon acute energy intake, appetite regulation 
and metabolic responses to feeding in a laboratory based protocol in obese individuals. 
Following a standardised breakfast there was a tendency for those who had undertaken 
a daily breakfast regimen to consume less at an ad libitum lunch following their 
intervention. There was no indication of altered postprandial insulin sensitivity in 
either group and the majority of appetite hormone responses remained stable following 
the intervention, apart from a tendency for divergent PYY responses between groups. 
Diet induced thermogenesis was not affected by either intervention. Subjective 
appetite responses indicated greater perceptions of hunger following the breakfast 
consumption intervention with reductions following daily fasting; however, it is 
unclear whether this response is a direct product of reduced energy intake at the ad 
libitum lunch in the breakfast group or meaningful adaptation to chronic exposure to 
the intervention. This work does not provide any evidence for negative metabolic 
consequences to feeding or increased hunger or acute energy intake in individuals that 
followed a daily morning fasting regimen for 6 weeks.    
 In contrast with our lean participants there was some evidence of reduced 
energy intake during the ad libitum lunch following adherence to the daily breakfast 
consumption regimen. The reduction observed is somewhat surprising considering 
that there was greater reported subjective hunger prior to lunch following the daily 
breakfast regimen. Therefore, either the food provided at lunch became more satiating 
following the intervention (explaining the reduced intake) or this provides more 
evidence of a potential dissociation between subjective measures of appetite and 
objective measures of intake in obese individuals (Flint et al., 2007). In a free-living 
setting described in Chapter 7, there was reduced reported dietary intake between 
weeks 1 and 6 to both the breakfast consumption and fasting interventions in the same 
cohort as the present study. This potentially indicates that either the food diaries may 
have lacked sensitivity to detect differences between the conditions, or that whilst 
energy intake at lunch may have been different (not an analysis that has been 
conducted) that any differences apparent may have been compensated for, either with 
differing food choices/intakes at other meals or increased snacking.  
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 Similar to our findings in lean individuals in Chapter 3, appetite hormone 
responses throughout the day were not affected by either the daily breakfast or 
morning fasting regimen. This appears to highlight that despite several investigations 
identifying different concentrations/patterns of response of appetite hormones in obese 
individuals (Batterham et al., 2003; Carroll et al., 2007; English et al., 2002; le Roux 
et al., 2006; le Roux et al., 2005; Shiiya et al., 2002; Tschop et al., 2001b), these 
regulatory hormones do not exhibit any adaptation to differing daily morning feeding 
regimens. This reinforces that feeding pattern seems to have little impact upon appetite 
hormone responses to feeding in the context of relative weight stability. 
 In those individuals who undertook the daily breakfast intervention, hunger 
was greater at the end of the testing day following the intervention. However, as 
discussed, participants also consumed less at the ad libitum lunch. Therefore, it is 
unclear whether this is a product of the reduced intake or an effect of the breakfast 
intervention in exacerbating the return of hunger after eating (of which there is some 
tentative evidence, as hunger was also increased 3 hours after the fixed breakfast meal 
in the breakfast group after the intervention). Whilst our current design provides 
valuable information with regards to self-selected intake, to establish the specific 
effects on subjective appetite of feeding interventions, fixed meals would be 
appropriate to remove this potential covariate and allow direct comparisons of the 
satiating effect of foods before and after long term interventions.     
 A previous investigation in lean women has resulted in reduced insulin 
sensitivity in response to a 2 week intervention where the first feeding of the day was 
delayed until 11am (Farshchi et al., 2005b). Our current investigation does not 
replicate these findings, as insulin concentrations were unaffected by either 
intervention. However, it has previously been contested that changes in fasting insulin 
sensitivity to feeding frequency interventions may be less apparent in obese 
individuals as they are likely to already have some degree of insulin resistance 
(Farshchi et al., 2005a).  
This explanation for a lack of effect in those that undertook the fasting 
intervention is unlikely in this instance, as changes have not been observed in lean 
individuals undertaking a similar intervention as described in Chapter 5. One 
methodological difference between the studies is the use of arterialised blood sampling 
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(Gallen and Macdonald, 1990) in the work of Farshchi and colleagues. While this 
would be expected to yield greater concentrations of glucose than venous sampling 
(McGuire et al., 1976; Nauck et al., 1992; Kurpad et al., 1994), there is no evidence 
to suggest that the pattern of response (or the response to an intervention in a repeated 
measures design such as the current work) should be different between the two 
techniques. Therefore it is unlikely that the discrepant results between these studies 
are attributable to differences in blood sampling methodology.                
The same research group have also reported reduced insulin sensitivity 
(Farshchi et al., 2004b) and dietary thermogenesis in both lean (Farshchi et al., 2004a) 
and obese (Farshchi et al., 2005a) women following irregular meal patterns. In the 
latter studies, the authors have attributed the reduced DIT as linked to the reduced 
insulin sensitivity induced by their interventions, due to the established links between 
these two phenomena (Ravussin et al., 1985a; Ravussin et al., 1983; Ravussin et al., 
1985b). It is therefore as would be expected that in the current investigation there was 
no change in DIT following either the breakfast or fasting regimen, as insulin 
concentrations in response to the meals fed were unaffected in both groups.  
This study has found that no adaptation of appetite regulatory hormone or 
metabolic responses to a fixed breakfast or ad libitum lunch, following 6 weeks of 
daily breakfast or morning fasting. There was a trend towards reduced lunch energy 
intake but greater hunger following the breakfast regimen. The morning fasting 
intervention did not result in reduced postprandial insulin sensitivity or diet induced 
thermogenesis. In conclusion, this work does not provide any evidence that a morning 
fasting intervention negatively affects metabolic responses to feeding but adherence 
to daily breakfast consumption may, after prolonged exposure, facilitate reduced 
energy intake at lunch despite increased hunger in obese adults.    
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 The overall aim of this thesis was to examine the effect of extended morning 
fasting upon energy balance and human health. In order to do this, a mixture of 
laboratory-based and free-living intervention studies were conducted in both lean and 
obese humans. 
 Specifically, Chapter 3 investigated the acute appetite, metabolic and 
hormonal responses to extended morning fasting and breakfast consumption using a 
laboratory based feeding protocol in lean participants. Chapter 4 then examined the 
impact of a 6-week free-living morning fasting or daily breakfast intervention upon 
all components of energy balance and selected metabolic outcomes and health markers 
in the same participants. Chapter 5 then established the effects of the two interventions 
described in Chapter 4 upon the acute responses to breakfast consumption first 
described in Chapter 3. Chapters 6,7 and 8 then repeated this progression of studies 
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 Overall energy intake was reduced when extending the morning fast, despite 
greater consumption of an ad libitum lunch. 
 The suppression of ghrelin after lunch consumption was blunted following 
breakfast consumption, but PYY and leptin concentrations were greater. 
 Insulin concentrations were substantially greater in response to lunch intake 
following morning fasting. 




 Daily total physical activity energy expenditure was lesser in those asked to 
extend their overnight fast, an effect most consistent in the morning. 
 Energy intake in those fasting during the morning was substantially lower 
than those eating breakfast, indicating little compensation for prescribed 
intake throughout the rest of the day in those consuming breakfast. 




 Energy intake at an ad libitum lunch meal was not significantly affected by 
adherence to either an extended morning fasting or daily breakfast regime. 
 Metabolic and appetite hormone responses throughout the day were generally 
unaffected by either chronic intervention. 











 Overall energy intake was reduced when extending the morning fast, with no 
difference in intake at an ad libitum lunch. 
 The suppression of ghrelin after lunch consumption was blunted following 
breakfast consumption, but PYY and leptin concentrations were greater. 
 Insulin concentrations were substantially greater in response to lunch intake 
following morning fasting. 
 There were no differences in subjective appetite ratings during the afternoon. 
 
Chapter 7 
 Daily total physical activity energy expenditure was similar in both 
intervention groups, although physical activity energy expenditure was 
greater prior to 12:00 in those consuming breakfast. 
 Energy intake in those fasting during the morning was similar to those eating 
breakfast, indicating additional intake throughout the rest of the day. 




 Energy intake at an ad libitum lunch meal was reduced by adherence to a 
daily breakfast regime. 
 Metabolic and appetite hormone responses throughout the day were generally 
unaffected by either chronic intervention. 
 Subjective appetite responses were mainly unaffected but there was some 
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9.3  Effect of Morning Fasting upon Energy Balance       
 Ultimately, the components of energy balance discussed throughout this thesis 
all contribute to body mass change/stability over the long term. Below is the effect of 
the 6 week morning fasting and daily breakfast consumption interventions on body 
mass change in both lean and obese individuals (Figure 9.1). As can be seen, the lean 
and obese cohorts displayed differing responses to the feeding interventions, with 
weight loss in both intervention groups in lean individuals and the opposite in obese. 
 
Figure 9.1: Body mass change in both groups during the breakfast and morning 
fasting interventions. p values on the figure represent the pre-post comparisons of body 
mass change within each group. 
  
While the individual interaction effects for weight were not significant in either 
lean or obese groups, simple pre-post contrasts within experimental groups identified 
that lean individuals omitting breakfast lost weight and obese individuals consuming 
breakfast gained weight. It therefore appears that lean individuals do not fully 
compensate for “missed” intake and obese individuals do not compensate for “added” 
intake (i.e the requirement to consume 700 kcal daily by 11:00 in the breakfast 
consumption group). Whether these changes in weight are considered of a relevant 
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regardless of weight status, those asked to extend their morning fast either lost more 
weight (lean) or gained less weight (obese) than counterparts asked to consume a self-
selected breakfast daily during the interventions. This is contrary to the strongly 
engrained popular health message that breakfast consumption is facilitative in 
managing weight (Brown et al., 2013) and also partially agrees with recent evidence 
suggesting no effect of breakfast recommendations upon weight change (Dhurandhar 
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9.4 Acute Appetite Regulatory Responses  
 
 In this thesis, short-term regulation of appetite and metabolic responses to 
feeding has been examined in both lean and obese individuals. The most striking 
finding from Chapters 3 and 6 is the similarity of the acute responses to morning 
fasting and breakfast in lean and obese individuals. The pattern of appetite regulatory 
hormones is consistent between the two populations, with the only difference for the 
majority of hormones being the concentrations of the hormones present. For PYY, this 
finding is relatively consistent with previous investigations that have reported lower 
concentrations of the hormone in obese individuals (Batterham et al., 2003; le Roux 
et al., 2006). However, despite acylated ghrelin concentrations being reduced in our 
obese cohort as would be expected (Tschop et al., 2001b; Shiiya et al., 2002), the 
patterns of response to feeding were in contrast with some evidence to suggest 
differential responses for ghrelin between lean and obese individuals (le Roux et al., 
2005; English et al., 2002). The consistency of these responses in lean and obese 
individuals seems to suggest that dysregulation of appetite hormone secretion to acute 
feeding/fasting may not be an important factor in the pathogenesis of obesity. 
Considering the complexity of appetite regulation, it appears that altered homeostatic 
regulation of energy intake may not be a probable explanation for development of 
obesity, and other factors (e.g hedonic regulation, societal and environmental 
influences) might be more prescient.  
 The work in Chapters 5 and 8 also provide minimal evidence that acute 
responses to feeding can be altered by either adherence to a morning fasting or daily 
breakfast intervention in either lean or obese individuals. This work combined with 
other similar findings manipulating diet/feeding frequency in the literature (Cameron 
et al., 2010; Carlson et al., 2007; Ellis et al., 2012) seem to suggest that subtle 
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9.5  Energy Intake in Laboratory and Free-Living Settings 
 As has been discussed throughout the thesis, appetite regulation is highly 
complex. Whilst the laboratory protocols employed in Chapters 3,5,6 and 8 allow us 
to examine in detail the effect of altered food intake patterns on some mechanisms of 
appetite regulation; by design, these protocols limit the potential influence of other 
relevant factors in “real world” regulation of energy intake. This is where the free-
living protocols employed in Chapters 4 and 7 can provide insight into how basic 
physiological mechanisms explored in the laboratory may impact upon energy intake 
when other contributory factors are not controlled. In this regard, it is interesting to 
compare the relative agreement (or lack thereof) between the acute laboratory and 
free-living responses in lean and obese individuals.  
 In lean participants, Chapters 3 and 4 showed relatively consistent energy 
intake responses in the laboratory and free-living. In both situations, there was 
evidence of some compensation for “missed” intake due to extended morning fasting,   
both in the laboratory fasting trials through increased lunch intake (Chapter 3) and in 
those individuals assigned the morning fasting intervention through a strong tendency 
(p = 0.06) for greater intake after 12:00 relative to the daily breakfast group (Chapter 
4). However, in both of these situations the additional intake in those that extended 
their fast was not sufficient to compensate for the intake through breakfast (i.e both in 
the laboratory and during free-living, total energy intake was greater when consuming 
breakfast). In contrast, obese individuals did not demonstrate significantly increased 
energy intake at an ad libitum lunch in the laboratory setting when asked to extend 
their morning fast (Chapter 6), but those that undertook the morning fasting 
intervention had sufficiently greater energy intake after 12:00, such that total daily 
energy intake was not different between the two intervention groups. 
 The discrepancy between the two groups suggests that energy intake in obese 
individuals may be more strongly influenced by environmental factors than lean 
individuals (Mela, 2006). The energy intake compensation that is evident in the obese 
cohort may be due to food choices and frequency, as opposed to energy intake 
increases at single homogenous meals as provided in the acute laboratory setting. 
Alternatively, it could be that free-living energy intake in obese individuals was 
underestimated in those that were consuming breakfast. This is a possibility that 
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cannot be ruled out, but that contention is also the case for each experimental group 
independent of their weight status (although underreporting of EI is greater in obese 
individuals) or experimental group allocation. Therefore, it seems unlikely that this 
issue should disproportionately affect one experimental group more than any others 
(i.e that obese individuals in the breakfast group should underreport energy intake to 
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9.6 Energy Expenditure during Free-Living Morning 
Fasting and Daily Breakfast Interventions 
 
In addition to establishing the acute responses to morning fasting and breakfast 
consumption, this thesis has examined the impact of free-living interventions in lean 
and obese individuals. Reported energy intake responses to the two interventions were 
different in lean and obese individuals. Similarities were evident in the relative 
stability of RMR to both interventions in both groups of participants, indicating that 
altering morning feeding frequency in the absence of substantial weight change has no 
impact upon resting metabolic rate. The other major contributor to energy expenditure 
is the daily physical activity expenditure measured during the intervention, which was 
found to be greater in those that consumed breakfast than those extending their fast in 
lean individuals, but was not different between intervention groups in obese 
individuals. However, in both lean and obese individuals, energy expenditure prior to 
12:00 was greater in those consuming breakfast.  
As discussed previously in Chapter 7, this effect is unlikely to simply be a 
product of the DIT due to breakfast consumption and therefore may reflect in both 
populations limited physical activity in those with restricted energy intake during that 
period. This is an area that warrants further investigation, as the relationship between 
temporary restriction of energy intake and physical activity has not received attention. 
Future investigations should also employ a baseline measure of physical activity to 
establish if the differences between those fasting during the morning are a result of 
increased physical activity in those that consume breakfast daily, or a reduction in 
physical activity during the morning in those fasting. The second possibility would 
appear more probable as the majority of individuals consume foods in the morning 





Chapter 9  General Discussion 
252 
9.7  Effect of Normal Breakfast Habits upon Outcomes 
 The present thesis was not designed to investigate the influence of participants’ 
habitual eating behaviours upon the outcomes examined. Due to the intensive nature 
of the studies undertaken, the work presented in this thesis used participant numbers 
sufficient to examine the outcomes measured in the intervention groups as a whole. 
However, while the randomisation scheme employed controlled for the impact of 
major imbalance in habitual breakfast consumers and skippers, the numbers of 
individuals did not allow a meaningful comparison of the effect of these pre-
randomisation habits upon response to the interventions. 
 The relevance of pre-randomisation breakfast consumption habits upon 
response to interventions was first introduced by Schlundt and colleagues in a seminal 
1992 publication that examined the effect of breakfast consumption/omission and a 
behavioural intervention upon weight loss, in individuals prescribed energy restricted 
diets. They reported that there was a tendency (p = 0.06) for those swapping their 
normal habits to lose more weight than those continuing their normal lifestyle. 
However, it has been subsequently suggested that participants’ normal breakfast habit 
has no impact upon weight change in a less prescriptive extended fasting intervention 
(Dhurandhar et al., 2014a).  
 As well as this lack of agreement within the literature, it is also pertinent to 
consider the actual relevance of pre-randomisation habits. There are a number of 
potential issues with inferring that habitual breakfast consumption can moderate 
responses to interventions manipulating morning feeding. Firstly, as introduced in 
Chapter 1, omission of breakfast is associated with a number of behaviours that are 
detrimental for health (e.g greater alcohol consumption, lower physical activity etc..). 
Therefore, as assessment of breakfast consumption habits are cross-sectional in nature 
it is likely that any moderating effect of breakfast consumption/omission would be 
partly contributed to by these other factors and not necessarily reflect a true effect of 
prior habitual breakfast consumption.                
Secondly, as also discussed in Chapter 1, the classification of habitual 
breakfast consumption or skipping is highly variable amongst different studies. This 
arises from several studies employing either self-report measures of breakfast habits 
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(e.g simply asking participants without any established criteria whether they consume 
breakfast or not) or asking individuals the frequency of their consumption. However, 
beyond these issues of methodological consistency there is a wider point that has to 
be acknowledged; that is, that definitions of breakfast “consumers” and “skippers” are 
essentially arbitrary. While they provide convenient ways of categorising individuals 
for studies it is highly unlikely that any differences in physiology between these groups 
would be so dichotomous. Future work should look to move beyond categorical 
definitions of these habits and develop “dose-response” relationships between habitual 
breakfast consumption size/frequency/type and any associated differences in 
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9.8  Assessment of Energy Balance 
 Amongst both the lean and obese participants studied, measured energy intake 
was less than energy expenditure in both lean and obese participants, such that the 
discrepancy did not correspond to the magnitude (in lean) or direction of weight 
change (in obese) in either group. It is therefore probable that there was some 
underreporting of energy intake. This is not an uncommon phenomenon in applied 
nutrition research (Livingstone and Black, 2003), and there have previously been 
methods suggested for the removal of energy intake records deemed implausible 
(Goldberg et al., 1991). However, in this investigation as these measures generally 
rely upon achievement of energy balance in participants, these measures were not 
employed, as the intervention employed meant that energy balance was not necessarily 
to be expected. Additionally, because of the laborious nature of recording of energy 
intake (and therefore to minimise the aforementioned underreporting), these diaries 
were only kept during the first and final week of the interventions participants 
undertook. Therefore, the food diaries employed may well have reflected the intake 
during the weeks of measurement, but energy intake may have changed in the weeks 
where participants were not being monitored.  
A possible solution to minimise the effect of dietary underreporting is to 
employ doubly labelled water for long term assessment of energy expenditure and 
obtain repeated measurements of weight to enable assessment of overall energy 
balance (Hall, 2010). Methods based around estimation of energy intake using these 
methods are referred to as the intake-balance method (Racette et al., 2012). These 
methods have been shown to be accurate in estimating energy intake during both 
weight gain (Gilmore et al., 2014) and weight loss (de Jonge et al., 2007). Despite the 
potential usefulness of this method for estimating total energy intake, this approach 
would not allow any assessment of macronutrient intake or feeding frequency. 
Therefore, ongoing assessments of dietary intake will have to balance the need for 
precision in total energy intake estimation versus the desire for additional information 
relating to the nature of energy intake. Future investigations might attempt to employ 
a combination of traditional food diaries and the intake-balance method to potentially 
scale total energy intake on an individual basis but still garner some insight into 
reported food intake patterns (with the associated limitations).               
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9.9  Future Directions 
 There has been limited use of fMRI to assess neural responses to breakfast 
skipping and differing breakfast types in adolescents (Leidy et al., 2013; Leidy et al., 
2011; Leidy and Racki, 2010). This work is also being extended to examine the 
specific neural responses to administration of various appetite regulating hormones 
(Batterham et al., 2006; De Silva et al., 2011; Goldstone et al., 2014; Malik et al., 
2008). Future investigations should attempt to investigate the neural responses to both 
acute breakfast consumption/fasting in adults but also examine the effect of long term 
extended fasting/breakfast interventions upon acute neural responses to feeding. This 
will extend the work completed in Chapters 5 and 8, to see if adherence to different 
morning feeding interventions causes adaptation of neural responses to exposure to 
food cues or consumption. 
 Two key problems arise when studying appetite and energy intake that must 
be reconciled to attempt to gain further insight into appetite regulation. As discussed 
throughout, laboratory studies tend to control external cues to attempt to study 
hormonal regulation of energy balance. However, the interaction of external cues and 
our hormonal/neural regulatory processes combine to ultimately result in feeding 
behaviours. In attempting to study these behaviours in a free-living environment we 
lose the ability to measure some aspects of appetite regulation (e.g hormonal 
responses) and lose precision in measuring the ultimate outcome we are interested in 
(energy intake). Future laboratory investigations should attempt to create as “natural” 
an environment as possible to allow the assessment of appetite in externally valid 
settings. For example, buffet style meals should be employed following extended 
morning fasting to establish if greater energy compensation occurs through selection 
of different food items at meals, as well as designs incorporating opportunities for 
snacking as well as meals.  
It is important to acknowledge that the work in this thesis is only a first step in 
attempting to establish the effects of breakfast consumption in energy balance and 
health. As discussed in the literature review and throughout, there is a paucity of 
literature examining the impact of extended fasting and as such this was the condition 
of most interest in the present work. Therefore, whilst there is little possible variability 
of the implementation of morning fasting, the potential for a multitude of different 
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breakfast conditions is apparent. The work in this thesis took a pragmatic approach to 
the prescription (or relative absence of) the breakfast intervention. Future 
investigations should examine the relative merits of varying compositions and sizes of 
breakfast in free-living individuals. Indeed, some emerging work is beginning this 
process (Adamsson et al., 2014; Rabinovitz et al., 2014), although the focus of these 
investigations have so far been on disease risk factors, studies examining control of 
energy balance with varying breakfast compositions warrants further attention.  
Future work should also attempt to further differentiate beyond the simple 
groupings (i.e lean or obese) used in these studies. As discussed in Chapter 1 both 
gender and dietary restraint may play a role in modifying appetite regulation. Neither 
of these factors were examined in the current investigation so it is currently unclear 
whether they may modify the response to either acute or chronic extended morning 
fasting. In the case of gender, the randomisation scheme accounted for gender to 
ensure equivalent distribution of males and females in each experimental group, so 
there is unlikely to have been any bias introduced due to imbalance of genders between 
experimental groups. With the effects of dietary restraint upon eating behaviours are 
far from clear (Martins et al., 2008; Johnson et al., 2012), future work should attempt 
to establish if responses to morning feeding interventions differ by comparing 
individuals with high and low dietary restraint (as opposed to simply excluding those 
displaying high restraint).      
As described in Chapter 7, breakfast consumption (as prescribed in this study) 
in obese individuals was associated with greater physical activity energy expenditure 
during the morning but also weight gain over the course of the intervention period. 
This weight gain could be suggested to be due to the size of the breakfast prescribed, 
and therefore future studies should aim to establish if a minimum size and/or specific 
composition of breakfast maintains physical activity levels but does not result in 
greater weight gain than omission of breakfast in obese individuals. High protein/fibre 
breakfasts are a promising first avenue for investigation due to their lasting effects on 
satiety (Hamedani et al., 2009; Leidy et al., 2013; Belza et al., 2013). 
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9.10  Conclusions 
 The work in this thesis has established that extended morning fasting is only 
minimally compensated for at an ad libitum lunch in both lean and obese individuals 
within a laboratory setting. Carbohydrate rich breakfast consumption causes differing 
hormonal and metabolic responses to a lunchtime meal, with opposing appetite 
hormone responses that are similar in both lean and obese individuals, with no 
difference in subjective appetite during the afternoon. In free-living individuals 
adhering to 6 weeks of morning fasting, physical activity was lower than those 
consuming breakfast, particularly in the morning. There was limited dietary 
compensation for the omission of breakfast in lean individuals but no difference in 
energy intake between the obese intervention groups. Daily extended morning fasting 
did not lead to significant weight gain in either lean or obese individuals. Markers of 
cardiovascular health were largely unaffected by either intervention, although there 
was some limited evidence of reduced free-living glycaemic control as a result of the 
fasting intervention in lean and differences in insulin response to an OGTT in obese 
individuals. Chronic adherence to either free-living intervention had little impact upon 
acute appetite regulation measured in a laboratory setting. 
 In conclusion, extended morning fasting does not appear to promote greater 
energy intake than breakfast consumption, but may limit physical activity to some 
extent. Chronic adherence to an extended morning fasting regimen does not result in 
clear deterioration of cardiovascular health markers and measures of 
glycaemic/insulinaemic control, and there does not appear to be evidence for the 
popular contention that breakfast skipping leads to weight gain. 
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Appendix 1: Example Breakfast  
 
Example breakfast as used for laboratory studies outlined in chapters 3, 5, 6 and 8: 
 
For an individual with an RMR of 1600 kcal·d-1, they would be provided with a 
breakfast in the quantities specified below: 
 
Braces White Bread: 60 g 
Kellogg’s Cornflakes: 40 g 
Sainsburys Semi-Skimmed Milk: 199 g 
Sainsburys Fresh Orange Juice: 157 g 
I Can’t Believe It’s Not Butter: 9 g 
Sainsburys Seedless Raspberry Jam: 11 g 
 
This breakfast provides: 
 
93 g Carbohydrate 
9.9 g Fat 
16.2 g Protein 
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Appendix 2: Obese Actiheart Inclusion Criteria 
 
When analysing the Actiheart daily physical activity data it was established 
that the data was not as robust as that collected for lean individuals. The data was 
therefore interrogated to establish if there could be some softening of the criteria so as 
not to substantially diminish the quality of the data obtained but allow more 
individuals to be included in the analysis. When doing this, the entire dataset was 
grouped (independent of experimental group allocation) to avoid knowledge of group 
results when adjusting inclusion criteria. Included on this (the original data inclusion 
criteria) and the next page (the revised inclusion criteria) are the obese dataset for 
Actiheart data depending on the processing method (either allowing a valid day of 
measurement to comprise daily wear time at a minimum of 90% and recovered data at 
22.5%, or the revised criteria of 85% and 30%, respectively. As can be seen, there is 
90/22.5 
criteria Week 1 Week 6   
Participant Days in Use EI Days in Use EI Mean of both weeks Acceptable data? 
8 7 725 5 657 691 Y 
13 7 2569 6 1633 2101 Y 
17 1 1453 5 1296 1375 N-Week 1 only 1 d 
22 7 821 0   821 N-Week 6  no data 
30 6 1767 6 1576 1671 Y 
38 7 700 7 623 662 Y 
43 0   0    N-No data 
45 4 911 7 1148 1030 Y 
46 0   3 1401 1401 N-Not enough days 
47 5 1220 3 1045 1132 N-Not enough days 
48 6 519 7 517 518 Y 
49 6 1129 6 1368 1248 Y 
51 7 895 7 816 855 Y 
52 2 1457 6 1446 1452 N-week 1 only 2 d 
54 7 724 7 909 817 Y 
55 7 304 5 521 413 Y 
56 1 812 5 804 808 N-Week 1 only 1 d 
57 5 317 5 524 420 Y 
58 3 489 6 611 550 N-Week 1 only 3 d 
60 7 1165 7 1227 1196 Y 
61 1 481 4 984 732 N-Week 1 only 1 d 
64 6 2728 6 2085 2406 Y 
65 7 927 7 1129 1028 Y 
Mean 4.7 1053.0 5.2 1062.9 1060.4 9 individuals excluded 
SD 2.6 653.0 2.0 429.1 521.3  
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very little difference in the mean (within 12 kcal for the group as a whole) and the SD 
(within 6 kcal). However, this revised criteria reduces the number of participants 
excluded from 9 to 4 for physical activity data. It should be noted that despite this 
change in criteria the average wear time of the devices for valid weeks of measurement 
was 97.3% of the day, with recovered data (as introduced in Chapter 2) only 
accounting for 4.6% of the day. Therefore these devices even with softened inclusion 
criteria for daily data quality are still providing a very comprehensive assessment of 






criteria       
 Days in Use EI Days in Use EI Mean of both weeks Acceptable data? 
8 7 725 5 657 691 Y 
13 7 2569 7 1626 2097 Y 
17 5 1390 5 1296 1343 Y 
22 7 821 0  821 N-Week 6  no data 
30 6 1767 6 1576 1671 Y 
38 7 700 7 623 662 Y 
43 1  0   N-No data 
45 4 911 7 1148 1030 Y 
46 0  7 1549 1549 N-Week 1 no data 
47 7 1022 4 1133 1078 Y 
48 6 519 7 517 518 Y 
49 6 1129 6 1368 1248 Y 
51 7 895 7 816 855 Y 
52 4 1627 6 1446 1536 Y 
54 7 724 7 909 817 Y 
55 7 304 6 490 397 Y 
56 3 697 6 764 731 N-Week 1 only 3 d 
57 6 329 7 478 403 Y 
58 4 586 6 611 598 Y 
60 7 1165 7 1227 1196 Y 
61 5 780 5 1020 900 Y 
64 6 2728 6 2085 2406 Y 
65 7 927 7 1129 1028 Y 
Mean 5.5 1063 5.7 1070 1072 4 individuals excluded 
SD 2.0 644.9 2.0 441.8 526.7  
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For the above outcomes there were no main effects of time or any time x group 
interaction effects observed (all p > 0.1). However, as described in Chapter 4 there 
were main effects of group observed for morning mean, peak and variability of glucose 
concentrations (all higher in the breakfast group). There was also greater glucose 











Overall Mean ±SD Mean ±SD Mean ±SD Mean ±SD
24 h mean glucose (mmol/l) 5.2 0.4 5.3 0.4 5.3 0.4 5.3 0.4
24 h peak glucose (mmol/l) 8.2 1.3 8.3 1.2 8.5 1.6 9.4 3.8
24 h glucose variability (SD) 0.7 0.2 0.7 0.2 0.7 0.2 0.8 0.3
24 h glucose variability (CV; %) 13 4 14 2 14 3 16 5
Morning
Waking until 1200 mean glucose (mmol/l) 5.3 0.5 5.5 0.5 5.0 0.4 5.1 0.5
Waking until 1200 peak glucose (mmol/l) 7.4 1.0 7.7 1.3 6.4 1.0 6.7 1.1
Waking until 1200 glucose variability (SD) 0.6 0.2 0.7 0.2 0.5 0.2 0.6 0.2
Waking until 1200 glucose variability  (CV; %) 12 3 13 3 10 4 11 4
Afternoon/Evening
1200 until bed mean glucose (mmol/l) 5.2 0.4 5.4 0.4 5.3 0.5 5.3 0.4
1200 until bed peak glucose (mmol/l) 7.7 1.1 7.9 1.3 8.2 1.2 9.1 3.9
1200 until bed glucose variability (SD) 0.7 0.2 0.7 0.2 0.8 0.2 0.9 0.4
1200 until bed glucose variability  (CV; %) 13.39 3.60 13.24 1.29 14.83 3.69 17.16 7.03
Nocturnal
Sleeping mean glucose (mmol/l) 5.1 0.5 5.2 0.4 5.2 0.5 5.2 0.5
Sleeping peak glucose (mmol/l) 6.9 0.9 6.9 0.9 7.0 1.3 7.4 1.6
Sleeping glucose variability (SD) 0.6 0.2 0.6 0.2 0.6 0.2 0.6 0.3
Sleeping glucose variability  (CV; %) 12 5 12 4 12 4 12 4
Wake-Up Time (hh:mm:ss) 07:21:30 00:41:03 07:33:04 00:42:33 07:26:34 00:45:32 07:15:07 00:35:31
Bed Time (hh:mm:ss) 22:46:12 00:40:17 22:18:43 00:49:23 22:52:15 00:35:11 22:35:53 00:55:45
Sleep Duration (min/night) 479 39 487 39 485 38 467 50
FASTING GROUPBREAKFAST GROUP
Week 1 Week 6 Week 1 Week 6
